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Introduction:  In developed nations like the United States of America, genetic counselors help 
patients understand the health implications of genetic information. However, in developing 
countries, overwhelming patient volumes and a lack of genetic providers has hindered the 
progression of genetics as part of patient evaluation. The goal of the present study is to 
implement genetic education in locations where practicing genetic counselors are unavailable to 
aid the physician in patient management. This pilot study focuses on ophthalmic genetics in nine 
eye clinics throughout India that requested such an intervention as part of a national research 
group in 2011. 
Methods:  The project consisted of two phases: education and implementation. The educational 
phase involved the creation and dissemination of an online training course designed for 
paramedical and health professionals. The course focused on the basics of genetics, 
communication of genetic concepts, and how to construct a three-generation pedigree. Pre- and 
post-test assessments were used to assess efficacy. A field trip to India to conduct in-person 
course review workshops was completed. The implementation phase allowed participants to 
integrate skills from the course into clinical practice for 6 months. After the implementation 
period, a second, non-interventional field trip to India allowed for clinical observations of patient 
pathway, content of interaction, and clinical supervision. Site supervisors were asked for 
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v 
feedback and to disclose any adverse events (defined as any negative event as a direct result of 
provision of genetic education) that occurred during the implementation period. 
Results:  Nine clinics in India completed the project. Average pre- and post-test score 
differences were statistically significant (p<0.05) in all modules. While all 9 centers have used 
genetic education with consistency, with pedigree-taking being the most widely implemented 
practice, 7 of 9 have sustained its use. Clinical observations revealed that all participants can 
construct three-generation pedigrees and zero adverse events were reported. 
Conclusion:  This pilot project is significant to public health because demonstrates an effective 
method of teaching the study population basic aspects of clinical genetics and that safe 
implementation of these skills with perceived benefit is realistic. Sustained implementation 
depends on a distinct patient pathway with defined responsibilities.
vi 
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1.0  INTRODUCTION 
This is a pilot study that aims to introduce genetic education in eye centers where formally-
trained genetic counselors and other genetic services are largely unavailable. We propose this to 
be possible by creating a subset of hospital employees (paramedical or other health 
professionals) as Genetic Educators through an online training course that teaches basic genetics 
as well as how to communicate the information to patients. Two major barriers to clinical 
genetics in developing countries are limited patient education and limited time. The purpose of 
Genetic Educators is informational in nature and they are not responsible for diagnosis, 
interpretation, or decision-making. This group of individuals is able to define and explain basic 
genetic terms to patients who may have minimal understanding, thereby preparing patients to 
receive inheritance counseling and medical evaluation from the physician. Genetic Educators are 
also trained to take detailed family histories in the form of a pedigree. This initial study takes 
place in eye clinics throughout India with the intent that the program can be modified to benefit 
other cultures and specialties in the future. 
1.1 SPECIFIC AIMS 
Plan:  To design an online genetics education course for paramedical/health professionals in 
selected Indian ophthalmic centers with the intent to equip participants with the knowledge and 
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skills to provide patients with basic, clinically-relevant genetic information. The course is to be 
disseminated online to study participants. It is not a specific aim of this project to train 
individuals to act as genetic counselors.  
Specific Aim 1:  To create an online education program that is effective in teaching our study 
population the basics of human genetics and how to communicate genetic information with 
patients. In order to evaluate the online course’s ability to increase participant knowledge of 
genetics, scores of pre- and post-test assessments are to be compared. The study staff 
hypothesizes a statistically significant difference between mean pre- and post-test scores for each 
module. This aim is to be furthered by the initial field trip to India to present the course review 
workshops in order to reinforce key concepts and to emphasize the role of the Genetic Educator. 
Specific Aim 2:  To have participants trained through the Genetic Educator Training Course 
implement the knowledge and skills into clinical practice. The study staff hypothesizes all 
centers will incorporate the training program uniquely in a way that benefits their current 
workflow. This is to be evaluated during the second, non-interventional field trip to India when 
Genetic Educator interactions are observed in clinic. 
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2.0  BACKGROUND AND SIGNIFICANCE 
2.1 INTRODUCTION OF GENETIC COUNSELING 
Clinical genetics is a rapidly-growing medical specialty in much of the developed world. The 
National Society of Genetic Counselors (NSGC) defines genetic counseling as the process of 
helping people understand and adapt to the medical, psychological, and familial implications of 
genetic contributions to disease. The process integrates i.) Interpretation of family and medical 
histories to assess the chance of disease occurrence or recurrence; ii.) Education about 
inheritance, testing, management, prevention, resources, and research; and iii.) Counseling to 
promote informed choices and adaptation to the risk or condition (Resta, et al., 2006). Genetic 
counseling takes a holistic approach, but revolves around the core components of collection of 
family history, review of medical history, establishment or verification of diagnosis, risk 
assessment, education, decision support, informed consent, genetic testing, and psychological 
counseling (Hahn, 2011). The concept of being able to receive genetic information and diagnosis 
at the same time as routine medical care burdens the patient with fewer obligations, which 
increases medical continuity (Salo-Mullen and Guillem, 2012). Overall, giving patients 
understandable genetics information improves their quality of care (Marks, 2004).  
A relatively new field, genetic counseling has grown from a primary focus in prenatal 
care to solid establishments in oncology, pediatric, and specialty practices (including 
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ophthalmology). In 2013, NSGC membership reached 2,960 individuals, reflecting the 
importance of giving genetics information to patients (Nagy, 2013).  
2.2 GENETICS COUNSELING EDUCATION PROGRAMS 
Since genetic counseling was established in the United States in the 1970s, at least 16 additional 
nations now offer Master’s level education programs in genetic counseling. Nationally-
recognized Master’s degree programs exist in Canada, Cuba, the United Kingdom, the 
Netherlands, France, Spain, Portugal, Israel, Norway, Japan, Taiwan, Korea, the Philippines, 
Saudi Arabia, South Africa, and Australia (TAGC, 2011). Other countries, including Finland, 
China, and India, are working toward developing more formal training programs to benefit their 
healthcare systems (Edwards, 2010).  
Genetic counseling education in much of North America and Europe must follow the 
guidelines and recommendations of established societies. These groups create proposed 
curriculums and core competencies for the profession. Both groups require the curriculum to 
include coursework on human genetics and psychosocial skills as well as clinical experiences 
through rotations under the supervision of genetic counselors (ACGC, 2014 and EBMG, 2014).  
North America currently has 35 graduate programs (USA: 32, Canada: 3) that offer Master’s 
degrees in genetic counseling. These programs are either fully or provisionally accredited by the 
Accreditation Council for Genetic Counseling (ACGC) (ACGC, 2014). In Europe, the European 
Board of Medical Genetics (EBMG) Genetic Counsellor Division has granted approval for 5 
genetic counseling Master’s programs. Two of these programs are located in the United 
Kingdom, whereas France, Spain, and Portugal each have 1 program (EBMG, 2014).  
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Countries with available clinical genetics services may not necessarily offer formal, 
specialized training programs in medical genetics or genetic counseling. Some of the reasons for 
this include a heavy burden of population, limited resources, and lack of available personnel. 
Genetics professionals in many of these countries often train in outside countries and then return 
to work in their home country. For example, the nations of Iceland and Turkey do not have 
training programs in genetic counseling (Stefandottir, et al., 2013; Yurdagül and Tekşen, 2013). 
Because of the small population size, Iceland does not have a graduate training program 
specifically for genetic counseling and depends on training programs in outside nations to train 
practicing counselors. In Iceland, genetic counseling technique is incorporated into the 
curriculums of medical and midwifery schools (Stefandottir, et al., 2013). 
2.3 GLOBAL CLINICAL GENETICS AND RESEARCH 
2.3.1 Global Clinical Genetics Services 
As clinical genetics in the United States of America and other nations continues to develop, 
expand, and specialize, its accessibility varies greatly worldwide. In the United States and 
Canada, genetics centers are often associated with academic settings where clinical services are 
integrated within the institutions (Battista, et al., 2012).  
  This is replicated in other developed nations such as Iceland where genetic services have 
been offered since 2002, combining laboratory and clinical services in a central institute 
(Stefandottir, et al., 2013). These services consist of 2 part-time medical geneticists, 1 full-time 
genetic counselor (formally trained at Cardiff University in the United Kingdom), 1 pediatric 
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medical geneticist and an oncologist also dedicates time to provide counseling for hereditary 
cancer syndromes. The population of Iceland is 325,671 and therefore a central institute is more 
easily accessible by everyone (Statistics Iceland, 2014). 
 While Cuba may not be considered a developed country economically, the medical 
infrastructure has allowed the implementation of genetics to reduce infant mortality caused by 
neural tube defects and to manage a founder population of sickle cell anemia, possibly related to 
the consanguinity rate which ranges from 1% to 11% nationwide (Cruz, 2013). By 1981, medical 
genetics grew beyond the capital city of Havana to a nationwide service (population: 11,047,251 
(CIA, 2014)), to offer prenatal genetic services, targeted newborn screening, and targeted 
molecular diagnostics for conditions common in Cuba (Cruz, 2013).  
 Saudi Arabia is considered a developed country, with a population of 27,345,986 (CIA, 
2014). It is highly conservative with traditions deeply rooted in Islam. One common social 
practice is consanguinity, which is estimated to be present in 56% of unions (Qadi, et al., 2013). 
Therefore, Saudi Arabia developed genetic services and genetic counseling due to the increased 
risk for autosomal recessive disease. The incidences of hemoglobinopathies are particularly high 
and led to the establishment of mandatory premarital screening for sickle cell disease and β-
thalassemia in 2005. Test results are connected electronically to marital courts and marriage 
certificates are only issued to couples that completed testing (Qadi, et al., 2013).  
 In Turkey, healthcare, including the provision of genetic services, is controlled by the 
Ministry of Health (Yurdagül and Tekşen, 2013). In a population of 74.7 million, the 
consanguinity rate is greater than 20%. Genetic counseling is available through 41 Turkish 
institutions, although it is performed by physicians or medical geneticists and not by genetic 
counselors. The main genetics services offered in Turkey are preconception carrier screening, 
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prenatal genetics, newborn screening, and cancer screening. The carrier screening is mainly 
focused on sickle cell disease and β-thalassemia (Yurdagül and Tekşen, 2013).  
2.3.2 Global Genetic Research Initiatives 
Many countries conduct genetic research to establish areas of need in public health and 
medicine. Cuba is an example of such an approach, conducting epidemiological studies 
addressing disability screening and genetic causes of intellectual disability. The results of these 
studies were used to assess the demand for genetic counseling services (Cruz, 2013). Others 
maintain databases for future research or for ancestry purposes, and Iceland is an excellent 
example where databases are focused on large family histories, cancer diagnoses, and other 
research studies (Stefandottir, et al., 2013).  
2.3.3 Genetic Counseling In India  
Genetic counseling is not a nationally recognized profession in India, as demonstrated by a lack 
of healthcare regulations or a professional organization. There are no organizations that establish 
requirements, guidelines, or core competencies in regards to who can provide genetic counseling 
and how it should be provided. Among the individuals that provide genetic counseling are 
clinical geneticists, ultrasound technicians, fetal medicine practitioners, pediatricians, 
gynecologists, and obstetricians (Elackett, 2013). These individuals may be trained abroad, 
trained informally, or self-trained. In this nation of 1.2 billion people, the 2nd largest in the world, 
there are 25 practicing genetic counselors (Elackett, 2013). 
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There has been an impetus to consider genetics as an aspect of public health in India with 
the motivation for disease prevention rather than treatment (Agarwal, 2009). In order to better 
establish clinical genetics, medical genetics information should be integrated into medical school 
curriculums as well as the creation of more specialized programs (Agarwal, 2009). Although 
there are no formal Master’s degree programs in genetic counseling in India, there are two 1-year 
certificate programs. Of the 25 practicing genetic counselors in India, 4 trained at institutions 
abroad while the others obtained post-graduate certificates, offered within hospital systems in 
Hyderabad and Bangalore. The Hyderabad certificate program in genetic counseling at Kamineni 
Hospital was established in 2007 and is modeled after the University of California, Irvine 
program in the United States. The certificate program in Bangalore at Manipal Hospital was 
established more recently in 2012 and is modeled after the Griffith University program in 
Australia. For both Indian programs, there is less emphasis on psychosocial counseling as this is 
considered a skill less needed by genetic counselors in India (Elackett, 2013). 
As far as other genetics professionals in India, there are 1,000 members of the Indian 
Society of Human Genetics, but only 50 of these individuals practice clinical genetics (Singh, et 
al., 2010). A total of 47 centers offer genetic diagnostic services including 40 that provide 
cytogenetic analysis, 28 that provide molecular testing, and 26 that provide prenatal diagnosis. 
Centers offering these services are responsible for varying numbers of patients ranging from 2.3 
million to 83 million individuals per center (Singh, et al., 2010). 
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2.4 GLOBAL OPHTHALMOLOGY 
2.4.1 Prevalence of Blindness 
Blindness is a significant burden worldwide. In 2010, World Health Organization estimated that 
blindness, defined as best correctable vision of 20/400, affects approximately 39.4 million people 
globally. Another 246 million people are affected by low vision, defined as best correctable 
vision between 20/60 and 20/400 (Mariotti. 2010). Among children, the prevalence of blindness 
is approximately 0.7 in 1000 (Rahi, et al., 1999). At least half of the cases of childhood blindness 
have a genetic cause (Graw, 2003). Although it is less common in children than in adults, 
childhood blindness has more long-term and widespread effects encompassing the family, 
education, employment, and social arenas (Rahi, et al., 1999). 
India contains a sizeable percentage of the world’s blind. There are 320,000 blind 
children in India, which exceeds the number of blind children in any other country. This number 
is 22.86% of the world’s blind children (Bhattacharjee, et al., 2008). In total, India’s blind 
inhabitants account for 20.5% of world blindness (with 8.1 million blind people), even though 
India’s population only accounts for 17.5% of the world population. There a further 54.5 million 
people with low vision in India (Mariotti, 2010).  
2.4.2 Financial Burden of Blindness 
Blindness and low vision services also put a significant financial burden on society. A proposed 
method of quantifying the cost of the blind to society is the loss of gross national product (GNP) 
caused by inability to initiate or continue income-generating employment. Combining the effects 
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of childhood and adult blindness worldwide, this ranges from $167.5 billion to $243.9 billion 
USD yearly (Smith and Smith, 1996). This burden continues to grow as the world population and 
life expectancy both increase (WHO, 2006). 
2.4.3 Congenital ocular malformations 
Congenital ocular malformations occur with an incidence of 6 in 10,000 births (Siddiqui, et al., 
2012). While the cause of many ocular malformations remains unknown, genetic etiologies 
(single gene defects and chromosomal abnormalities) account for the majority of known causes, 
including 39.13% of all congenital ocular malformations (Bermejo and Martinez-Frías, 1998). 
Studies in India have suggested rates of congenital ocular malformations ranging from 
0.75 in 1,000 births to 10.5 in 1,000 births (Stoll, et al., 1992; Singh, et al., 1980). Reported 
incidence rates vary depend on study methodology and geographic region. In a study of 12,337 
live births in South India, congenital ocular malformations occurred in 1.64 in 1,000 births, 
where microphthalmia was the most commonly seen anomaly (Ravikumara and Bhat, 1996). The 
incidences reported in India are generally comparable to incidences reported elsewhere. 
However, with a population of over 1.2 billion, the burden of ocular malformations is much more 
significant.  
2.5 OPHTHALMIC GENETICS 
Approximately one-third of all genetic disorders include eye abnormalities and there are over 
170 known heritable ocular genetic conditions (MacDonald, et al., 2004; McKusick, et al., 
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1994). However, because genetic eye disorders are specific in nature and therefore it is beneficial 
to have specialized genetic counselors with a deeper knowledge of ophthalmic conditions to best 
explain the details to patients in lay terms (Sutherland and Day, 2009). Even in developed 
countries such as Canada, this specialized genetic counseling service has an 18-month waiting 
list for individuals that need an appointment (Sutherland and Day, 2009). 
The American Academy of Ophthalmology (AAO) has newly established guidelines for 
clinical genetic testing of inherited eye conditions. The AAO views genetic testing as a medical 
intervention with great potential benefit. However, it also involves some degree of risk and 
should be accompanied by skilled counseling (either by a knowledgeable physician or genetic 
counselor). A main recommendation is that if a physician lacks formal knowledge of genetics 
and genetic testing, a referral to a certified genetic counselor is advised (Stone, et al., 2013). 
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3.0  METHODS 
This was a descriptive and interventional pilot study approved by the University of Pittsburgh 
Institutional Review Board (IRB) with Exempt Status as an Educational Curriculum on March 
26, 2013 (PRO13020479). A modification was approved on May 16, 2013 (See Appendix A). 
Letters of Permission were obtained from each center or hospital in India granting the University 
of Pittsburgh to conduct the present study. Each location met with an ethics review board 
individually and concluded that formal review for participation in the study was not required 
(See Appendix B). A diagram of the full study layout including participant actions is displayed in 
Figure 1.   
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Figure 1. Layout of study schedule 
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3.1 SELECTION OF CENTERS AND PARTICIPANTS 
Centers participating in this study had expressed interest in developing a component of genetic 
evaluation in their clinics and thus, participation was voluntary. Although ten centers expressed 
an interest, nine centers completed the project:  Dr. Shroff Charity Eye Hospital in New Delhi, 
All India Institute of Medical Sciences (AIIMS) in New Delhi, LV Prasad Eye Institute (LVPEI) 
Main Campus in Hyderabad, LVPEI-Vizag Campus, LVPEI-Vijayawada Campus, LVPEI-
Bhuvaneshwar Campus, Post Graduate Institute of Medical Education and Research (PGIMER) 
in Chandigarh, Aravind Eye Hospital in Madurai, and Narayana Nethralya in Bangalore. 
Each center had one designated site supervisor who was asked to identify one to three 
individuals employed as paramedical or health professionals to participate. Since the course and 
other correspondence was to be in the English language, each participant was required to be able 
to read and understand English. In total, 26 individuals were given Study ID numbers to 
complete the online training course. During the course of the project, one participant and center 
withdrew from the study and one site supervisor left his position during the course of the study. 
Table 1 provides a summary of centers and participants for the online course and their locations 
in India (Figure 2). 
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Table 1. Centers participating in online course 
CITY INSTITUTION # OF PARTICIPANTS 
Bangalore Narayana Nethralya 1 
Bhubaneswar LVPEI-Bhubaneswar† 3* 
Chandigarh PGI MER 2* 
Hyderabad LVPEI-Main Campus† 2 
Madurai Aravind Eye Hospital 4* 
Mumbai Aditya Jyot Foundation 1‡ 
New Delhi All India Institute of Medical Sciences (AIIMS) 3* 
New Delhi Dr Shroff Charity Eye Hospital 4** 
Vijayawada LVPEI-Vijayawada† 3* 
Visakhapatnam LVPEI-Vizag† 3* 
Total Participants: 26 
* Indicates that a site supervisor (** = 2 supervisors) is included as a participant  
The site supervisor at LVPEI-Bhubaneswar left his position during the present study 
† LVPEI = LV Prasad Eye Institute 
‡ This participant was unable to attend review workshop and was excluded from data 
analysis after knowledge assessments 
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Figure 2. Map depicting locations of centers able to complete full study  
3.1.1 Informed Consent 
Since the current study was accepted under “Exempt Status,” formal informed consent was not 
required from participants. Participants were informed of the commitment expectations as well 
as risks and benefits of participation via a script that preceded the first page of the first online 
questionnaire (See Appendix C). As delineated by the University of Pittsburgh Institutional 
Review Board, the script included the following:  the word “research,” expected study duration, 
subject responsibilities, risks and benefits, how confidentiality will be maintained, voluntariness 
and the ability to withdraw, and the e-mail address of a contact person. 
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3.2 ONLINE COURSE DEVELOPMENT 
3.2.1 Module Topics and Information Presentation 
A projected timeline for the online component of the study was seven weeks. The course, titled 
the Genetic Educator Training Course, was modular in format (seven modules in total) with each 
module available online for one week. The content of course modules 1 through 5 was based on 
major concepts in molecular, human, and ophthalmic genetics while modules 6 and 7 focused on 
interacting and communicating with patients. Titles of all modules are displayed in Table 2. The 
Core Competencies in Genetics for Health Professionals outlined by the National Coalition for 
Health Professional Education in Genetics (NCHPEG) were considered in the creation of the 
course and basic content from introductory undergraduate and graduate genetics courses was also 
included. Information was presented in clear and simple terms recognizing that English was not 
the first language of the participants.  
 
Table 2. Module titles 
Module Title 
Module 1 Molecular Biology 
Module 2 Cell Cycle & Genetics 
Module 3 Inheritance   
Module 4 Mutations and Genetic Testing  
Module 5 Inherited Congenital Anomalies of the Eye 
Module 6 Talking to a Patient I:  Patient Education Basics  
Module 7 Talking to a Patient II:  Taking a Family Pedigree 
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An international advisory committee was formed in order to ensure that all material 
within the course lectures was accurate, easily understandable, and culturally sensitive. The 
advisory committee consisted of 6 individuals: 2 pediatric ophthalmologists (one practicing in 
the USA, one practicing in Portugal), 2 ophthalmic genetic counselors, a medical geneticist that 
previously practiced ophthalmology in India, and a genetic counseling program director that has 
conducted extensive research in India. These individuals were integral in creating an informative 
course that was culturally sensitive. Examples of edits included removal of American slang 
language and presenting X-linked inheritance in a more objective fashion that minimized the 
possibility of guilt and blame of females. In addition to the advisory committee, we were also in 
contact with site supervisors that helped devise the timeline and logistics of the project. This 
helped ensure that the course was realistic for participants. 
The modules were narrated, animated lectures created using Microsoft PowerPoint and 
converted into video files (See Appendix D). This presentation allowed participants to both hear 
and see the written language to maximize understanding and accommodate different individual 
learning styles. Each module began with a title slide followed by a slide outlining the purpose 
and objectives for the current module. The remaining slides included informational text 
accompanied by simple illustrations and animations when possible. The lectures were posted as 
videos and participants were able to pause and rewind in order to repeat portions as needed. 
Video lengths ranged from roughly 7 minutes to roughly 19 minutes. 
3.2.2 Generation of Study ID Numbers 
Study ID numbers were used to as a way to track responses over the course of the project. ID 
numbers were created and assigned to each participant using an online random number generator 
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(http://www.mathgoodies.com/calculators/random_no_custom.html). Each number was 
generated using a lower limit of 1000 and an upper limit of 1999. Participants were informed of 
their study ID numbers via email along with the initial information regarding participation in the 
online course. Participants were required to enter their assigned number at the beginning of each 
online questionnaire. 
3.2.3 Questionnaires 
Questionnaires included a demographic questionnaire, pre- and post-test knowledge assessments 
for each module (1-7), and follow-up questionnaires. (See Appendix E for knowledge 
assessments and Appendix F for demographic and follow-up questionnaires). All questionnaires 
were created for the purposes of this study. None of the surveys were validated largely due to the 
inclusion of fact-based questions. They questionnaires were posted online via SurveyMonkey®, 
a website easily accessible to participants. The first question in each survey asked for participant 
Study ID numbers so that responses could be correlated to the correct individual and reminders 
could be sent for completion of tasks. 
The demographic questionnaire was distributed to participants at the beginning of the 7-
week course, immediately before Module 1. This questionnaire gathered information about 
participants’ history (education, job title, number of years employed), practice (patient volume 
per day), and knowledge and comfort levels regarding genetics.  
Each online module was preceded by a 15-question pre-test knowledge assessment and 
followed by the same 15-question post-test assessment. This allowed a comparison between 
baseline knowledge and knowledge gained following the educational presentations.  
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Identical follow-up questionnaires were repeated at three time points:  immediately 
following the 7th and final online module (“post-course”), following the course review 
workshops (“post-workshop”), and after the study staff observed utilization of skills in the clinic 
(“final”). The follow-up questionnaire echoed many questions from the demographic 
questionnaire, in order to determine if answers regarding patient volume, comfort, and 
knowledge of genetics changed, and if so, at which time point. These questionnaires also 
included an additional section of questions that serve as a course evaluation. Using a Likert 
scale, a previously validated method of measuring attitudes (Likert, 1932), participants were 
asked to describe how the training program affected their professional development, 
understanding of genetics, communication skills, and confidence, as well as their opinions on 
genetics and integrating the practice into their workflow. The response categories were as 
follows: 1 = Strongly Disagree; 2 = Moderately Disagree; 3 = Neutral/Don’t Know; 4 = 
Moderately Agree; 5 = Strongly Agree. 
3.2.4 Webpage Hosts and User Interface 
Materials were hosted online through two websites due to differences in Information Technology 
permissions between participating centers. Both websites created URLs (2 per week) only 
accessible by having the link and not able to be navigated to through the main website 
homepages. These hosts were World Society of Paediatric Ophthalmology and Strabismus 
(WSPOS) as an Area of Research Collaboration (aRc) and University of Pittsburgh Graduate 
School of Public Health’s Department of Human Genetics. All questionnaires including pre- and 
post-test knowledge assessments, demographic questionnaires, and follow-up questionnaires 
were created and housed online through SurveyMonkey® (http://www.surveymonkey.com).  
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Participants were emailed weekly with URLs to a landing page for the current module, 
with the option to complete the module through either WSPOS or the Department of Human 
Genetics. The landing pages provided a link to the SurveyMonkey® pre-test knowledge 
assessment. At the conclusion of the pre-test survey, users were automatically redirected to the 
website containing the educational video presentation and links to the SurveyMonkey® post-test 
knowledge assessment. Finally, users were re-directed back to the original landing page to 
confirm that they had completed all actions necessary for the module. 
Module completion was tracked using Study ID numbers in SurveyMonkey® results. 
Individuals who had not completed the current module were sent up to two reminder emails per 
week, as necessary. Once all post-test assessments were completed, participants were emailed 
with their score expressed both as number correct out of 15 and as a percent. Answer keys were 
attached to result emails that included justification for each correct answer and explanation for 
each incorrect answer (See Appendix E).  
3.3 ACTIVITIES IN INDIA 
3.3.1 Course Review Workshops 
Following the 7-week online course, the study staff traveled to India to offer two-day course 
review workshops in two locations. Participants and supervisors were asked to attend the 
location that was most convenient for them. One workshop was held in southern India in 
Hyderabad at LV Prasad Eye Institute’s Main Campus and one in northern India in New Delhi at 
Dr Shroff Charity Eye Hospital. It was important that the information be reviewed, but more 
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important for participants to understand the duties and limitations associated with the Genetic 
Educator role. 
Prior to the workshops, participants were asked to complete a short survey to identify the 
three course modules that were the most challenging. Data was collected separately for each 
location. This information was used to indicate which modules should be addressed more 
intensely during the review. However, all modules were reviewed at both workshops with 
particular emphasis on collecting pedigrees. Centers were also requested to formally delineate 
current patient pathways and their proposed pathways to incorporate genetic education.  
A major portion of the format was reviewing the training course slides, interjecting 
multiple-choice questions to assess retention of important concepts. Participants were also 
broken into partners and small groups to do some communication activities. They were asked to 
discuss how they might explain genetic concepts to patients (chromosomes, gene, inheritance 
patterns, etc.) and to then present it to the full group. The last piece of the review workshop was 
to practice eliciting pedigrees from a patient. Pre-conceptualized scenarios were role-played 
between participants in pairs and as a group with study staff and participants. This focused on 
using accurate pedigree notation and symbols and asking the right questions appropriately to 
collect the necessary information. 
Following the workshop, participants were asked to complete the follow-up questionnaire 
second time. Additionally, participants that successfully completed all 7 online educational 
modules and attended a review workshop received a certificate of completion (See Appendix G). 
Certificates were emailed to site supervisors to distribute amongst the participants at their 
centers.  
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3.3.2 Clinical Observations 
After the review workshops, sites were asked to implement genetic education into their workflow 
to the extent they were comfortable. It was suggested for the purposes of personal audit that each 
participating center keep a de-identified logbook of patients that received genetic education. 
Approximately six months after implementation, the study staff traveled to India to observe 
Genetic Educators interacting with patients at 6 sites: PGIMER in Chandigarh, Dr Shroff Charity 
Eye Hospital and AIIMS in New Delhi, Aravind Eye Hospital in Madurai, LVPEI-Main Campus 
in Hyderabad, and Narayana Nethralya in Bangalore. Two sites (LVPEI-Bhubaneswar and 
LVPEI-Vijayawada) that could not be physically visited due to time and financial constraints had 
evaluations via teleconference. Genetic educators from LVPEI-Vizag traveled to LVPEI-Main 
Campus for assessment.  
The purpose of clinical observations was to assess the patient pathway including routine 
of referral, presence or absence of dedicated space, relationship of site supervisor to educator, 
method of pedigree obtainment, and content of the interaction. Site supervisors were also asked 
to disclose any occurrences of adverse events, defined as any negative event occurring as a 
direct result of genetic education during the 6-month implementation period. Clinical visits 
also allowed for the opportunity for participants and supervisors to comment on their experiences 
and perceived impact of the project. 
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3.4 STATISTICAL ANALYSIS 
Statistical analysis was performed on responses to SurveyMonkey® questionnaires using 
descriptive statistics. SurveyMonkey® tabulates some basic statistics automatically such as 
averaging response values and the remaining tests were performed using Microsoft Excel®. 
First, knowledge assessment scores were examined to determine if there was a significant 
difference between pre- and post-test knowledge assessment scores. For each educational 
module, the mean pre-test score was compared with the mean post-test score using two-tailed t-
tests, where significance was defined as a p-value of less than 0.05. 
Likert scale questions in the series of follow-up questionnaires were assessed by 
frequency and averaged. Two-tailed t-tests were performed to compare responses to the same 
questions between different time points. Although the questionnaires asked participants to rank 
their agreement with statements using a scale from 1 (Strongly Disagree) to 5 (Strongly Agree), 
the rating scale used for statistical analysis was as following: 0=Strongly Disagree, 
1=Moderately Disagree, 2=Neutral/Don’t know, 3=Moderately Agree, 4=Strongly Agree. This 
statistical rating scale was used to be consistent with the statistical analysis of other questions in 
this study. Again, significance was defined as a p-value of less than 0.05. 
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4.0  RESULTS 
4.1 DEMOGRAPHICS 
4.1.1 Education  
The demographic survey revealed the highest level of formal education achieved by study 
participants and is summarized in Table 3. The most common education level achieved by 
participants was a Bachelor’s degree in Optometry or Ophthalmic Techniques (11 out of 26, 
42.3%). 
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Table 3. Participant demographics: Education 
HIGHEST LEVEL OF EDUCATION # OF PARTICIPANTS 
Higher secondary 1 
Diploma in Optometry 3 
Bachelor’s Degree 11 
Optometry or Ophthalmic Techniques (9)  
Nursing (1)  
Physics (1)  
Master’s Degree 3 
Optometry or Ophthalmology (2)  
Sociology (1)  
PhD 2 
MD in Ophthalmology 4 
Fellowship in Pediatric Ophthalmology 1 
DNB, FRCS 1 
Total Participants 26 
4.1.2 Workplace  
Participants were asked about their current employment status. Job titles among participants 
included consultant, optometrist, ophthalmologist, professor, intern, scientist, sister (equivalent 
to nurse), and technician. The number of years employed at current workplace averaged 6.19 
years, ranging from 0 to 18 years.  
 Participants were asked to estimate the number of total patients seen per day at their 
clinic or institute. The average patient volume was 196 patients per day; however, there was a 
wide range in responses, with estimates from 5 to 1,000 patients per day. When asked how many 
patients per day a participant was individually responsible for, the average patient load was 34 
patients per day. 
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4.1.3 Baseline Genetics Knowledge and Practice  
The demographic questionnaire, administered prior to the modular course was a baseline 
assessment of the participants’ current knowledge and practice of genetics. 
 First, participants were asked to rank their knowledge of genetics, ranging from No 
Knowledge, Very Poor, Satisfactory, Good, to Very Good (Figure 3). The most frequent answer 
was “Satisfactory,” accounting for 42.3% (11 of 26) of responses. The remaining answers 
represented a lower self-assessment of knowledge (11 of 26, 42.3%) than a high self-assessment 
of knowledge (4 of 26, 15.4%). Of note, no participants considered their current knowledge of 
genetics to be “Very Good.” 
 
Figure 3. Demographic questionnaire: Response to “How would you rank your knowledge of genetics?” 
 
Participants were asked if they received formal genetics education. Of the 26 participants, 
3 (11.5%) reported formal training, in which a one-year ocular genetics fellowship and a genetics 
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To assess the availability of genetic services in the selected institutions prior to this 
project, participants were asked if they were aware of any genetics clinics within their 
workplace. Twelve out of 26 (46.2%) were aware of a genetics clinic in their institute and 14 out 
of 26 (53.8%) were not aware of such a clinic. 
Participants were asked to rate their comfort approaching genetic issues with patients, 
ranging from Very Comfortable, Comfortable, Neither Comfortable Nor Uncomfortable, 
Uncomfortable, or Very Uncomfortable (Figure 4). Fourteen of 26 participants (53.8%) indicated 
they felt “Comfortable” approaching these issues. Of note, one participant (3.8%) reported to be 
“Very Comfortable” discussing genetics issues with patients. Nine participants (34.6%) reported 
being “Neither Comfortable Nor Uncomfortable,” 2 participants (7.7%) reported being 
“Uncomfortable,” while zero participants reported being “Very uncomfortable.”  
 
 
Figure 4. Demographic questionnaire: Response to “In general, how comfortable do you feel with dealing 
with genetics issues with your patients?” 
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Last, two items asked participants about their current clinical practice, including the 
frequency of collecting family health histories and discussing genetics with patients. Regarding 
the frequency of collecting health histories, the most common answer was “Always,” chosen by 
11 out of 26 individuals (42.3%). Nine participants (34.6%) reported collecting family histories 
“Often,” 5 participants (19.2%) reported “Sometimes,” and 1 participant (3.8%) specified 
“Never.” All responses are shown in Figure 5. Regarding the frequency of discussing genetics 
with patients, the most commonly selected answers were “Only if the patient has a genetic 
condition” (8 of 26, 30.8%), and “Occasionally, but only if there seems to be a good reason for 
it” (7 of 26, 26.9%). One participant (3.8%) reported “Never,” 5 participants (19.2%) reported 
“Often, whenever it seems appropriate,” 3 participants (11.5%) reported “Mostly it is my usual 
practice,” and 2 participants (7.7%) reported “Almost always, with almost all patients when 
taking a medical history.” All responses to this question are shown in Figure 6. 
 
 
Figure 5. Demographic questionnaire: Response to “How often do you complete a family history for a 
new patient?” 
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Figure 6. Demographic questionnaire: Response to “In your practice, how often do you discuss genetics 
with a patient?” 
 
4.2 MODULE KNOWLEDGE ASSESSMENTS 
Throughout the educational course, 7 knowledge assessments were administered before and after 
each module. All assessments included 15 fact-based items, which were identical pre- and post-
module. All 26 course participants successfully completed all of the pre-test and post-test 
knowledge assessments.  
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determine whether scores differed between pre-test and post-test assessments, a two-tailed t-test 
was performed. Statistical significance was indicated by a p-value less than 0.05. The test scores 
for each module are shown in Figure 7. All seven modules showed a statistically significant 
difference between average pre-test scores and average post-test scores, where the post-test 
demonstrated higher scores.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Summary of knowledge assessment scores.  
P-values for each module are indicated below module number. * indicates statistical significance. 
*3.903×10-6 *2.495×10-7 *3.823×10-4 *7.905×10-7 *6.105×10-9 *4.022×10-4 *1.581×10-5 
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4.3 REVIEW WORKSHOPS 
The first field trip to India (to Hyderabad and New Delhi) occurred 1 week after participants 
completed the online course. At the Hyderabad workshop, 15 individuals (participants and site 
supervisors) attended the workshop in person and 3 individuals attended via teleconference. At 
the New Delhi workshop, 7 individuals were present.  
The workshops focused on reviewing the course, including slideshow presentations of the 
information presented in each module. Multiple-choice questions were distributed throughout 
each module for reinforcement. The questions did not repeat those that were asked on the 
knowledge assessment questionnaires. As part of the course debriefing, role-playing of drawing 
complex pedigree was performed but no data was actively collected. 
4.4 CLINICAL OBSERVATIONS 
4.4.1 Overview 
Clinical observations were carried out by the study staff 6 months after genetic education was 
initiated in the clinics. Genetic Educators from all 9 sites were observed totaling 16 in number 
(the 9 site supervisors were not observed and 1 original participant from the online course failed 
to complete all requirements). The Genetic Educators were observed in person at 6 sites (Dr 
Shroff Charity Eye Hospital, AIIMS, Aravind Eye Hospital, Narayana Nethralya, PGIMER, and 
LVPEI-Main Campus). The Genetic Educators from the LVPEI-Vizag satellite location traveled 
to LVPEI-Main Campus in Hyderabad to see patients and be observed. The Genetic Educators 
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from the remaining 2 LVPEI satellite locations (Vijayawada and Bhubaneswar) were observed 
through video teleconference. The staff observed 16 Genetic Educators interact with 2-4 patients, 
depending on the clinic load. In total, 45 patient encounters were observed over the course of the 
trip. 
It was noted how each center was implementing genetic education into their workflow 
and comments from participants and supervisors were collected regarding their experience with 
the project as well as its perceived impact. Supervisors also expressed their thoughts on potential 
future studies or extension studies regarding genetic education. 
Although not a requirement, some centers tracked patient interactions with Genetic 
Educators during the implementation period through de-identified logbooks.  Across all centers, 
the logbooks documented a total of 497 patient encounters. 
4.4.2 Workflow 
Each site utilized Genetic Educators in a manner that was appropriate based on clinic 
responsibilities and workflow, as determined by site supervisors. Descriptions of patient 
pathways for each participating center are summarized in Table 4. 
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Table 4. Patient pathways at participating centers 
 
AIIMS* 
Genetic Educator seeks patients in separate clinic à Pedigree taken in private, but not 
dedicated room à Pedigrees kept in notebook, not in patient chart 
Aravind Eye Hospital (Genetics Clinic held 2 days/week) 
 
Referral (physician may draw out pedigree relationships) à Pedigree taken (or health 
history elicited for each individual on pedigree drawn by physician) in private, 
dedicated room 
Dr Shroff Charity Eye Hospital (Genetic Educators each see patients 2 days/week) 
Referral à Genetic Educator appointment created à Pedigree taken and explanation 
of genetic concepts as necessary in private, dedicated room à Pedigree placed in 
patient chart à Patient attends remaining appointments 
LVPEI (4 locations)* 
Referral à Pedigree taken (often while dilating or during imaging appointments) in 
private, but not dedicated room à Pedigree placed in patient chart à Physician 
documents pedigree is done and provides interpretation 
Narayana Nethralya* 
Genetic Educator travels from remote location as needed à Pedigree taken in a 
private, but not dedicated room à Pedigree not maintained in patient chart à Blood 
drawn for future genetic studies 
PGIMER (Genetic Educator sees patients for a half day on Fridays) 
Referral à Genetic Educator reviews chart à Pedigree taken in semi-private, 
dedicated room à Pedigree placed in patient chart à Patient returns to waiting room 
for other appointments à Physician reviews pedigree and provides necessary 
counseling 
* These locations do not have a specific time dedicated to genetic education. 
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4.4.3 Pedigrees 
For the centers that have been using genetic education, pedigrees are the most commonly applied 
skill in clinic. A majority of the sites (7 out of 9) maintained pedigrees created by Genetic 
Educators as part of the patient’s permanent medical record. Dr Shroff Charity Eye Hospital 
created its own standardized pedigree form, which is used for all genetic education patients (See 
Appendix H). 
All Genetic Educators were observed taking pedigrees. Of the 45 patient encounters 
observed, 45 3-generation pedigrees were obtained (100%). In encounters, ocular histories on 
family members were elicited (100%) and 32 encounters (71.1%) included additional, extra-
ocular information. Eleven of 45 encounters (24.4%) elicited information about miscarriages and 
39 of 45 encounters (86.7%) elicited information about consanguinity. 
4.4.4 Impact  
Through conversation and informal interview with Genetic Educators and site supervisors, the 
perceived impacts of the project were collected on observation visit days. These informal 
interviews were performed based on availability and thus not all participating individuals were 
available to answer each question. Genetic Educators or site supervisors from 7 out of 9 centers 
expressed that implementing genetic education has benefited their clinic or patient population in 
some capacity. PGIMER stated that it increased awareness of genetics among physicians and 
fellows, as they are now identifying patients for whom genetic education is appropriate.  Four 
site supervisors stated that it has increased the overall efficiency and throughput of the clinic.  
No site supervisor volunteered the need to repeat pedigrees taken by Genetic Educators.  
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Implementation of genetic education has also been perceived to benefit the patients. Prior 
to implementation, patients had little to no awareness of genetics. It was also mentioned that it 
enabled clinicians to reach out to other family members that may need ophthalmic evaluation; a 
striking example of this was at PGIMER, where systematic pedigree taking allowed clinics to 
identify a large pedigree with developmental glaucoma and affected individuals were being seen 
by up to 5 different attendings. Once this scenario was realized, the family members were able to 
see the same ophthalmologist who was able to personalize treatment as a result. 
Negative impacts were also reported. The site supervisor at AIIMS feels that Genetic 
Educators are currently interrupting the clinic because an established workflow has not been put 
into place, speculating that an established workflow would allow them to see a greater positive 
impact. The Genetic Educator trainees at AIIMS feel that their current workload is too great for 
implementation at this time but would be possible once a pathway is established and more 
trainees are added. 
There is also a notion that this research project has large potential impact for the future. 
The site supervisor from AIIMS felt that the results of this study may be used as “ammunition” 
to justify further development of clinical genetics in Indian ophthalmic centers.  
4.4.5 Genetic Educator Feedback 
Genetic Educators were asked to provide open-ended feedback about all aspects of the project. 
The Genetic Educators feel that they are increasing their professional skill sets and feel value in 
doing so. They feel they are becoming better at obtaining relevant histories compared to before 
the project when they were only asking basic questions about the proband. As they continue to 
practice, they are becoming more comfortable in their role and are able to ask more sophisticated 
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questions to collect better information. At least 3 Genetic Educators expressed interest furthering 
their education by pursuing formal training in either medical genetics or genetic counseling. 
The Genetic Educators noted challenges that they have experienced over the course of the 
project. Genetic Educators expressed difficulty in addressing miscarriages and consanguinity 
while taking a pedigree. They expressed interest in learning different approaches in how to 
broach these topics because while they may be uncomfortable, they are crucial for accurate 
pedigree interpretation. They also felt that introducing the purpose of the pedigree to the patient 
is a challenge. Sometimes it was difficult for the patient to understand the utility of this form of 
history taking. Lastly, they have had issues when patients with home internet access attempt to 
seek out information on diagnoses. This often led to patients asking complex questions which 
must be deflected to the physician.  
4.4.6 Site Supervisor Feedback 
In addition to elaborating on the perceived impact of the course, site supervisors were asked 
about their level of confidence in interpretation of pedigrees. They were also asked for general, 
open-ended feedback. These informal interviews were performed based on the availability of the 
supervisors and thus not all supervisors were available to answer each question. 
Most supervisors were interested in a course designed specifically for ophthalmologists 
on pedigree interpretation (5 centers). The primary goal of this course would be to maximize the 
clinical utility of the pedigrees obtained by Genetic Educators. Two supervisors, with formal 
training in genetics, did not feel this would be of personal benefit, but one indicated that it would 
be of benefit to other physicians at his institute. 
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Interest was also expressed for repeating this course so that the centers can increase their 
number of trained Genetic Educators. Three centers were interested in growing their number of 
trained Genetic Educators. The supervisor of LVPEI-Main Campus stated that he envisions 
running his clinic with 7-8 Genetic Educators. Four centers (AIIMS, Dr Shroff Charity Eye 
Hospital, LVPEI-Main Campus, and LVPEI-Vizag) suggested that when repeating the course, 
more emphasis should be placed on pedigrees and less emphasis on the molecular basis of 
genetics. The supervisor from AIIMS thought it would be beneficial to have the course presented 
in person, rather than online. The suggestion entailed offering a two-day in-person course at 3 
times so that multiple individuals from a center could participate without having to cancel full 
clinic days. 
4.5 FOLLOW-UP QUESTIONNAIRE SERIES 
4.5.1 Response Rate 
The series of three follow-up questionnaires were distributed post-course, post-workshop, and 
post-observations (final). All 26 participants (100%) completed the post-course questionnaire, 23 
participants completed the post-workshop questionnaire (88.5%), and 25 participants (96.2%) 
completed the final questionnaire. 
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4.5.2 Patient Volume 
The three follow-up questionnaires in conjunction with the demographic questionnaire were 
designed to evaluate the effect of added genetic education tasks on average patient volume. The 
average number of patients seen by each individual per day (34 patients) remained the same after 
6 months of implementation as it was prior to the initiation of this project.  
4.5.3 Genetics Knowledge, Comfort, and Practice  
The series of 3 follow-up questionnaires repeated the questions from the demographic 
questionnaire regarding genetics knowledge, comfort, and practice. The repeated questions were 
“How would you rank your knowledge of genetics?”, “How comfortable do you feel with 
dealing with genetics issues with your patients?”, “How often do you complete a family history 
for a new patient?”, and “In your practice, how often do you discuss genetics with a patient?” 
Responses to each question were compared using two-tailed t-tests (with statistical significance 
defined as a p-value less than 0.05) to see if responses were significantly different at separate 
time points. T-tests compared the following time points: (1) demographic and post-course, (2) 
post-course and post-workshop, and (3) post-workshop and final. For statistical analysis, the 
most negative response category was scored as 0 and increased in increments of 1 for each 
subsequent response category.  
Two t-tests yielded statistical significance. First, responses to the question “How would 
you rank your knowledge of genetics” in the demographic questionnaire were significantly 
different than the responses to the question in the post-course questionnaire. Comparison of 
responses between these time points showed that the average knowledge of genetics among 
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participants was significantly higher at the time of the post-course questionnaire as compared to 
the demographic questionnaire (p=7.31x10-7). Second, the responses to the question “How 
comfortable do you feel with dealing with genetics issues with your patients?” in the 
demographic questionnaire were significantly different than the responses to the question in the 
post-course questionnaire. Comparison of responses between these time points showed that the 
average knowledge of genetics among participants was significantly higher at the time of the 
post-course questionnaire as compared to the demographic questionnaire (p=1.19x10-4). 
These significant values are indicated in the following table using an asterisk (*). All 
other t-tests did not show statistical significance at any time point. A breakdown of these 
questions examining the proportion of positive responses is available in Figures 8-11 and 
complete summary of responses is available in Table 5. 
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Figure 8. Analysis of responses to How would you rank your knowledge of genetics? 
 
 
Figure 9. Analysis of responses to How comfortable do you feel with dealing with genetics issues with 
your patients? 
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Figure 10. Analysis of responses to How often do you complete a family history for a new patient? 
 
 
Figure 11. Analysis of responses to In your practice, how often do you discuss genetics with a patient? 
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Table 5. Responses to selected questions from demographic and follow-up questionnaires 
 
*denotes statistical significance between responses of two time points, defined as p-value <0.05 
 
 
How would you rank your knowledge of genetics? 
 
 
No 
Knowledge Very Poor Satisfactory Good Very Good 
Demographic* 2 (7.7%) 9 (34.6%) 11 (42.3%) 4 (15.4%) 0 (0%) 
Post-Course* 0 (0%) 0 (0%) 7 (26.9%) 17 (65.4%) 2 (7.7%) 
Post-Workshop 0 (0%) 0 (0%) 6 (26%) 12 (52.2%) 5 (21.7%) 
Final 0 (0%) 0 (0%) 5 (20%) 15 (60%) 5 (20%) 
      
How comfortable do you feel with dealing with genetics issues with your patients? 
 
 
Very 
Uncomfortable Uncomfortable 
Neither 
Comfortable 
nor 
Uncomfortable Comfortable  
Very 
Comfortable 
Demographic* 0 (0%) 2 (7.7%) 9 (34.6%) 14 (53.9%) 1 (3.9%) 
Post-Course* 0 (0%) 0 (0%) 2 (7.7%) 14 (53.9%) 10 (38.5%) 
Post-Workshop 1 (4.5%) 0 (0%) 1 (4.6%) 14 (63.6%) 6 (27.3%) 
Final 2 (8%) 0 (0%) 3 (12%) 13 (52%) 7 (28%) 
      
How often do you complete a family history for a new patient? 
 
 Never Sometimes Often Always  
Demographic 1 (3.9%) 5 (19.2%) 9 (34.6%) 11 (42.3%)  
Post-Course 6 (19.2%) 5 (19.2%) 7 (26.9%) 8 (30.8%)  
Post-Workshop 2 (8.7%) 7 (30.4%) 3 (13%) 11 (47.8%)  
Final 0 (0%) 5 (20%) 6 (24%) 14 (56%)  
      
In your practice, how often do you discuss genetics with a patient? 
 
 Never 
Only if the 
patient has 
a genetic 
condition 
Occasionally, 
but only if 
there is a 
good reason 
Often, 
whenever 
appropriate 
Mostly, it is 
my usual 
practice 
Almost 
always, with 
almost all 
patients 
Demographic 1 (3.9%) 8 (30.8%) 7 (26.9%) 5 (19.2%) 3 (11.5%) 2 (7.7%) 
Post-Course 1 (3.9%) 10 (38.5%) 0 (0%) 7 (26.9%) 2 (7.7%) 6 (23.1%) 
Post-Workshop 0 (0%) 8 (34.8%) 0 (0%) 5 (21.7%) 4 (17.4%) 6 (26.1%) 
Final 1 (4%) 4 (16%) 3 (12%) 7 (28%) 6 (24%) 4 (16%) 
      !
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4.5.4 Course Evaluation 
A course evaluation was administered in the follow-up questionnaires at all three time points. It 
was composed of seven Likert scale questions that asked participants to consider how this project 
affected their professional development and the perceived value to both their patients and to 
themselves. 
For all seven statements, participants responded most frequently with Moderately Agree 
and Strongly Agree. T-tests were performed comparing responses between (1) post-course and 
post-workshop, (2) post-workshop and final, and (3) post-course and final.  
Responses to statement 3, “This training program helped me to communicate basic 
inheritance patterns to patients,” in the post-workshop questionnaire (n=23, 88.5% response rate) 
were significantly different from the responses in the final questionnaire (n=25, 96.2% response 
rate). Comparison of responses between these time points showed a statistically significant 
difference in average attitudes between post-workshop the final questionnaire with respect to the 
ability of communicating basic genetic information to patients  (p=0.04).  
A breakdown of these questions examining the proportion of positive responses (Agree or 
Strongly Agree) is available in Figures 12-18 and complete summary of responses to these 
questions is available in Table 6, where significance is indicated using an asterisk (*).  
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Figure 12. Analysis of attitudes toward This training program advanced my professional development. 
Figure 13. Analysis of attitudes toward This training program increased my knowledge and 
Figure 14. Analysis of attitudes toward This training program helped me to communicate 
basic inheritance patterns to patients. 
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understanding of genetics.
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Figure 15. Analysis of attitudes toward I feel confident in my ability to provide basic 
genetic education to patients. 
Figure 16. Analysis of attitudes toward Providing patients with basic genetic education 
fits into the workflow of our clinic. 
Figure 17. Analysis of attitudes toward Basic genetic education benefits the 
patients to whom I provide it. 
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Figure 18. Analysis of attitudes toward It is important to stay current on  
fundamental information in inherited genetic disease. 
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1. This training program advanced my professional development. 
 1 2 3 4 5 
Post-Course 0 (0%) 0 (0%) 1 (3.9%) 8 (30.8%) 17 (65.4%) 
Post-Workshop 0 (0%) 0 (0%) 1 (4.4%) 5 (21.7%) 17 (73.9%) 
Final 0 (0%) 0 (0%) 1 (4%) 5 (20%) 19 (76%) 
      
2. This training program increased my knowledge and understanding of genetics. 
 1 2 3 4 5 
Post-Course 0 (0%) 0 (0%) 0 (0%) 8 (30.8%) 18 (69.2%) 
Post-Workshop 0 (0%) 0 (0%) 1 (4.4%) 3 (13%) 19 (82.6%) 
Final 0 (0%) 0 (0%) 2 (8%) 5 (20%) 18 (72%) 
      
3. This training program helped me to communicate basic inheritance patterns to patients. 
 1 2 3 4 5 
Post-Course 0 (0%) 0 (0%) 1 (3.9%) 9 (34.6%) 16 (61.5%) 
Post-Workshop* 0 (0%) 0 (0%) 1 (4.4%) 3 (13%) 19 (82.6%) 
Final* 1 (4%) 0 (0%) 2 (8%) 9 (36%) 13 (52%) 
      
4. I feel confident in my ability to provide basic genetic education to patients. 
 1 2 3 4 5 
Post-Course 0 (0%) 0 (0%) 0 (0%) 10 (30.8%) 16 (61.5%) 
Post-Workshop 0 (0%) 1 (4.4%) 0 (0%) 5 (13%) 16 (69.6%) 
Final 0 (0%) 0 (0%) 1 (4%) 9 (20%) 15 (60%) 
      
5. Providing patients with basic genetic education fits into the workflow of our clinic. 
 1 2 3 4 5 
Post-Course 0 (0%) 1 (3.9%) 4 (15.4%) 10 (38.5%) 10 (38.5%) 
Post-Workshop 0 (0%) 1 (4.4%) 1 (4.4%) 9 (39.1%) 12 (52.2%) 
Final 0 (0%) 0 (0%) 1 (4%) 12 (48%) 12 (48%) 
      
6. Basic genetic education benefits the patients to whom I provide it. 
 1 2 3 4 5 
Post-Course 0 (0%) 0 (0%) 1 (3.9%) 12 (46.2%) 13 (50%) 
Post-Workshop 0 (0%) 1 (4.4%) 1 (4.4%) 8 (34.8%) 13 (56.5%) 
Final 0 (0%) 0 (0%) 0 (0%) 10 (40%) 15 (60%) 
      
7. It is important to stay current on fundamental information on inherited genetic disease 
 1 2 3 4 5 
Post-Course 1 (3.9%) 0 (0%) 0 (0%) 4 (15.4%) 21 (80.8%) 
Post-Workshop 0 (0%) 0 (0%) 0 (0%) 2 (8.7%) 21 (91.3%) 
Final 0 (0%) 0 (0%) 1 (4%) 2 (8%) 22 (88%) !
Table 6. Course evaluations 
*denotes statistical significance between responses of two time points, defined as p-value <0.05 
1 = Strongly Disagree, 2 = Moderately Disagree, 3 = Neutral/Don’t know, 4 = Moderately 
Agree, 5 = Strongly Agree 
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5.0  DISCUSSION 
5.1 CONSIDERATION IN PROGRAM DESIGN 
This project was designed and implemented at the request of a group of medical professionals 
interested in having more accessible clinical genetics services within Indian eye clinics. Lack of 
access to genetic services across India is outlined in existing literature and acts as a needs 
assessment for such services. Many studies, although small in number and focused on a single 
disease, have been conducted in locations in many regions of India demonstrating the need for 
genetic counseling or similar services in areas with limited access. These authors share 
conclusions of a need for genetic counseling as well as a need for genetic awareness in India 
based on India being a developing country, high birth rate, low literacy and socioeconomic 
status, absence of widely available genetic testing, and the existence of molecular laboratories 
without genetic counseling staff members (Ramprasad, et al., 2007; Mohanty and Das, 2011; 
Verma, et al., 2012; Kumar, et al., 2012; Muthuswamy, 2011).  
In order to ensure the highest cultural awareness and competence possible, an 
international advisory committee was formed to review and edit all course materials. This was 
felt to be important because previous studies have demonstrated the diversity of ethnic groups in 
India as well as risks associated with interventions performed without careful considerations 
(Mohanty and Das, 2011). Over 4,635 ethnic groups make up the population of India, and thus 
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many considerations went into the design of this project. A study within tribals of India by 
Mohanty and Das in 2011 concluded that sophisticated and intricate exploration of psychosocial 
and cultural aspects considered before implementing counseling in tribals of India  (Mohanty and 
Das, 2011). This statement may be generalized that cultural considerations should be explored 
before implementing any change in another nation. Without these considerations, projects may 
carry great risk of adverse events and/or unintended outcomes. Furthermore, The National 
Society of Genetic Counselors (NSGC), in 2010, informally proposed two ideas to aid in 
incorporating greater diversity and cultural competence into the field of genetic counseling. One 
proposed creating a network to share cultural information with applicable counseling strategies 
that included experiences as they are gained. The other was to develop a standard of 
multicultural competencies, similar to the NSGC code of ethics that outlines the minimum 
requirements for cultural competency in education programs (Warren, 2011). 
It was decided that this project would be disseminated in an online, modular presentation 
format as previous studies with pre- and post-test assessments as other studies have shown 
success in using this type of course for medical students and primary care physicians to increase 
confidence, comfort, and competency in the subject. This has been done successfully through 
different delivery models including online programs and in-person workshops (Carroll 2007; 
Metcalf 2010). 
5.2 SPECIFIC AIM 1: EFFICACY OF EDUCATION PROGRAM 
A total of 26 individuals took part in the online training course and all participants were able to 
complete all tasks on time suggesting that the format and timeline were realistic for our study 
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population. Our hypothesis for Aim 1 was supported in that the online education program 
showed a statistically significant difference between pre- and post-test knowledge assessment 
scores for each module. The statistically significant differences in scores between pre- and post-
test knowledge assessments are an indication that the educational video modules were a 
successful method in teaching the information to our study population. The efficacy of this 
online education program is consistent with a previous study that used a modular online course 
to teach genetics to medical students. This study also saw a statistically significant difference 
between pre- and post-test scores for all modules (Metcalf, et al., 2009). These results suggest 
that Specific Aim 1 was successfully achieved. 
5.3 SPECIFIC AIM 2: IMPLEMENTATION 
As shown by logbooks maintained by a subset of participating centers, Genetic Educators saw a 
cumulative total of 497 patients during the implementation period, which is likely an 
underestimate. Our hypothesis for Aim 2 was supported by the way that sites implemented skills 
from the education program based on their clinical workflows. For two centers, implementation 
was initiated but not sustained for reasons to be discussed later. In centers that have routinely 
implemented genetic education, this project has been of benefit, as described by participants and 
site supervisors. Therefore, we can conclude that uptake of implementation occurred in 100% of 
centers, but sustained implementation has occurred in 77.8% of centers. In the 7 out of 9 of 
centers where implementation has been sustained, a distinct clinical flow pathway had been 
constructed, with Genetic Educators working in the same clinics as the site supervisors. In the 2 
centers where implementation was not sustained, no specific patient flow had been delineated 
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and the Genetic Educators worked in clinics remote from the site supervisors. We conclude, 
therefore, that the success of sustained implementation is dependent on a proposed protocol for 
delivery of genetic education with Genetic Educators working in close proximity, if not the same 
clinic, as the site supervisor. 
Centers that have not been using Genetic Educators formally thus far do note that they 
are in the process of creating a protocol to implement. Busy clinics and limited personnel are 
current barriers. Challenges associated with adding genetic service provision duties onto the 
existing responsibilities of physicians have been reported. In a systematic literature review, 
Suther and Goodson reveal that the most frequently described barrier is lack of genetic 
information (2003). However, lack of time was a common barrier among 4 of 18 studies 
reviewed (Suther and Goodson, 2003).  
5.4 DATA EVALUATION 
Two questions achieved statistical significance between the demographic questionnaire and post-
course follow-up questionnaire. These questions were “How would you rank your knowledge of 
genetics?” and “How comfortable do you feel with dealing with genetics issues with your 
patients?” Knowledge and comfort in genetics increased significantly following the online 
education course as demonstrated by analysis of questionnaire responses. Comparison of 
responses of these questions between other time points did not yield statistical significance and 
analysis of all other demographic/follow-up questions was not significant across any of the 
assessed time points.  
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Likert scale responses to the statements included in the series of follow-up questionnaires 
served as course evaluation. Answers closer to 1 (Strongly Disagree) indicated a more negative 
opinion while answers closer to 5 (Strongly Agree) indicated a more positive opinion. For all 
statements, the large majority of individuals moderately or strongly agreed while relatively few 
individuals were neutral or disagreed. This suggests that participants viewed the project 
positively overall. 
5.5 COMMENTS AND OBSERVATIONS  
5.5.1 Factors Influencing Degree of Implementation 
All centers were asked to implement an in-person service delivery model for genetic education; 
however, the efficient patient pathways between the participating centers are not identical.  This 
approach was reasonable as in-person service delivery is the most common method of providing 
genetic counseling services in the United States, despite the unique and individual needs for the 
included organizations (Cohen et al., 2013).  
Following clinical observations, it was clear that degree of implementation varied across 
participating centers. The exposure to Genetic Educators was greater where (1) a patient pathway 
was established including designated time and space for genetic education and (2) direct 
supervision of the Genetic Educator by the site supervisor. There are three main ways in which 
centers in the current study are utilizing genetic education. The first method utilizes the Genetic 
Educator on an on-call basis where any physician within the center can refer a patient as 
necessary. Genetic education can then occur in a dedicated and private space. The second 
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method designates certain clinic days each week to genetic education patients. The last method 
integrated responsibilities of genetic education into the pre-existing duties of the Genetic 
Educator. An example of this included taking a pedigree and providing genetic education during 
an appointment to obtain imaging or testing. The need for integration of responsibilities has been 
described in the context of a neurogenetics clinic, a medical specialty with expanding genetics 
knowledge similar to ophthalmic genetics. It has been suggested that individuals with 
neurogenetics training (training in both the medical specialty of neurology and in genetics) 
provide more effective and efficient patient care than having separate neurologists and medical 
geneticists. (Hanna and Wood, 2002). 
Some centers implemented genetic education in a specialized outpatient clinic with a high 
incidence of genetic disease, such as pediatric glaucoma clinic, pediatric retina clinic, and adult 
retina clinic. Centers where the Genetic Educator’s primary responsibilities were within the 
clinic where genetic education was introduced also affected the degree of implementation.  
In eye clinics where the above two criteria were not met, patient exposure to Genetic 
Educators was decreased. Other factors that were observed in these centers included Genetic 
Educators having to leave their main duties to provide genetic education in other clinics or 
working in a different location. These are barriers to implementation of genetic services within 
ophthalmic clinics that, to our knowledge, have not been previously described. 
5.5.2 Educational Content and Family History Taking 
In 45 patient encounters, a 3-generation pedigree was collected in all cases, but genetic concepts 
were explained in only 8. This discrepancy cannot be easily explained, although lack of time, 
comfort, and assumed patient understanding are possible barriers; the clinical utility of 
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explanation of genetic concepts may be less important clinically, and its emphasis in the course 
should be re-evaluated.  
History of miscarriage was directly addressed in only 11 of 45 encounters. Inclusion of 
miscarriage in health history taking was reviewed in Module 6 of the course due to the 
associations of miscarriages with chromosomal abnormalities and perinatal lethal conditions. 
Genetic Educators felt uncomfortable asking about miscarriages but stated that it was not due to 
any specific cultural aspect. Further education regarding the clinical importance of miscarriages 
in family history taking may be necessary to better equip Genetic Educators to broach this issue 
with patients. 
In all encounters, ocular histories were asked of family members while gathering 
pedigree information. However, only 32 encounters elicited extra-ocular history. The differences 
in diversity of questions provide insight on the way that specific clinics evaluate medical 
histories to establish diagnoses, management and treatment. Questions to collect information 
during pedigree taking were often generalized.  
5.5.3 Cultural Themes 
Cultural themes became apparent during family history taking across participating centers, with 
the main issue being the subject of consanguinity. The major cultural groups in India, Hindu and 
Muslim, have strong views on consanguinity and the distribution of these two groups varies 
based on geographic region. In the Hindu tradition consanguineous marriages are opposed 
(except in regions of South India, specifically Andhra Pradesh, where LVPEI centers are located) 
while in Muslim tradition they are common and preferred (Sathyanarayana Rao, et al., 2009). 
This affected the way in which consanguinity was addressed or not addressed by Genetic 
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Educators. A striking example of this was in New Delhi, where patients of Hindu origin were not 
asked about consanguinity for fear of causing offense, while patients of Muslim faith were 
repeatedly asked for possibility of consanguinity—not only in the parental union, but also in 
previous generations. In eye clinics serving a large, regional population in which Hindus and 
Muslims are both represented, the Genetic Educators used cultural indications such as name and 
appearance to determine which group a patient belonged.  
In southern India, consanguinity rates reach as high as 36.5% in the state of Andhra 
Pradesh, where most of the LVPEI centers are located (Bittles and Black, 2013). Due of this, 
some Genetic Educators based in these regions misinterpreted the purpose of taking a pedigree as 
being related to the high rate of consanguinity. Here, the Muslim population was in the majority 
so consanguinity was often assumed. Consanguinity was asked about in session to identify 
potentially multiple consanguineous marriages within a family. In summary, one important point 
to consider when implementing genetic education across India, is the importance of promoting 
distance from cultural stereotypes as they may limit patient care. It was stressed that it is 
important to address consanguinity with every patient, regardless of cultural norms. 
5.5.4 Adverse Events 
Site supervisors were asked to inform us of any adverse events as a direct result of genetic 
education. As part of the observational period, all supervisors were asked directly about the 
occurrence about adverse events and none were reported.  
 Anecdotally, people have had reservations about doing such interventions because of the 
risk for adverse events. This is the first study to our knowledge that has used informal interview 
to document the presence or absence of adverse events as a result of the implementation of 
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genetics education. The absence of adverse events in this study suggests that interventions can be 
successful if proper precautions are considered. 
5.5.5 Feedback from Genetic Educators and Site Supervisors 
During the second field trip, informal interview allowed for feedback from Genetic Educators 
and site supervisors. Their comments can generally be categorized into positive impact of the 
project, barriers, and implications for the future.  
Many positive comments were received regarding the impact of the current study. The 
most frequent comment shared between participating centers is that implementation of this 
program increased the throughput and efficiency of clinics. Other comments mentioned 
increasing awareness of genetics not only among other staff members, but also increasing 
awareness of genetics among patients. This is a shared goal of other similar clinics. At the Ocular 
Genetics Program within the Hospital for Sick Children in Toronto, Ontario of Canada, one of 
the main program goals is to increase patient knowledge of genetics (Morad, et al., 2007). 
 In addition to conclusions drawn from data, participants and supervisors also verbalized 
some perceived barriers to extent and consistency of implementation. These included 
interrupting heavy clinical flow and discomfort broaching potentially uncomfortable topics with 
patients.  
 In terms of implications for the future, this is two-fold. First, the project has generated an 
interest in multiple participants to continuing education in genetic counseling or medical 
genetics. Interest from the medical community in genetics and genetic counseling is an important 
step in initiating clinical genetics services. In the United Kingdom, genetics services in a primary 
care setting have been able to be provided by nurses with a specific interest in genetics 
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(Westwood, et al., 2006). Second, a supervisor feels that this pilot study is an early step in 
justifying the need for wider development of ophthalmic genetics in India.  
5.6 FUTURE STUDIES 
Due to the documented improvements in genetic education of paramedical health staff 
participating in this pilot study, the 100% implementation rate of genetic education and the 
perceived improvement in patient care, it is clear that a similar course could be repeated. When 
repeated, the course should focus less on molecular genetics and more on clinical applications. 
The in depth background information was not necessary for the way in which genetic education 
was implemented through the current project. Resources can be provided to any individual 
interested in learning that information.  
Since the most widely implemented skill has been pedigree-taking, the new course should 
increase emphasis on this, including more complicated cases. Additional focus should be placed 
on more detailed medical history taking including symptom-based questions of both ocular and 
systemic features. Participants have also expressed desire to learn more strategies in explaining 
why pedigrees or genetic education is of benefit to a patient as well as strategies to ask about 
uncomfortable topics like miscarriages and consanguinity. More emphasis must also be placed 
on the role of the Genetic Educator, outlining what is within their responsibilities and what has to 
be deferred to physicians.  
The accuracy of pedigrees obtained during the implementation period was not analyzed. 
This accuracy would be defined as use of standard pedigree conventions as detailed by Bennett, 
et al (1995). Our group plans to obtain a number of pedigrees from each participant for analysis 
  59 
by an independent observer. This study would serve as an indirect measure of the ability of 
present study to effectively teach standardized pedigree notation. 
When asked directly, a site supervisor expressed interest in the potential for this course to 
be offered in person, rather than online. Another supervisor suggested included providing 
incentive for participants, as some had to cover the cost of travel to the workshop out-of-pocket. 
Genetic Educator duties often did not replace but were added onto pre-existing clinic 
responsibilities; compensation was suggested as a motivating factor. 
There is a current plan to repeat the course in India before launching programs in other 
countries. Repeating the course in India will allow participation of other centers as well as pilot 
centers to train additional individuals. It is important that the study be replicated with success 
within the same nation before altering the course to accommodate other cultures or medical 
subspecialties.  
There is also interest in the creation of a course for site supervisors and physicians in 
pedigree interpretation. Many physicians are not absolutely confident in their ability to analyze 
complex pedigrees. It is felt that a course that details complex analysis would help these selected 
eye clinics utilize pedigrees in patient care. Concepts that could be covered include variable 
expressivity, penetrance, age of onset, anticipation, sex-limited traits, skewed X inactivation, 
gonadal mosaicism, de novo mutations, regions of homozygosity, and founder effect. Other 
programs in the United States have provided similar education to physician’s assistants, 
nutritionists, dentists, and other medical groups as continuing education as clinical genetics 
services have become more prevalent in medicine (NCHPEG, 2014). This shows that there is a 
need for such education in both developed and developing countries.   
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5.7 CONCLUSION 
Overall, this pilot study was successful in introducing a clinical service that was not previously 
offered or uniformly available in the participating institutes. The education course was effective 
in teaching participants the information contained in the seven course modules, as shown by 
statistically significant improvements in test scores from pre-tests to post-tests. Implementation 
has been ongoing for over six months and there have been no adverse events reported from 
patients or colleagues, which provides support that this service can be provided safely. The 
majority of centers have implemented the pedigree aspect of this course rather than the 
explanation of genetics concepts. This was dependent on workflow of the clinic and the 
confidence of the Genetic Educator. Of note, all participants are able to construct at least 3-
generation pedigrees through conversation with patients. It is clear that for successful, sustained 
implementation, the following are necessary: (1) an established patient pathway with designated 
space and/or time for genetic education, and (2) direct supervision of the Genetic Educator by the 
site supervisor. At every stage of this course, it was apparent that the Genetic Educators did not 
attempt counseling and understand the gravity of inappropriate counseling interactions. The 
overall opinion of the course, as gathered by evaluations and informal interviews, is positive. It 
appears the greatest perceived benefit to physicians is the increased efficiency of clinic, 
demonstrated by the number of pedigrees obtained and less professional time spent detailing 
patient histories. The goal of this project was met in that the results show that an online course 
was sufficient to teach paramedical and health professionals to provide basic genetic services in a 
manner that is safe and of perceived benefit to clinical flow and patient care.  
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UNIVERSITY OF PITTSBURGH INSTITUTIONAL REVIEW BOARD APPROVAL 
 
 
 
 
 
University  of  Pittsburgh
Institutional  Review  Board
3500  Fifth  Avenue
Pittsburgh,  PA  15213
(412)  383-­1480
(412)  383-­1508  (fax)
http://www.irb.pitt.edu
Memorandum
     
To: Dr.  Kanwal  Nischal
From: Sue  Beers  ,  Ph.D.,  Vice  Chair
Date: 3/26/2013
IRB#: PRO13020479
Subject: Providing  basic  genetics  education  to  to  paramedical/health  professionals  at  selected  Indian
ophthalmic  centers
The  above-­referenced  project  has  been  reviewed  by  the  Institutional  Review  Board.    Based  on  the
information  provided,  this  project  meets  all  the  necessary  criteria  for  an  exemption,  and  is  hereby
designated  as  "exempt"  under  section
45  CFR  46.101(b)(1)  Educational  strategies,  curricula  or  classroom  management  methods
.
Please  note  the  following  information:
If  any  modifications  are  made  to  this  project,  use  the  "Send  Comments  to  IRB  Staff"  process
from  the  project  workspace  to  request  a  review  to  ensure  it  continues  to  meet  the  exempt
category.
Upon  completion  of  your  project,  be  sure  to  finalize  the  project  by  submitting  a  "Study
Completed"  report  from  the  project  workspace.
Please  be  advised  that  your  research  study  may  be  audited  periodically  by  the  University  of  Pittsburgh  Research
Conduct  and  Compliance  Office.
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University of Pittsburgh .GraduateSchool of PublicHealth
Departmentof HumanGenetics
Date: I. M1'te.C.,. 20t3.
LETTER OF PERMISSION
I, rt'j)F. g. V. A:zAD . , herebygive permissionto the Universityof
Pittsburgh to conduct the study "Providing basic genetic education to
paramedical/health professionals at selected Indian ophthalmic centers" with employees
of my center. I also give permission to the study staff to personally visit my center as
outlined in the project methods. Any specific visitor policies will be made available to the
study staff.
I have read the description of the project in its entirety and believe that the study staff is
taking the necessary steps to ensure that its execution is culturally competent and
appropriate for taking place in India.
Check one below:---
L The IRS or Ethics Committee of my center has been consulted on this project
and DOES NOT require review in order for our employees to participate.
The IRS or Ethics Committee of my center has ~en consulted on this project
and DOES require review in order for our emplo~ees to participate.
Signature:
Center:
PROF. RAJVARDHAN AZAD
CHIEF
Dr. R.P. Centre for Ophthalmic-Sciences
AI/MS, NewDelhi-110029
Unin:rsity of Pius burgh 1130 De Soto Street 1PiUsburgh, PA 152131 United States of America I LOP Page 1 of 1
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University of Pittsburgh 
Graduate School of Public Health 
Department of Human Genetics !
University of Pittsburgh | 130 De Soto Street | Pittsburgh, PA 15213 | United States of America     | LOP Page 1 of 1 
Date: _________________ 
LETTER OF PERMISSION 
I, _______________________________, hereby give permission to the University of 
Pittsburgh to conduct the study “Providing basic genetic education to 
paramedical/health professionals at selected Indian ophthalmic centers” with employees 
of my center. I also give permission to the study staff to personally visit my center as 
outlined in the project methods. Any specific visitor policies will be made available to the 
study staff. 
I have read the description of the project in its entirety and believe that the study staff is 
taking the necessary steps to ensure that its execution is culturally competent and 
appropriate for taking place in India. 
Check one below: 
_____ The IRB or Ethics Committee of my center has been consulted on this project 
and DOES NOT require review in order for our employees to participate. 
_____ The IRB or Ethics Committee of my center has been consulted on this project 
and DOES require review in order for our employees to participate. 
Signature: ____________________________________ 
(Site supervisor representing the below center) 
Center:   ____________________________________ 
5 March 2013
Prof G Kumaramanickavel
Narayana Nethralaya, Bangalore and Aditya Jyot Hospital, Mumabi, India.
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Urr iversi ty of  P i t tsburgh
(lraduatc School o1'  Publ ic I- lcal th
Department of '  IJuman Genetics
Date: a:lp:Lr^r2T-/
LETTER OF PERMISSION
:reby give permission to the University of
asrc genetic education to
I  Ind ian ophthalmic enters"  wi th  employees
tudy staff to personally visit  my center as
;  v i i i tor  po l ic ies wi l l  be made avai lab le to  the
study staff.
I  have read the descript ion of the project in i ts entirety and believe that the study staff is
taking the necessary steps to ensure that i ts execution is cultural ly competent and
appropr ia te for  tak ing p laee in  Ind ia '
Check one below:
he IRB or  Eth ics Commit tee of  rny center  has been consul ted on th is  pro ject
and DOES NOT require review in order for our employees to part icipate'
The IRB or Ethics Committee of my center has been consulted on this project
and DoES require review in order for our employees to part icipate.
Signature:
Center:
t - r n i ' c r s r t y  o f  p i r r s b g r g h  |  1 3 0  D c  5 o 1 6  S r r c c r  l P i r t s t r u r g h .  P A  1 5 2 1 3 l L r n i t c d  S t a t c s  o f ' A t t t s - t t c a  I  L O P  P a g e  
' l  o f  1
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Date: 4th March 2013 
LETTER OF PERMISSION 
I, Dr. Suma Ganesh, hereby give permission to the University of Pittsburgh to conduct 
the study “Providing basic genetic education to paramedical/health professionals at 
selected Indian ophthalmic centers” with employees of my center. I also give permission 
to the study staff to personally visit my center as outlined in the project methods. Any 
specific visitor policies will be made available to the study staff. 
I have read the description of the project in its entirety and believe that the study staff is 
taking the necessary steps to ensure that its execution is culturally competent and 
appropriate for taking place in India. 
Check one below: 
√_____ The IRB or Ethics Committee of my center has been consulted on this project 
and DOES NOT require review in order for our employees to participate. 
_____ The IRB or Ethics Committee of my center has been consulted on this project 
and DOES require review in order for our employees to participate. 
Signature: 
 ____________________________ _______ 
(Site supervisor representing the below center) 
Center: Dr. Shroff’s Charity Eye Hospital 
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SCRIPT FOR PARTICIPANTS 
Dear Course Participant, 
This genetics course is part of a research study that assesses the effectiveness of an online 
program to teach paramedical/health professionals about basic genetics and inherited ophthalmic 
conditions.  We plan to use three types of questionnaires, which will be administered throughout 
the 7-week course. 
If you are willing to participate, this first questionnaire will ask you about your work 
environment and responsibilities.  At the beginning of each weekly module, you will be asked to 
complete a knowledge assessment.  This allows us to measure your baseline knowledge of the 
information that is about to be presented.  We do not expect you to answer all of the questions 
correctly and no grade or score will be provided.  After completing the week’s module, you will 
be asked to complete another knowledge assessment.  After this assessment, you will receive a 
test score and feedback about each of your answers will be provided.  After the course, you will 
be asked to rank the 3 lectures you found most challenging and to complete a follow-up 
questionnaire. 
Shortly after the conclusion of the online course, some of the course administrators will travel 
from Pittsburgh to India.  You will have the opportunity to discuss the course material in detail 
prior to applying the content to your job responsibilities in your workplace. 
You may benefit from participating by gaining knowledge and skills that expand the services of 
your clinical practice. There are no foreseeable risks associated with this project. Your 
confidentiality will be maintained by a unique login ID that will allow you to access the course 
and questionnaires. You will not receive payment for participating.  Participation is voluntary 
and you may withdraw from the project at any time. This study is being conducted by Dr. Ken K. 
Nischal, a pediatric ophthalmologist, and Holly Babcock of the University of Pittsburgh, who 
can be contacted at heb36@pitt.edu with any questions. 
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GENETIC EDUCATOR 
TRAINING COURSE 
University of Pittsburgh Graduate School of Public Health  
World Society of Paediatric Ophthalmology and Strabismus 
                                                                      UPMC EYE CENTER    
MODULE 1: 
MOLECULAR BIOLOGY 
Module 1 
Purpose:   
To provide a foundation of basic molecular biology concepts 
 
Objectives: 
Upon completing this module, participants should be able to: 
1.  Identify the functions of DNA, RNA, and Protein 
2.  Compare and contrast DNA and RNA 
3.  Explain the Central Dogma of Molecular Biology 
Basic Molecules of Life 
•  All living things are made up cells containing basic 
organic molecules  
•  Some of the most important organic molecules are: 
•  Nucleic Acids (DNA and RNA) 
•  Proteins 
•  This module will focus on these molecules, as they 
relate to human genetics 
Human Cell Diagram 
CYTOPLASM 
NUCLEUS 
DNA 
CELL MEMBRANE 
Protein 
RNA 
mito
cho
ndri
a 
ribosomes 
endosom
e 
lysosomes 
This drawing is an example of some of the parts found in one human cell. 
You can imagine that each part is floating around in the cell, contained in 
either the nucleus or cytoplasm. 
Introduction to the Central Dogma  
•  DNA, RNA, and Protein are the 3 components of the 
theory called “The Central Dogma” 
•  The Central Dogma refers to the cellular flow of 
information which reads our genetic material and 
converts it to functional molecules 
•  In order for the genetic information in our DNA to be 
useful, it has to be converted into different molecules 
(mRNA and protein) through this process, The Central 
Dogma 
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Introduction to the Central Dogma  
•  The Central Dogma flow of information is: 
DNA          RNA          Protein 
•  We will build on this important concept throughout this 
module and discuss each of the 3 components in detail 
Nucleic Acids – Introduction 
•  Nucleic acids include:  DNA and RNA 
 
•  All nucleic acids are composed of nucleotides 
•  Each nucleotide consists of: 
•  1 Sugar-phosphate group  
•  1 Base 
•  DNA bases:  A, C, G, T 
•  RNA bases:  A, C, G, U 
sugar-phosphate group 
base 
sugar-phosphate group 
base 
Nucleic Acids 
•  We will begin discussing the 1st part of the Central Dogma:    
 
DNA 
Nucleic Acids – DNA  
•  DNA stands for deoxyribonucleic acid 
•  DNA is an individual’s source of genetic information 
that tells the body how to grow and develop 
•  DNA is packaged into genes, which are further packaged 
into chromosomes. These concepts will be discussed 
more in Module 2. 
 
DNA (Building Blocks) 
•  DNA is a larger molecule built from single units 
•  Single units of DNA are called NUCLEOTIDES 
 
 
 
Nucleic Acids – DNA  
•  Location in human cell:  Nucleus 
•  Structure:  Double-stranded and then twisted into a    
                   “double helix” 
 
nucleus 
DNA 
cytoplasm 
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DNA (nucleotides) 
•  DNA consists of nucleotides with bases A, C, G, and T 
•  These letters represent the 4 DNA nucleotides that make up a DNA 
sequence. The letters stand for: 
 
  A = Adenine  C = Cytosine 
  G = Guanine  T = Thymidine 
 
•  Each of DNA’s double strands has a nucleotide sequence and the 
two strands are connected by hydrogen bonds between bases.  
•  Each DNA nucleotide should always pair with its complement. 
•  A always pairs with T and vice versa 
•  C always pairs with G and vice versa 
DNA (double-stranded structure) 
sugar-phosphate group 
A 
sugar-phosphate group 
G 
sugar-phosphate group sugar-phosphate group 
C T 
sugar-phosphate group 
A 
sugar-phosphate group 
G 
sugar-phosphate group sugar-phosphate group 
C T 
“A” nucleotide 
“A” pairs with “T” 
“C” pairs with “G” 
Matched nucleotides on opposite 
strands are called a BASE PAIR 
Transcription (DNA ! RNA) 
•  The first arrow in the Central Dogma represents the process of 
transcription which reads information on DNA to create RNA 
      DNA                    RNA                    protein 
 
•  During transcription, the 2 strands of DNA are unzipped and one 
strand is used as a template to make RNA 
transcription 
Transcription (DNA ! RNA) 
•  In human cells, the process of transcription takes place in 
the nucleus 
cytoplasm 
nucleus 
DNA           RNA 
TRANSCRIPTION 
Nucleic Acids – RNA  
•  RNA stands for ribonucleic acid and is made during the 
nuclear process of transcription 
•  RNA is also built from 4 nucleotides 
  A = Adenine  C = Cytosine 
  G = Guanine  U = Uracil 
•  There are three (3) major types of RNA: 
•  Messenger RNA (mRNA) 
•  Transfer RNA (tRNA) 
•  Ribosomal RNA (rRNA) 
same as DNA 
unique to RNA 
RNA (Building Blocks) 
•  RNA is also a larger molecule built from single units 
•  Single units of RNA are also called NUCLEOTIDES 
 
 
 
  74 
2/23/14&
1&
Nucleic Acids – RNA  
•  As mentioned, there are 3 major types of RNA, but in this 
module we will focus our attention on:  
messenger RNA (mRNA) 
•  mRNA molecules are created in the nucleus but move into 
the cytoplasm 
•  The job of mRNA is to act as an intermediate molecule 
that carries the genetic code of DNA into the cytoplasm to 
be made into proteins 
mRNA  
•  Structure:  Single-stranded 
•  The sequence of nucleotides in a strand of mRNA 
determines the protein that will be created. Thus, different 
sequences of mRNA are used to make different proteins. 
sugar-phosphate group 
A 
sugar-phosphate group 
G 
sugar-phosphate group sugar-phosphate group 
C U 
mRNA  
cytoplasm 
nucleus 
DNA 
TRANSCRIPTION 
RNA 
protein 
mRNA is made in the nucleus and carries 
the genetic code into the cytoplasm where 
proteins are created. 
Translation (RNA ! protein) 
•  The second arrow in the Central Dogma represents the 
process of translation which reads information from 
mRNA to create protein 
 
 DNA                    RNA                    protein 
 
 
•  mRNA sequence codes for amino acids which are strung 
together to make proteins 
transcription translation 
Translation (RNA ! protein) 
•  In human cells, the process of translation takes place in 
the cytoplasm 
cytoplasm 
nucleus 
RNA            protein 
TRANSLATION 
Proteins 
• Proteins are created after the cytoplasmic 
process of translation 
• Proteins are built from amino acids linked 
together in different combinations and lengths 
 
• Proteins are the functional molecules that do 
most of the jobs of the cell including: 
•  Structure, transport, repairs, reactions 
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Protein (Building Blocks) 
•  Proteins are also larger molecules built from single units 
 
•  Single units of protein are called AMINO ACIDS 
Proteins 
•  Location in human cell:  Everywhere  
 
•  Primary Structure:  String of “beads”  
      (beads are amino acids) 
nucleus 
cytoplasm 
protein 
protein 
protein 
protein 
protein 
protein 
protein 
protein 
protein 
protein 
protein 
Proteins 
• After translation, proteins look like a string 
of beads 
• They must then be specially folded in 
order to function  
Proteins 
• In summary, for proteins to function 
properly, they must: 
• Be translated from mRNA  
• Have the correct sequence of amino acids 
• Be folded correctly 
Central Dogma Summary 
•  Below is what has been covered regarding the Central Dogma: 
DNA RNA protein 
Made of nucleotides Made of nucleotides 
Double-stranded Single-stranded 
Holds genetic code Transports genetic 
code to cytoplasm 
Made of amino acids 
String of beads 
Functional molecules 
of the cell 
transcription 
(in nucleus) 
translation 
(in cytoplasm) 
Module 1 complete! 
•  Please take the Module 1 Knowledge Test 
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GENETIC EDUCATOR 
TRAINING COURSE 
University of Pittsburgh Graduate School of Public Health  
World Society of Paediatric Ophthalmology and Strabismus 
                                                                      UPMC EYE CENTER    
MODULE 2: 
CELL CYCLE & GENETICS 
Module 2 
Purpose:   
To provide a context for molecular biology in human genetics and 
reproduction 
 
Objectives: 
Upon completing this module, participants should be able to: 
1.  Describe the relationship between genetic structures and 
their functions 
2.  Describe the human genome and its chromosomes 
3.  Compare and contrast mitosis and meiosis 
Introduction to Genetics 
 
Genetics is the study of 
inherited differences found 
in and between human 
populations and individuals 
Packaging of Genetic Information 
• Each cell in our body 
contains the same DNA 
• The amount of DNA in 
each cell is very large 
•  The long double strands of 
DNA must be condensed 
and packaged so that it all 
fits within the nucleus 
Packaging of Genetic Information 
•  The strands of DNA are coiled up into structures called 
chromosomes, which contain a massive amount of 
genetic information 
•  Genes are made up of DNA 
•  Chromosomes are made up of many lined up genes 
DNA double helix 
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Packaging of Genetic Information 
•  Let’s consider the amount of genetic information 
contained in each structure 
•  The order of genetic organization is below: 
Nucleotide  Gene Chromosome 
smallest amount of 
information 
largest amount of 
information 
Genes 
•  As introduced before, a gene is a section of DNA made of 
many nucleotides 
•  Genes are the pieces of DNA that go through the  
Central Dogma to become functional proteins 
•  A gene is like a single instruction for the body 
•  Each gene makes a different protein 
Genes 
 
•  From the image above: 
•  GENE 1 will make PROTEIN 1  
 
 
•  GENE 2 will make PROTEIN 2 
DNA 
GENE 1 GENE 2 
GENE 1 
PROTEIN 1 
GENE 2 
PROTEIN 2 
•  Genes are even further divided into two types of regions: 
•  Exons – regions that code for proteins 
•  Introns – regions that separate exons and do not code 
for proteins 
 
Genes 
exon 1 exon 2 exon 3 exon 4 
intron 1 intron 2 intron 3 
Chromosome Structure 
•  Many genes on a long strand of DNA coil up to make one 
chromosome, which looks something like the picture below 
 
•  The top and bottom segments are called the two “arms”  
•  The short arm is also called the “p arm” (named for being “petite”) 
•  The long arm is also called the “q arm” 
•  The arms connect at the “centromere” which resembles the “waist” 
of the chromosome 
Chromosomes 
•  Each human being typically has 23 pairs of chromosomes  
(46 total chromosomes) in the nucleus of every cell in the body 
Having 2 copies of 
each chromosome 
means that we have 
2 copies of every 
gene! 
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Human Genome 
• All of the genes on all 46 chromosomes together 
make up the human genome 
• The human genome contains about 20,000 genes 
in total 
Human Chromosomes 
•  Chromosomes come in pairs because one comes from the 
mother and one from the father 
•  Therefore, individuals have half of their mother’s and half of their 
father’s genes, explaining why children resemble both mom and dad 
MOTHER 
(46 chromosomes) 
FATHER 
(46 chromosomes) 
CHILD 
(46 chromosomes) 
Father gives  
23 chromosomes 
Mother gives  
23 chromosomes 
Germline Cells – Egg and Sperm 
•  There is one exception to every cell in the body having 46 
chromosomes:  germline cells (egg and sperm) 
•  Egg and sperm contain 23 chromosomes each 
•  Egg and sperm cells contain one of each paired 
chromosome (23 chromosomes total) so that when they join 
at conception, the baby has the correct number  
(46 total: 23 from the mother and 23 from the father) 
 
•  Egg and sperm are created in a process called meiosis, 
which we will discuss later in this module 
Karyotype 
•  A karyotype is a picture of a single cell’s chromosomes 
•  The chromosomes are shown as 23 pairs, which are numbered 
according to size (largest to smallest) 
•  The first 22 pairs of chromosomes (numbered 1 to 22) are 
called autosomes, which are the same in males and females 
•  The last pair of chromosomes is the sex chromosomes  
(X and Y) and determines whether a person is male or female 
•  Females have 2 X chromosomes 
•  Males have 1 X and 1 Y chromosome 
Karyotype 
AUTOSOMES 
SEX 
CHROMOSOMES 
Karyotype Nomenclature 
•  If a karyotype is made for an individual, there is a special method 
to tell us which chromosomes are present, absent or rearranged 
•  A normal female karyotype with all chromosomes present: 
46,XX 
(tells us there are 46 chromosomes and the sex chromosomes are XX for female) 
 
•  A normal male karyotype with all chromosomes present: 
46,XY 
(tells us there are 46 chromosomes and the sex chromosomes are XY for male) 
 
 
These two notations: 46,XX and 46,XY indicate that 
no abnormalities were found 
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The Cell Cycle 
• The cell cycle is how our body creates new cells 
• All cells come from existing cells through cell 
division 
• All new cells must have the correct amount of 
genetic material: 
•  46 chromosomes for most cells 
•  23 chromosomes for egg or sperm 
The Cell Cycle 
•  For a cell to divide and form a new cell, it must grow, 
double its genetic material, and then split into two cells 
which are exact copies of the original cell 
•  The cell cycle has four (4) phases: 
•  G1 Phase 
•  S Phase 
•  G2 Phase 
•  M Phase 
•  The phases occur in the 
above order 
G1 
S 
G2 
M M 
The Cell Cycle – G Phases 
•  The “G” in G1 and G2 phase stands for “GROWTH” 
•  The cell needs to become large enough to split into 2 functional cells 
G1 
S 
G2 
M M 
The Cell Cycle – S Phase 
•  S Phase stands for “SYNTHESIS” 
•  The cell must double its genetic material to have enough for 2 cells 
•  New DNA is made or synthesized by DNA Replication 
G1 
S 
G2 
M M 
The Cell Cycle 
•  There are two kinds of M Phase depending on what type of 
cell is being made 
•  Mitosis: creates cells with same amount of genetic information 
•  Meiosis: creates cells with half the genetic information (egg/sperm) 
G1 
S 
G2 
M M 
MITOSIS 
• The cell has doubled its amount of DNA in S 
phase 
• Splits into 2 identical cells with the SAME DNA 
as the original cell 
• This is how MOST cell division occurs 
 
46 
46 46 
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MEIOSIS 
•  The cell has doubled its amount of DNA in S phase 
•  Splits into 2 identical cells with the same DNA as the 
original cell 
•  Each cell goes through the cell cycle a SECOND TIME 
but skips the 2nd S phase (DNA does not double) 
•  Second cell division results in 4 cells  
with HALF the original DNA 
•  This is how EGG and SPERM are made 
46 
46 46 
23 23 23 23 
Mitosis vs. Meiosis 
• Mitosis 
•  New cells have identical 
genetic material of 
original cell 
•  New cells have 46 
chromosomes 
•  One cell division 
•  Creates most new cells 
in the body 
• Meiosis 
•  New cells have half the 
genetic material of 
original cell 
•  New cells have 23 
chromosomes 
•  Two cell divisions 
•  Creates egg and sperm 
Module 2 complete! 
•  Please take the Module 2 Knowledge Test GENETIC EDUCATOR 
TRAINING COURSE 
University of Pittsburgh Graduate School of Public Health  
World Society of Paediatric Ophthalmology and Strabismus 
                                                                      UPMC EYE CENTER    
MODULE 3: 
INHERITANCE 
Module 3 
Purpose:   
To illustrate the various inheritance patterns and etiologies of 
ophthalmic disease 
 
Objectives: 
Upon completing this module, participants should be able to: 
1.  Identify various underlying etiologies of ophthalmic disease 
2.  Describe the characteristics and recurrence risks for 
Mendelian traits and diseases 
3.  Describe factors that may mask or alter possible inheritance 
patterns 
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Introduction to Inheritance 
Inheritance is the passing 
of genetic information from 
parent to child 
Introduction to Inheritance 
In this module, we will refer to a 
genetic condition as a condition, 
disease, or pattern of symptoms that 
run in families and therefore can be 
seen in multiple family members 
Alleles 
•  Remember that we have 2 copies of every gene 
•  1 copy on the chromosome inherited from the mother 
•  1 copy on the chromosome inherited from the father 
•  There can be different forms of the same gene 
•  The different forms are called alleles  
•  For example, the gene that determines blood type  
has three alleles: A, B, and O  
•  Each individual gets one allele from each parent 
•  The combination of two alleles determine blood type 
•  If you receive alleles A and A, you are blood type A 
Cause of Genetic Conditions 
•  Genetic conditions result from a change in a gene (in one 
or both copies) that causes it to not work properly 
•  This change may occur in one or both gene copies 
•  The way genetic conditions and their symptoms are 
inherited depend on how many gene copies are affected 
non-working gene copy gene 
Cause of Genetic Conditions 
•  The change in a gene that causes it to not work may be a: 
•  Mutation (a change in the DNA sequence) 
•  Deletion (missing pieces of the DNA sequence) 
•  Duplication (extra regions of the DNA sequence) 
non-working gene copy gene 
Cause of Genetic Conditions 
•  The non-working gene copy can be referred to as a 
“disease allele” 
•  Some genetic conditions require one disease allele and 
others require two disease alleles for an individual to be 
affected 
or 
Genetic condition 
with 1 disease allele 
Genetic condition 
with 2 disease alleles 
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Genotype 
•  The combination of alleles you have for a certain gene is 
called your genotype 
•  The genotype is homozygous if the copies are the same 
•  The genotype is heterozygous if the copies are different 
The words homozygotes and heterozygotes refer to people 
that have the corresponding gene copy combinations 
Genotype 
Copies are the same: 
HOMOZYGOUS for 
the normal allele 
Copies are different: 
HETEROZYGOUS 
Copies are the same: 
HOMOZYGOUS for 
the disease allele 
Phenotype 
•  We will define phenotype as the way a particular genotype 
is expressed in an individual, what you see as the 
symptoms 
•  Does the individual show symptoms and which symptoms 
are present? 
•  In this module, phenotype will be either: 
•  Affected (individual has a disease) 
•  Unaffected (individual is free of a disease) 
Mendelian Inheritance 
•  Mendelian inheritance refers to traits, characteristics, or 
diseases that are caused by a change in one single gene 
 
•  We will discuss 3 patterns of Mendelian inheritance: 
•  Autosomal Dominant 
•  Autosomal Recessive 
•  X-Linked Recessive 
Autosomal Dominant Inheritance 
•  Autosomal dominant is a Mendelian inheritance pattern where 
ONLY ONE disease allele is required to cause a disease 
Let’s break down the meaning of the term 
•  AUTOSOMAL  
•  The gene change occurs on an autosome chromosome (1 to 22) 
•  Equally expressed in males and females 
•  DOMINANT 
•  The disease can be passed from one generation  
to the next generation within a family 
Autosomal Dominant Inheritance 
•  Heterozygotes are affected 
•  “Dominant” implies that one copy of the affected gene is enough to 
express the symptoms of a condition 
•  Individuals with an autosomal dominant disorder typically 
have one affected parent 
•  Autosomal disorders show a high level of variability 
•  Variability means that people in the same family with the same 
disorder may show different disease symptoms and different 
severity of disease 
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If Parent 1 passes 
their affected allele, 
the offspring will have 
the condition, like 
Parent 1 
Autosomal Dominant Inheritance 
•  A person with an autosomal dominant disorder has a  
50% chance of passing the condition onto a child 
Parent 1: 
affected 
Parent 2: 
unaffected 
Possibilities for child: 
UNAFFECTED AFFECTED 
50% 50% 
or 
If Parent 1 passes their 
unaffected allele, the 
offspring will not have 
the condition. 
The rate of 
transmission is 50% 
Autosomal Recessive Inheritance 
•  Autosomal recessive is a Mendelian inheritance pattern 
where TWO disease alleles are required to cause disease 
Let’s break down the meaning of the term 
•  AUTOSOMAL  
•  The gene change occurs on an autosome chromosome (1 to 22) 
•  Equally expressed in males and females 
•  RECESSIVE 
•  The disease may be hidden in some family 
generations as carriers do not express the condition 
•  Family history is usually negative for the disease 
Autosomal Recessive Inheritance 
•  Heterozygotes are NOT affected 
•  One working gene copy is sufficient to prevent symptoms 
•  Unaffected heterozygotes are called “carriers” because they can 
pass on disease alleles along without having the disease 
themselves 
•  In order to be affected with an autosomal recessive disorder, 
one must inherit two non-working gene copies (one from 
each parent) 
•  Children with an autosomal recessive disorder are usually born 
to carrier parents who do not have the disease 
 
Autosomal Recessive Inheritance 
•  Here are the risks when both parents are unaffected carriers 
Parent 1: 
unaffected 
carrier 
Parent 2: 
unaffected 
carrier 
Possibilities 
for child: 
AFFECTED 
50% 
unaffected unaffected 
carrier 
unaffected 
carrier 
25% 25% 
75% unaffected 
3 in 4 
25% 25% 
1 in 4 
X-Linked Recessive Inheritance 
•  Here we are talking about mutations in genes on the  
X chromosome – one of the sex chromosomes 
•  In X-Linked inheritance, males and females are affected 
differently because: 
•  Females have two (2) X chromosomes 
•  Males only have one (1) X chromosome 
X       X       female X       Y       male 
X-Linked Recessive Inheritance-Males 
•  An individual will be unaffected with an X-Linked disorder as long as 
he or she has ONE WORKING copy of the gene on the X 
chromosome 
•  Males have a higher frequency of X-Linked disease because they 
only have one copy of the X chromosome and therefore only need 
one mutation to show disease, as there is no working copy of the 
gene on the Y chromosome 
 
X       Y 
In males, one mutation in 
an X chromosome gene 
means there will be zero 
working copies  
AFFECTED male: 
UNAFFECTED male: 
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X-Linked Recessive Inheritance-Females 
•  An individual will be unaffected with an X-Linked disorder as long as 
he or she has ONE WORKING copy of the gene on the X 
chromosome 
•  Females have a lower frequency of X-Linked disease because they have two 
copies of the X chromosome and require mutations in both to show disease 
(just as in autosomal recessive inheritance) 
•  Female heterozygotes are carriers in X-Linked inheritance as well but can 
sometimes show symptoms of the disorder 
 
X       X 
In females, one mutation 
in an X chromosome 
gene still leaves one 
working copy  
AFFECTED female: 
UNAFFECTED female: In females, TWO 
mutations in an  
X chromosom  ge
result  disease 
X-Linked Recessive Inheritance 
•  Disease alleles are usually passed down through unaffected carrier females 
Mother: 
unaffected 
carrier 
Father: 
unaffected 
Possibilities 
for child: 
affected 
male 
unaffected 
female 
carrier 
female 
unaffected 
male 
75% unaffected 
3 in 4 OVERALL: 
25% 
1 in 4 
Daughters: 
•  All unaffected 
•  50% are carriers 
Sons: 
•  50% affected 
•  50% unaffected 
Genetic Heterogeneity 
•  Genetic Heterogeneity refers to genetic disorders 
caused by mutations in multiple different genes 
•  For example, a particular autosomal dominant disorder 
may be known to be caused by mutations in 5 separate 
genes  
•  A mutation in any of these genes can cause the disorder 
•  You do not need to have a mutation in all 5 genes, just a mutation 
in 1 of the 5 genes 
Non-Mendelian Inheritance 
•  There are several non-Mendelian, forms of inheritance 
and we will mention two: 
•  Multifactorial inheritance 
•  Mitochondrial inheritance 
•  Less is known about these types of inheritance and they 
are very different from Mendelian inheritance 
Multifactorial Inheritance 
•  Multifactorial diseases are named because they are 
influenced by multiple factors 
•  This usually means that changes in many genes  
(not just one) contribute to disease onset as well as 
environmental factors 
•  We often do not know all of the genes involved 
•  Environmental factors include anything that is not genetic 
•  Examples include behaviors, nutrition, exposures, weight, etc. 
•  These diseases may cluster in families but we usually 
cannot see any clear inheritance patterns 
Mitochondrial Inheritance 
•  Mitochondria are structures that produce  
energy and are found in the cytoplasm (not nucleus) 
•  Mitochondria have their own different, separate 
chromosome which carries different genes and DNA 
than the 46 chromosomes in the nucleus 
•  Mitochondrial DNA: 
•  Is contained on one, circular chromosome 
•  Codes for only 37 genes 
•  Is ALWAYS and ONLY inherited from the MOTHER 
mito
cho
ndri
a 
mitochondrial DNA 
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Mitochondrial Inheritance 
•  In families with mitochondrial inheritance 
•  All children (sons and daughters) of an affected female will be 
affected, but there is variability in the expression of the condition 
•  Children of an affected male will NOT be affected 
mito
cho
ndri
a 
Other factors to consider 
•  In these last slides we will talk about a few things that can 
affect how inheritance looks in a family 
•  Consanguinity 
•  New mutations 
•  Reduced penetrance 
Consanguinity 
• All humans are unaffected carriers of 8 to 10 
autosomal recessive disorders 
• Consanguineous families tend to show a higher 
rate of autosomal recessive disease, as parents 
who are related by blood are more likely to be 
carriers of the same disease 
New Mutations 
•  New mutations can happen such that a change occurs 
spontaneously in a gene, causing an individual to be the first 
person affected in the family 
•  New mutations are also called de novo mutations and are 
most typically seen in autosomal dominant diseases, since 
one non-working gene can cause disease 
•  After the new mutation, the disease allele can  
be passed on in the same way as discussed  
earlier in this module as an autosomal dominant 
condition 
Reduced Penetrance 
•  In some disorders, not all individuals with the disease 
genotype will display the disease phenotype 
•  Reduced penetrance means not every person with a 
disease mutation will have symptoms of the disease 
•  Penetrance is always expressed as a percentage: 
  
      Penetrance  =  number of people with symptoms 
number of people who have disease mutation 
Module 3 complete! 
•  Please take the Module 3 Knowledge Test 
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GENETIC EDUCATOR 
TRAINING COURSE 
University of Pittsburgh Graduate School of Public Health  
World Society of Paediatric Ophthalmology and Strabismus 
                                                                      UPMC EYE CENTER    
MODULE 4: 
MUTATIONS AND GENETIC TESTING 
Module 4 
Purpose:   
To describe deleterious (harmful) effects on genes and 
chromosomes with respect to available testing options 
 
Objectives: 
Upon completing this module, participants should be able to: 
1.  Describe the general effect of chromosome abnormalities or 
mutations 
2.  Define available testing technologies and their limitations 
3.  Understand the benefits and risks of genetic testing 
Causes of Genetic Disorders   
•  Genetic disorders are caused by changes in genetic 
material (DNA or chromosomes) and are often 
suspected when multiple individuals in a family show 
the same symptoms 
•  The change in genetic material can occur in:  
•  One single gene 
•  More than one gene 
•  An unknown gene or a gene that is not yet identified 
•  Genetic disorders can also be caused by a 
combination of genes and environmental factors 
Mutations 
•  In Module 3, we defined mutation as a change or 
alteration in the DNA sequence of a gene 
•  A mutation may not have any effect but it can cause 
improper function of a protein, and ultimately, disease  
•  Here we will introduce three types of mutations: 
•  Missense mutations 
•  Nonsense mutations 
•  Frameshift mutations 
Missense Mutations 
•  A Missense Mutation is a single nucleotide change which causes a 
single amino acid (building block of protein) to change 
•  Missense mutations are also called “point mutations” 
•  In the example above, a guanine (G) was changed to a thymine (T) which 
changed one base pair in the DNA sequence 
T G A T G A C G C T T A C 
A C T A C T C G A A T G G T
now “C” is paired with “T” which is incorrect 
Remember that in DNA… 
•  “A” pairs with “T” 
•  “C” pairs with “G” 
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Missense Mutations 
•  During translation (the last step of the Central Dogma) a Missense 
Mutation will result in a single amino acid change.  
•  This creates a mutated protein. 
mutation 
correct protein mutated protein 
Nonsense Mutations 
•  A Nonsense Mutation is a single nucleotide change which causes 
single amino acid to STOP forming the protein 
•  The sequence change creates something called a stop codon 
•  Nonsense mutations result in truncated (shortened) proteins 
 
•  In the example above, a guanine (G) was changed to another nucleotide 
that will stop protein formation during translation at that location 
T G A T G A C G C T T A C 
A C T A C T C G A A T G G STOP 
Nonsense Mutations 
•  The Nonsense Mutation will result an amino acid change that will 
stop translation (the last step of the Central Dogma). 
•  This creates a truncated (shortened) protein 
mutation 
correct protein mutated (truncated) 
protein 
Frameshift Mutations 
•  A Frameshift Mutation occurs when multiple nucleotides in a DNA 
sequence are inserted or deleted.  
•  This causes a shift in the DNA sequence. 
•  Due to this shift, all amino acids after the insertion or deletion are changed. 
•  It may result in a stop codon 
•  Above is an example of a DELETION causing a frameshift mutation 
•  The entire sequence after the deletion is out of place, and thus incorrect 
•  If the mutation was an insertion, the effect would be the same but the 
sequence would shift in the opposite direction 
T G A T G A C G C T T A C 
A C T A C  G A A T G T C G 
Frameshift Mutations 
•  The Frameshift Mutation will result in incorrect amino acids after the 
mutation during translation (the last step of the Central Dogma)  
•  This results in an abnormal protein product 
mutation 
correct protein mutated protein 
New Mutations 
•  Recall from Module 3 that a new mutation can cause an 
individual to be the first person in the family to be affected 
by a genetic disorder 
•  New mutations are also known as de novo mutations 
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Chromosome Abnormalities 
•  We have now introduced the concept that types of 
mutations in a single gene can cause genetic disorders 
•  There are also other, larger genetic changes that can 
cause genetic disorders at a chromosomal level 
•  Aneuploidy 
•  Deletions and Duplications 
•  Translocations 
Aneuploidy 
•  Aneuploidy is a genetic change that means an individual 
has an entire extra or missing chromosome in each cell 
Chromosomal Abnormalities 
Aneuploidy 
Some examples of Aneuploidy: 
•  Trisomy (“tri-” = three / “-somy” = chromosome) occurs when there are 3 
copies of a chromosome instead of the expected 2 copies 
•  The karyotype designation 47,XY,+21 tells us: 
•  An extra chromosome is present (47 instead of 46) 
•  This individual has 3 copies of chromosome 21 instead of 2 copies 
•  This condition is Down syndrome, or Trisomy 21  
•  Monosomy (“mono-” = one / “-somy” = chromosome) occurs when there is 
1 copy of a chromosome instead of the expected 2 copies 
•  The karyotype designation 45,X tells us: 
•  A chromosome is missing (45 instead of 46) 
•  This individual has only 1 copy of the X chromosome instead of 2 copies 
•  This condition is Turner syndrome, or Monosomy X 
Chromosomal Abnormalities 
Chromosome Deletions 
•  Chromosome deletions occur when a piece of a chromosome 
is missing  
•  It does not involve the entire chromosome 
•  Chromosome deletions may involve multiple genes 
Chromosomal Abnormalities 
DELETION: All genes in this part 
of the chromosome will be deleted 
Missing multiple genes can be 
problematic and cause multiple 
symptoms in a patient 
 
Deletions can cause  
severe disease 
Chromosome Duplication 
•  Chromosome duplications occur when part of a chromosome 
is copied (duplicated) resulting in extra genetic material in the 
duplicated segment 
•  It does not involve the entire chromosome 
•  Chromosome duplications cause over-expression or over-activity of 
multiple genes 
Chromosomal Abnormalities 
DUPLICATION: All genes in this part 
of the chromosome are doubled 
Having too many gene 
copies can cause symptoms 
but is generally less severe 
than a deletion 
Translocations 
•  A translocation is an alteration in which a whole chromosome or 
broken segment of a chromosome becomes attached to or 
interchanged with another whole chromosome or segment 
•  A balanced translocation means that the segments both reattach to the 
other breakpoint  
Chromosomal Abnormalities 
chromosome 7 chromosome 14 
14 
7 
NOTE: In a balanced 
translocation, NO genetic 
material is lost or gained! 
 
Patients do not 
typically show disease 
  89 
2/23/14&
1&
Translocations 
•  A translocation is an alteration in which a whole chromosome or 
broken segment of a chromosome becomes attached to or 
interchanged with another whole chromosome or segment 
•  A unbalanced translocation means that only one of the broken off 
pieces reattaches and the other is lost 
Chromosomal Abnormalities 
chromosome 7 chromosome 14 
14 
7 
NOTE: In an unbalanced 
translocation, genetic 
material IS lost! 
 
This example acts like a 
chromosomal deletion 
from chromosome 7 
Introduction to Genetic Testing 
 
Now we will discuss the genetic 
testing options that are used to 
detect the gene mutations and 
chromosomal abnormalities 
discussed in this module 
Screening vs. Diagnostic Testing 
•  Genetic screening tests 
•  Used to identify individuals at increased risk for developing a 
genetic disease 
•  Screening tests DO NOT give a diagnosis or confirm disease 
•  Diagnostic tests 
•  Diagnostic tests are specific to certain diseases and DO NOT 
address a patient’s risk for every genetic disease or health problem 
•  Diagnostic tests can confirm or deny the presence of a disease or 
condition 
•  Give a “yes” or “no” answer 
Why Genetic Testing? 
•  There are many scenarios that genetic testing could be 
beneficial for an individual or a family 
 
Some examples: 
•  A couple who experiences multiple pregnancy losses/miscarriages 
•  A child born with multiple birth defects 
•  A family with a history of an illness or disease 
•  A genetic test may provide a genetic diagnosis that can 
help prevent or manage symptoms and guide treatment  
Benefits and Risks of Genetic Testing 
•  Benefits 
•  Gives patients more information 
•  Can guide management and treatment 
•  Can aid family planning decisions (i.e. recurrence risks) 
•  Risks 
•  Expensive cost 
•  Emotional and social impact 
•  Can be too much information for a patient to handle 
•  Possibility of not finding and answer or diagnosis after multiple 
tests 
•  Genetic testing is a PATIENT’S CHOICE and they 
maintain the right not to know 
Genetic Testing Process 
•  Genetic testing is most often performed on a blood 
sample 
•  Generally, the 1st person in a family to have a genetic test 
should be someone who is affected with the disease or 
someone with the most severe symptoms 
•  If a mutation or genetic abnormality is found, other family members 
can be tested for that specific change 
•  If the same disease is “running in a family,” it is usually caused by 
the same genetic change 
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Types of Testing - Karyotype 
•  We have already mentioned Karyotype, which evaluates 
the number and structure of every chromosome in a cell 
•  A karyotype can also be called a “chromosome study” 
•  Karyotyping can detect large scale genetic changes: 
•  Aneuploidy 
•  Large chromosome deletions or duplications 
•  Translocations 
•  Karyotyping can NOT detect:  mutations in the DNA 
sequence 
Types of Testing – Karyotype   
46,XX 
Types of Testing – FISH  
•  FISH stands for Fluorescent In Situ Hybridization 
•  FISH is a test that looks for genetic changes on the 
chromosome level. However, FISH is typically performed for 
specific genetic conditions, rather than testing all of the 
chromosomes 
•  FISH probes tag specific sequences on a chromosome with a 
fluorescent label that acts like a magnet. Using a microscope, 
the testing laboratory counts the number of fluorescent signals 
in each cell 
•  2 signals would indicate 2 copies of a specific sequence, 
1 signal would indicate 1 copy of a specific sequence,  
and so on 
Types of Testing – FISH  
•  Can detect large scale genetic changes: 
•  Aneuploidy 
•  Large chromosome deletions or duplications 
•  Translocations 
•  Can NOT detect:   
•  Mutations 
Imagine 2 microscope 
fields to the left.  
 
The green dots are 
fluorescent tags on a 
specific chromosome 
segment or region 
tagged segment 
present in 2 copies 
tagged segment 
present in 1 copy 
Types of Testing – DNA Sequencing 
•  DNA Sequencing is a test that reads the nucleotide 
sequence of a specific gene 
•  It compares the individual’s DNA sequence to the known 
genetic sequence to look for any changes 
•  Can detect:  single base pair (missense, nonsense) 
mutations and small frameshift mutations 
•  Can not detect:  deletions or duplications, chromosome 
abnormalities 
Types of Testing – Del/Dup Analysis 
•  Deletion/Duplication analysis detects missing or extra 
pieces of DNA within a gene. In some cases it can detect 
if an entire gene is deleted or duplicated. 
•  For some genetic conditions, this test is performed as a 
secondary test if DNA sequencing is unable to detect a 
mutation 
•  Del/Dup analysis DOES NOT detect single base pair 
mutations or small frameshift mutations 
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Types of Testing – Genome Sequencing 
•  Genome sequencing is a new technology that has the 
ability to rapidly sequence all ~20,000 genes in an 
individual 
•  Pros:   Looks at all known genes in one test 
 Can detect mutations 
•  Cons:  Expensive cost 
  Returns massive amount of information 
 Will find many changes of unknown significance 
 May reveal genetic information a family or patient  
     did not want to know (i.e. risk for another disease) 
Genetic Test Results 
•  Positive Genetic Test = mutation or alteration found 
•  For some disorders, a mutation is diagnostic 
•  For other disorders, a mutation is not enough information to be 
diagnostic 
•  Can also indicate a person is a carrier of a recessive disorder 
Genetic Test Results 
•  Negative Genetic Test = no mutation or alteration found 
•  Many tests cannot detect all mutations even in a single gene, so a 
negative result does not necessarily mean the person does not 
have a genetic disease 
•  Does not mean a person’s disease is not genetic or inherited 
•  Does not mean that all possible genetic causes for a person’s 
disease have been eliminated 
 
A negative result means that a person does not have a 
mutation that is detectable by a particular genetic test 
Module 4 complete! 
•  Please take the Module 4 Knowledge Test 
GENETIC EDUCATOR 
TRAINING COURSE 
University of Pittsburgh Graduate School of Public Health  
World Society of Paediatric Ophthalmology and Strabismus 
                                                                      UPMC EYE CENTER    
MODULE 5: 
INHERITED CONGENITAL ANOMALIES  
OF THE EYE 
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Module 5 
Purpose:   
To increase awareness of congenital ocular conditions that may 
have an inherited component and patients/families that may 
benefit from an overview of basic genetics education. 
 
Objectives: 
Upon completing this module, participants should be able to: 
1.  Describe the genetics of a subset of congenital ocular 
conditions 
2.  Identify patients/families with potentially inherited congenital 
ocular conditions 
Characteristics of Disease 
• We will begin by introducing some descriptors 
used when discussing diseases and conditions: 
 
• Congenital and Acquired 
•  Isolated and Syndromic 
• Spectrum 
“Congenital” and “Acquired” 
•  Used to describe the onset of a disease or malformation 
•  Congenital means a disease or malformation was present  
at birth 
•  Congenital conditions develop during embryonic or fetal stages 
•  Congenital conditions are more likely due to an inherent GENETIC 
change, thus present at the time of conception 
•  The genetic change is present in every cell of the body 
•  Acquired means onset of a disease or malformation occurs 
after conception or birth 
•  Acquired conditions may or may not be present at birth 
•  Acquired conditions are more likely due to an ENVIRONMENTAL 
influence and may only affect parts of the body 
“Isolated” and “Syndromic” 
•  Used to describe the symptoms of a genetic disease or 
malformation 
 
•  Isolated means a genetic change resulted in a single symptom 
or manifestation 
•  Isolated coloboma is caused by a genetic change, and coloboma is 
the only symptom that the patient displays 
•  Syndromic means a genetic change results in a recurring 
pattern of symptoms, usually affecting different parts of the 
body 
•  Syndromic coloboma is present in genetic disorders like CHARGE 
syndrome, where other symptoms such as hearing loss and heart 
defects are all caused by the same, single genetic change 
Spectrum 
•  A Spectrum is a term used to describe a disease or 
condition that has a range of clinical symptoms and 
patients can be affected in differing degrees of severity 
(mild, moderate, severe) 
mild • • • • • • • • • • • moderate • • • • • • • • •  severe 
Genetic Eye Disease 
•  It may seem difficult to know when to suspect an eye condition 
has a genetic cause 
•  There are certain characteristics that are more commonly seen 
when eye conditions are GENETIC: 
•  Congenital / Early-onset 
•  Bilateral 
•  Multiple affected family members 
•  Co-occurrence of other symptoms in other body parts 
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Genetic Eye Disease 
•  It is important to learn the genetics of eye 
disease because: 
•  Approximately 33% of ALL genetic conditions have eye 
abnormalities 
•  Cells in the eye express approximately 90% of the 
body’s genes 
•  About 50% of childhood blindness has a genetic cause 
Genetic Overview of Eye Conditions 
•  We will now introduce known genetic causes and 
inheritance patterns of some inherited ophthalmic 
conditions you may see in the clinic 
•  Families with the following disorders may benefit from 
basic genetics education 
Anophthalmia, Microphthalmia, and 
Coloboma 
•  Anophthalmia is the absence of the globe, but the external eye 
structures (lids, lashes, etc.) are intact 
•  Microphthalmia is a small eye, based on standardized 
measurements and the patient’s age 
•  Coloboma is a closure defect in the eye, which may affect any of the 
tissues of the eye (commonly, the iris) 
•  These three malformations exist on a spectrum, where the mild end of 
the spectrum is coloboma and the severe end of the spectrum is 
anophthalmia. They also share common genetic causes. 
Anophthalmia, Microphthalmia, and 
Coloboma 
•  They may be caused by a chromosome abnormality or 
by a mutation in multiple genes, most commonly: 
•  SOX2, RAX, PAX6, CHD7, SHH, SIX3, SIX6, and POMT1 
•  The inheritance of these malformations is mostly 
sporadic, but can also be autosomal dominant, 
autosomal recessive, or X-linked recessive 
Aniridia 
•  Aniridia is a malformation in which the iris is absent 
•  This condition can be caused by 2 separate genetic changes: 
•  Mutation in the PAX6 gene:  This results in isolated aniridia 
 - OR - 
•  Deletion that includes more than just the PAX6 gene:   
•  This results in syndromic aniridia  
•  When the deletion also involves the WT1 gene, individuals are at 
increased risk to develop Wilms tumor as a young child 
•  Autosomal dominant inheritance or sporadic (especially with 
the deletion) 
 
Glaucoma 
•  Glaucoma is a condition where an increased pressure within the eye 
results in damage to the optic nerve 
•  Primary Congenital Glaucoma 
•  Caused by mutations in CYP1B1 or LTBP2 
•  Autosomal recessive inheritance 
•  Note: The incidence of Primary Congenital Glaucoma is 1 in 3,300 in the Indian state of 
Andhra Pradesh, where the disease accounts for approximately 4.2% of all childhood 
blindness 
•  Juvenile Open-Angle Glaucoma 
•  Caused mainly by mutations in MYOC, other less common genes exist 
•  Autosomal dominant inheritance in most families but can be autosomal 
recessive in some families 
•  “Juvenile” implies onset after 2 years of age 
•  Infantile Glaucoma can be a feature of many other syndromes 
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Congenital Cataracts 
•  A Congenital Cataract is a cloudiness in the lens of the 
eye, present at birth or within the first year of life 
•  It is known to be caused by certain chromosome 
abnormalities or by a mutation in multiple genes 
•  Many of the genetic causes have not yet been identified 
•  Congenital Cataracts can be seen following patterns of: 
•  Autosomal dominant (most common) 
•  Autosomal recessive 
•  X-linked recessive 
Retinitis Pigmentosa (RP) 
•  Retinitis Pigmentosa is a degeneration of the rod and cone cells in 
the retina, with onset as early as the first decade of life. It is 
characterized by night blindness, visual field constriction, and a 
particular pigmentation pattern on an eye exam 
•  There are many genes that can cause RP if mutated 
•  RP can be inherited in the following manners: 
•  Autosomal dominant 
•  Autosomal recessive 
•  X-linked recessive 
•  Mitochondrial 
Leber’s Congenital Amaurosis (LCA) 
•  Leber’s Congenital Amaurosis is a disease involving 
severe retinal dystrophy in the first year of life which leads 
to significant vision loss 
•  The LCA phenotype can be caused by mutations in  
many different genes 
•  Inheritance is mainly autosomal recessive, although 
autosomal dominant has been reported in some families 
Retinoblastoma (RB) 
•  A Retinoblastoma is a retinal tumor 
•  RB is caused by changes in the RB1 gene including: 
•  Mutations and deletions 
•  Chromosome rearrangements involving chromosome 13q, where 
the gene is located 
•  Autosomal dominant inheritance or sporadic 
•  Genetic testing for this disorder includes chromosome 
analysis, and RB1 sequencing and deletion studies 
•  Testing may be attempted on blood sample but may need to be 
done on tumor biopsy 
CHARGE Syndrome 
•  CHARGE syndrome is an acronym where each letter stands for a  
symptom 
C = coloboma 
H = heart defects 
A = choanal atresia 
R = retardation of growth/development 
G = genital/urinary defects 
E = ear anomalies 
 
•  CHD7 is the only gene that, when mutated, is known to cause 
CHARGE syndrome. Mutations in this gene account for about 
two-thirds (2/3) of cases. 
•  Most mutations are sporadic, and then inherited as autosomal 
dominant in future generations 
Patients DO NOT need to 
have all 6 symptoms to 
have a diagnosis of 
CHARGE syndrome 
Leber’s Hereditary Optic Neuropathy (LHON) 
•  Leber’s Hereditary Optic Neuropathy is a form of 
painless, bilateral vision loss. Usually loss of vision occurs 
in one eye, and vision loss in the other eye follows a few 
months later. 
•  Males are 5 times more likely to be affected than 
females 
•  The majority of LHON cases are caused by 4 mutations 
in the mitochondrial DNA (mtDNA, circular chromosome) 
•  Mitochondrial inheritance (maternal) 
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Ophthalmic Genetic Testing 
•  If ophthalmologists at your institute are interested in 
offering genetic testing, it will be necessary to investigate 
which tests are available in your area  
•  Tests to investigate include karyotype/chromosome 
analysis, gene sequencing, deletion/duplication study, 
FISH 
Ophthalmic Genetic Testing 
•  Possible test results: 
•  Positive:  A known disease-causing mutation identified  
•  Negative:  No mutation identified 
•  Variant of Uncertain Significance: A genetic change was 
identified but it has never been reported or proven to cause 
disease. No diagnostic conclusions can be drawn and further 
evaluation is necessary. 
•  The technology of genetic testing is imperfect. If no 
mutation is found (negative test), an individual may still 
have an inherited ophthalmic condition that cannot be 
found using available testing options 
Module 5 complete! 
•  Please take the Module 5 Knowledge Test GENETIC EDUCATOR 
TRAINING COURSE 
University of Pittsburgh Graduate School of Public Health  
World Society of Paediatric Ophthalmology and Strabismus 
                                                                      UPMC EYE CENTER    
MODULE 6: 
TALKING TO A PATIENT I –  
PATIENT EDUCATION BASICS 
Module 6 
Purpose:   
To describe basic methods for communicating fact-based health 
information to patients 
 
Objectives: 
Upon completing this module, participants should be able to: 
1.  Communicate basic genetic information to patients and 
families 
2.  Understand the purpose of providing patients with genetic 
information 
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Educating Patients in Genetics 
•  Giving patients genetic information is a complex task, and 
you should know WHY you are doing it 
•  The main reason for giving patients basic genetic 
education is so they better understand their health 
•  A genetic diagnosis may be able to improve the 
TREATMENT AND MANAGEMENT of a patient’s eye 
problems 
Educating Patients in Genetics 
•  The goal IS NOT to teach patients every detail about 
genetics and inheritance 
•  Rather, the goal IS to teach patients basic information that 
is relevant to their health 
•  You can expect barriers that will affect the way your 
patient understands what you say about genetics 
including their: 
•  Educational background 
•  Cultural practices 
•  Language 
The Role of Genetic Educator  
•  A Genetic Educator will meet briefly with patients who 
may benefit from genetic education, as determined by 
their ophthalmologist by review of their medical chart 
•  The patient will meet with a Genetic Educator BEFORE 
seeing the ophthalmologist 
•  The role of a Genetic Educator is to complete a family 
pedigree and define general terms prior to the patient 
receiving personalized genetic information from the 
ophthalmologist 
The Role of a Genetic Educator 
•  Genetic information may be difficult for a lay person to 
understand 
•  Ways to help improve understanding may include: 
•  The job of a Genetic Educator is to explain genetic concepts in a 
simplified way using easy-to-understand wording 
•  SPEAK CLEARLY!  
•  Stop to ask if they understand the information already discussed 
•  As a Genetic Educator, it is important to be informative, 
but at the same time respectful and sensitive 
In a Patient Session… 
•  After introducing yourself as a Genetic Educator, the 
session will begin by taking a family pedigree 
•  How to draw a family pedigree will be detailed in Module 7 
•  Taking a pedigree is an extremely important part of a 
genetics consultation because:  
•  It provides useful information about the medical history of other 
family members 
•  It is organized so that it acts as a visual tool that may aid in 
diagnosis and identifying an inheritance pattern 
•  Note of Caution:  It DOES NOT usually provide enough information 
to make a genetic diagnosis on its own and should be interpreted 
by the ophthalmologist 
In a Patient Session… 
•  A family pedigree provides useful information for: 
•  The Patient 
•  The Patient’s Family 
•  The Ophthalmologist 
•  After you take the pedigree, it should be kept in the 
patient’s medical chart or file 
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In a Patient Session… 
•  The session will include explanation of basic terms 
learned throughout this course including: 
•  Sporadic and Inherited 
•  Congenital and Acquired 
•  Isolated and Syndromic 
•  Potential inheritance patterns  
(Mendelian and non-Mendelian, as relevant) 
 
In a Patient Session… 
•  It is important to try to present the information in an 
unbiased manner 
•  It is important to stress that we have no control over the 
genes we inherit or the genes we pass on to our children 
•  Some parents may feel a sense of guilt or blame and it is important 
to make it clear that this something beyond our control 
•  Try not to present the concept of non-working gene copies 
as something that is wrong with the patient 
In a Patient Session… 
•  Allow patients to ask questions AT ANY TIME during your 
conversation 
•  If you do not know the answer to a patient’s question, it is 
important to be honest and direct the question to the 
ophthalmologist 
•  DO NOT make up an answer to appear informed 
•  It is never appropriate to use the names of other patients 
in your conversation 
Importance of Communication 
•  The way in which you communicate is one of the 
most important aspects of being a good Genetic 
Educator 
•  As we have mentioned, you must speak slowly and 
clearly so the information is conveyed to the patient in a 
way they can understand 
•  Genetics may be intimidating, scary, or confusing to a 
patient so it is extremely important to be respectful 
Importance of Communication 
•  Being an effective communicator involves more than 
talking. It also requires that you: 
•  Be an active LISTENER 
•  Check in with the patient to ask about their understanding during 
the session 
•  Speak clearly and clarify what you say so you are sure the patient 
understands 
•  Be confident about the information that you present, while also 
being honest when you do not know the answer to a question 
Module 6 complete! 
•  Please take the Module 6 Knowledge Test 
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GENETIC EDUCATOR 
TRAINING COURSE 
University of Pittsburgh Graduate School of Public Health  
World Society of Paediatric Ophthalmology and Strabismus 
                                                                      UPMC EYE CENTER    
MODULE 7: 
TALKING TO A PATIENT II –  
TAKING A FAMILY PEDIGREE 
Module 7 
Purpose:   
To provide a foundation for obtaining family health histories and 
generating a pedigree. 
 
Objectives: 
Upon completing this module, participants should be able to: 
1.  Communicate with patients and families for the purpose of 
obtaining family health histories 
2.  Understand the basic relationships and symbols used in 
pedigrees 
3.  Draw a pedigree using standardized nomenclature 
The Pedigree 
•  Module 6 introduced the pedigree as an important visual 
tool which provides family health information that is helpful 
for the patient, the patient’s family, and the 
ophthalmologist 
•  Now we will introduce how to collect the information 
needed as well as how to draw a pedigree using correct 
symbols 
A 3-Generation Pedigree 
•  A useful pedigree includes THREE (3) GENERATIONS 
•  If your patient is a child, include their generation, their 
parents’ generation, and their grandparents 
•  If your patient is an adult: 
•  If they have children, include their children’s and their parent’s 
generation 
•  If no children, include their parents’ generation and their 
grandparents 
Comprehensive or Targeted 
•  A COMPREHENSIVE family history collects information 
about any and all health problems for each family 
member. This provides a very broad, complete picture of 
the family’s health 
•  A TARGETED family history only asks for information 
regarding specific health problems. 
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Basic Pedigree Symbols 
•  On a pedigree, each family member is represented by a 
shape. 
•  MALES are represented by a SQUARE 
•  FEMALES are represented by a CIRCLE 
•  Family members of unknown sex are represented by a neutral 
DIAMOND 
Family Relationships 
•  On a pedigree, a familial relationship is represented by 
a STRAIGHT LINE 
This horizontal line connecting a 
male and a female indicates a 
MARRIAGE or that the two individuals 
have had children together. 
Family Relationships 
•  On a pedigree, a familial relationship is represented by 
a STRAIGHT LINE 
A vertical line indicates 
OFFSPRING.  
 
If this couple had 1 son, it 
would be drawn like this: 
Family Relationships 
•  On a pedigree, a familial relationship is represented by 
a STRAIGHT LINE 
If this couple had 
more than one child, 
it would be drawn 
like this: 
This family has 2 sons and 1 daughter. Brothers and sisters are depicted 
as coming down (descending) vertically from the same horizontal line. 
Family Relationships 
Twins 
•  Twins are shown as two diagonal lines beginning from the 
same point 
 
This depicts 
FRATERNAL twins 
(dizygotic) 
Family Relationships 
Twins 
•  Twins are shown as two diagonal lines beginning from the 
same point 
 
This depicts 
FRATERNAL twins 
(dizygotic) 
The addition of an 
extra horizontal line 
indicates IDENTICAL 
twins (monozygotic) 
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Family Relationships 
Consanguinity 
•  Consanguineous couples (when a mother and father  
of a child are related by blood) are connected by a  
DOUBLE HORIZONTAL LINE 
*Offspring of consanguineous 
couples are at increased risk 
for autosomal recessive 
disorders, as related parents 
are more likely to be carriers 
of the same disorders 
Basic Pedigree Symbols 
Deceased Individuals 
 
•  Any individual who has passed away, has a diagonal line 
through the symbol: 
Basic Pedigree Symbols 
Pregnancy 
•  If a woman is pregnant, the pregnancy is represented by a 
diamond with a “P” written inside 
•  The pregnancy is placed in the same line as the future 
siblings, but note that it is not yet a CURRENT CHILD 
P 
This shows 2 
CURRENT children 
and 1 pregnancy 
Basic Pedigree Symbols 
Pregnancy Losses 
•  Miscarriage:  Represented as a small, slightly raised triangle in 
the row of children/siblings 
•  Stillbirth:  Represented as a small, slightly raised symbol (square 
for male, circle for female) with a diagonal line through it, with the 
letters “SB” underneath 
miscarriage 
SB 
This family shows a 
couple with 1 living son, 
1 miscarriage, and 1 
female stillbirth 
 
NOTE: It is not necessary to 
write “miscarriage” below the 
triangle, but it IS standard to 
write “SB” below a stillbirth 
The Proband 
•  The PROBAND is your current patient who is to be 
evaluated by the ophthalmologist 
•  Your proband can be any age: If you work in pediatrics, the 
proband will be the child or minor 
•  The proband is indicated on a pedigree by drawing a 
DIAGONAL ARROW to his or her symbol, shown below 
OR 
Collecting the Information 
•  As a Genetic Educator in Ophthalmology, it will be best to 
take a more targeted approach to taking a family pedigree 
(instead of comprehensive) 
•  For each family member, you should write down: 
•  AGE:  an individual’s current age, or if the individual has died, the 
age at which he or she passed away 
•  ANY VISION PROBLEMS:  Describe briefly 
•  Ex: Wears glasses, myopia 
•  ANY DIAGNOSES of EYE DISORDERS:  Include age at diagnosis 
•  All of this information is written directly below the 
corresponding individual’s symbol 
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Collecting the Information 
•  Example below  
•  *Note this is only a 2-generation pedigree 
38 y 
wears glasses 
myopia 
12 y 
AW 
15 y 
AW 
32 y 
RP dx. 20 y 
4 y 
 
“AW” stands for 
“alive and well” 
indicating no known 
health concerns 
The mother, current 
age 32, was 
diagnosed (dx) at 
age 20 with Retinitis 
Pigmentosa (RP) 
Collecting the Information 
•  The best way to learn to draw pedigrees is to practice and 
develop your own personal process 
•  We will demonstrate an example of an order to follow 
40 y 
wears glasses 
myopia 
15 y 
32 y 
12 y 
AW 
35 y 
AW 
24 y 
amblyopia 
58 y 
poor vision 
cataracts 
58 y 
AW 
45 y 
wears glasses 
myopia 
70 y 
wears glasses 
myopia 
d. 65 y 
d. MI 
P
20 y 
AW 
In the narrated version, this will be a mock conversation with the patient, 
 with details appearing as they reveal information 
CHARGE dx 10 y 
Referring to a Pedigree 
I 
III 
II 
 1                        2                             3                        4 
 1                       2                        3                  4               5 
  1                           2               3               4                                       5    
GENERATION 
INDIVIDUALS 
Circled, is 
individual 
II-3 
Referring to a Pedigree 
•  You may also ask for the names of each family member, if 
it is helpful for you to keep track 
•  For example, 
Holly 
26 y 
wears contacts 
astigmatism 
lazy eye in childhood 
Special Notations 
•  Now we will discuss ways to label the symbols in a 
pedigree if there are known disease diagnoses 
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Family Disease Diagnoses 
•  If there is a known disease that has been diagnosed in a 
family individual, or in multiple family members, you can 
record this in an easy-to-see manner 
•  Instead of simply writing the disease name under the 
symbol, fill in the symbol to show the individual is 
AFFECTED with a known disease or disorder 
unaffected male AFFECTED male 
Family Disease Diagnoses 
40 y 
wears glasses 
myopia 
32 y 
AW 
12 y 
35 y 24 y 
AW 
58 y 
AW 
58 y 
AW 
45 y 
RP dx. 18 y 
70 y 
AW 
d. 65 y 
d. MI 
RP dx. 35 y 
P
20 y 
RP dx. 16 y 
25 y 
AW 
Primary 
congenital 
glaucoma 
Carriers 
•  Carriers, or unaffected heterozygotes, are possible  
in families seeing patterns of autosomal recessive or  
X-linked recessive inheritance 
•  Carriers are drawn on a pedigree as a symbol with a dot 
in the middle 
 
•  While unaffected, carriers have a 50% chance to pass on a non-
working gene copy, and 50% chance to pass on a working gene copy 
Male carrier Female carrier 
Module 7 complete! 
•  Please take the Module 7 Knowledge Test 
  103 
APPENDIX E 
KNOWLEDGE ASSESSMENT ANSWER KEYS 
     
  104 
 
 
 
 
 
MODULE 1:  MOLECULAR BIOLOGY – ANSWER KEY 
 
 
1. DNA is composed of: 
a. Protein 
b. Cells 
c. Amino acids 
d. Nucleotides 
 
Choice (a.) is incorrect.  Protein is the product of the last step in the Central Dogma (DNA -> RNA -> 
Protein).  DNA is not made of protein; rather, discrete DNA sequences, called genes, create proteins. 
Choice (b.) is incorrect.  Cells are the basic building blocks of the body which contain DNA within their 
nucleus. 
Choice (c.) is incorrect.  Amino acids are the basic building blocks of protein. 
Choice (d.) is correct.  Nucleotides are the basic building blocks of DNA. 
 
 
2. The four DNA nucleotides are: 
a. Adenine, Cytosine, Guanine, Uracil  (A, C, G, U) 
b. Adenine, Cytosine, Guanine, Thymidine  (A, C, G, T) 
c. Adenine, Cytosine, Pyrimidine, Purine  (A, C, P, P) 
d. Adenine, Guanine, Pyrimidine, Thymidine  (A, G, P, T) 
 
Choice (a.) is incorrect.  Adenine (A), cytosine (C), and guanine (G) are DNA nucleotides.  However, 
uracil (U) is a RNA nucleotide and is not present in DNA. 
Choice (b.) is correct.  The four nucleotides of DNA are adenine (A), cytosine (C), guanine (G), 
and thymidine (T). 
Choice (c.) is incorrect.  Adenine (A) and cytosine (C) are DNA nucleotides.  However, pyrimidine and 
purine are classifications of nucleotides.  To be specific, the DNA nucleotides cytosine (C) and 
thymidine (T) are pyrimidines and adenine (A) and guanine (G) are purines. 
Choice (d.) is incorrect.  Adenine (A), cytosine (C), and thymidine (T) are DNA nucleotides.  However, 
pyrimidine is a classification of nucleotides.  To be specific, the DNA nucleotides cytosine (C) and 
thymidine (T) are pyrimidines. 
 
 
3. The structure of DNA is: 
a. Folded 
b. Single-stranded 
c. Double-stranded 
d. Triple-stranded 
 
Choice (a.) is incorrect.  DNA structures are not folded.  This is a behavior of newly created proteins. 
Choice (b.) is incorrect.  DNA is a double-stranded molecule, whereas RNA is single-stranded. 
Choice (c.) is correct.  DNA is a double-stranded molecule that is twisted into a double helix. 
Choice (d.) is incorrect.  DNA is a double-stranded molecule and does not exist in a triple-stranded 
state. 
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4. DNA nucleotides (A, C, G, T) on the two strands bond to form base pairs. Which nucleotide ALWAYS pairs 
with C? 
a. A 
b. C 
c. G 
d. T 
 
Choice (a.) is incorrect.  The DNA nucleotide adenine (A) always pairs with thymidine (T). 
Choice (b.) is incorrect.  A cytosine (C) to cytosine (C) pairing is not possible because the DNA 
nucleotides are unable to pair with themselves.  The DNA nucleotide cytosine (C) always pairs with 
guanine (G). 
Choice (c.) is correct.  The DNA nucleotide cytosine (C) always pairs with guanine (G). 
Choice (d.) is incorrect.  The DNA nucleotide thymidine (T) always pairs with adenine (A). 
 
 
5. DNA nucleotides (A, C, G, T) on the two strands bond to form base pairs. Which nucleotide ALWAYS pairs 
with A? 
a. A 
b. C 
c. G 
d. T 
 
Choice (a.) is incorrect.  An adenine (A) to adenine (A) pairing is not possible because DNA 
nucleotides are unable to pair with themselves.  The DNA nucleotide adenine (A) always pairs with 
thymidine (T). 
Choice (b.) is incorrect.  The DNA nucleotide cytosine (C) always pairs with guanine (G). 
Choice (c.) is incorrect.  The DNA nucleotide guanine (G) always pairs with cytosine (C). 
Choice (d.) is correct.  The DNA nucleotide adenine (A) always pairs with thymidine (T). 
 
 
6. The three main types of RNA are mRNA, tRNA, and rRNA. What does the  “m”  in  mRNA  stand  for? 
a. Mitosis 
b. Meiosis 
c. Messenger 
d. Molecular 
 
Choice (a.) is incorrect.  Mitosis is a process of cell division that generates new cells.  Mitosis has no 
relationship to RNA. 
Choice (b.) is incorrect.  Meiosis is a process of cell division that generates reproductive cells.  
Meiosis has no relationship to RNA. 
Choice (c.) is correct.  Messenger (m) RNA is created in the nucleus from a DNA sequence.  
Then, it is transported into the cytoplasm where the mRNA is read by a ribosome, creating a 
specific protein.  Messenger (m) RNA plays a primary role in the second step of the Central 
Dogma (DNA -> RNA ->  Protein),  acting  as  the  “message”  between  DNA  sequences  and  protein  
translation. 
Choice (d.) is incorrect.  The  word  “molecular”  or  “molecule”  refers  to  small,  fundamental units that 
contribute to the function of a larger structure.   
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7. The structure of mRNA is: 
a. Folded 
b. Single-stranded 
c. Double-stranded 
d. Triple-stranded 
 
Choice (a.) is incorrect.  RNA structures are not folded.  This is a behavior of newly created proteins. 
Choice (b.) is correct.  RNA is a single-stranded molecule. 
Choice (c.) is incorrect.  RNA is single-stranded molecule, whereas DNA is double-stranded. 
Choice (d.) is incorrect.  RNA is a single-stranded molecule and does not exist in a triple-stranded 
state. 
 
 
8. The flow of information from DNA Æ RNA Æ protein is known as: 
a. The Genetic Code 
b. The Central Dogma 
c. The Golden Rule 
d. The Tree of Life 
 
Choice (a.) is incorrect.  “The  Genetic  Code”  is  a  term  that  is  often  used to describe DNA or RNA.  
However, it generally does not include protein. 
Choice (b.) is correct.  “The  Central  Dogma” is the term used to describe the process and flow 
of information from DNA to RNA to Protein. 
Choice (c.) is incorrect.  “The  Golden  Rule”  is  not  a  scientific  term.    Rather,  it  has  many  meanings,  
such as an infallible truth or expectation in a field of study or the principal of treating others the way you 
would like to be treated. 
Choice (d.) is incorrect.  “The  Tree  of  Life”  has many meanings.  In the sciences, it is a branched 
diagram that illustrates the evolutionary relationship of all living creatures. 
 
 
9. What  does  “transcription”  do? 
a. Reads DNA to make mRNA 
b. Makes DNA 
c. Divides cells 
d. Reads mRNA to make protein 
 
Choice (a.) is correct.  Transcription describes the first to second step of The Central Dogma, or 
using DNA sequences to generate mRNA. 
Choice (b.) is incorrect.  DNA is replicated from itself in a separate process from The Central Dogma. 
Choice (c.) is incorrect.  Cell division is not part of The Central Dogma and has no relationship to 
transcription. 
Choice (d.) is incorrect.  This  response  is  describing  the  process  of  “translation.”    Translation  is  the  
second to third step of The Central Dogma, where mRNA sequences and tRNA molecules are used to 
generate protein. 
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10. Where  in  the  cell  does  “transcription”  happen?     
a. Cytoplasm 
b. Nucleus 
c. Mitochondria 
d. Lysosome 
 
Choice (a.) is incorrect.  The cytoplasm is a semi-fluid substance that fills a cell.  The term cytoplasm 
is also used to describe the entire cell area that is not within the nucleus.  With regard to The Central 
Dogma, translation (the step of RNA -> Protein) occurs in the cytoplasm. 
Choice (b.) is correct.  The nucleus is the central hub of a cell and the location of DNA.  As DNA 
is used to create RNA, transcription occurs in the nucleus. 
Choice (c.) is incorrect.  Mitochondria  are  the  “powerhouses”  of  a  cell.    . 
Choice (d.) is incorrect.  Lysosomes are digestive structures inside a cell.  Their main role is to 
process or destroy materials that the cell no longer requires.  No step of The Central Dogma occurs in 
the lysosomes. 
 
 
11. What  does  “translation”  do? 
a. Reads DNA to make mRNA 
b. Makes DNA 
c. Divides cells 
d. Reads mRNA to make protein 
 
Choice (a.) is incorrect.  DNA sequences are read to make mRNA through transcription.  This is the 
first to second step of The Central Dogma. 
Choice (b.) is incorrect.  DNA is replicated from itself in a separate process from The Central Dogma. 
Choice (c.) is incorrect.  Cell division is not part of The Central Dogma and has no relationship to 
translation. 
Choice (d.) is correct.  Translation describes the second to third step of The Central Dogma, or 
using mRNA sequences and tRNA molecules to generate protein.  This is distinct from choice 
(b.) because translation is the process of reading the mRNA sequence and signaling tRNAs 
(literally,  “translating”  the  mRNA  message  into  the  final  product  - protein). 
 
 
12. Where  in  the  cell  does  “translation”  happen?     
a. Cytoplasm 
b. Nucleus 
c. Mitochondria 
d. Lysosome 
 
Choice (a.) is correct.  The cytoplasm is a semi-fluid substance that fills a cell.  The term 
cytoplasm is also used to describe the entire cell area that is not within the nucleus.  With 
regard to The Central Dogma, translation (the step of RNA -> Protein) occurs in the cytoplasm. 
Choice (b.) is incorrect.  The nucleus is the central hub of a cell and the location of DNA.  The mRNA 
is transported out of the nucleus and into the cytoplasm before translation can begin.  No proteins are 
made within the nucleus. 
Choice (c.) is incorrect.  Mitochondria  are  the  “powerhouses”  of  a  cell,  located  in  the  cytoplasm and 
their role is to create energy for cell functions.  . 
Choice (d.) is incorrect.  Lysosomes are digestive structures inside a cell, located in the cytoplasm.  
Their main role is to process or destroy materials that the cell no longer requires.  No step of The 
Central Dogma occurs in the lysosomes. 
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13. What functional molecules perform most of the jobs of the cell? 
a. Proteins 
b. Membranes 
c. Ribosomes 
d. Endosomes 
 
Choice (a.) is correct.  Proteins are the final product of discrete DNA sequences called genes.  
Protein is a generalized term for the functional molecules in cells.  As a group, proteins have a 
wide range of functions and participate in all cellular activities. 
Choice (b.) is incorrect.  Membranes are thin structures that act as dividers within and between cells.  
For example, the plasma membrane surrounds the entire cell and keeps all of its contents contained.  
There is also a plasma membrane around the nucleus, which keeps the nucleus and cytoplasm 
separated. 
Choice (c.) is incorrect.  Ribosomes are structures located in the cytoplasm of the cell.  Ribosomes 
are the functional molecules in translation, as they help with the process of converting an mRNA 
sequence into its protein product. 
Choice (d.) is incorrect.  Endosomes are capsule-like structures that are created  when  the  cell’s  
exterior plasma membrane folds in onto itself.  Endosomes take in materials from outside the cell, 
where these materials may be digested in lysosomes or be deposited back outside of the cell. 
 
 
14. Proteins are made up of: 
a. Nucleotides 
b. Chromosomes 
c. Mitochondria 
d. Amino acids 
 
Choice (a.) is incorrect.  Nucleotides are the basic building blocks of DNA. 
Choice (b.) is incorrect.  Chromosomes are a condensed form of DNA that is visible under a 
microscope.  Proteins participate in the organization of chromosomes ?is this going to confuse them?; 
however, the opposite is not true and chromosomes are not a component of proteins.  
Choice (c.) is incorrect.  Mitochondria  are  the  “powerhouses”  of  the  cell.    Although  numerous  proteins  
have a function within the mitochondria, the mitochondria are not components of protein. 
Choice (d.) is correct.  Amino acids are the basic building blocks of proteins.  There are 20 
amino acids that are used to build protein.  During translation, mRNA sequences signal tRNA 
molecules, to which amino acids are attached and a protein is made. 
 
 
15. In order to work correctly, proteins must: 
a. Be translated from mRNA 
b. Be folded correctly 
c. Have the correct sequence of amino acids d. All of the above 
 
Choice (a.) is incomplete.  Proteins are translated from mRNA as a step in The Central Dogma.  
Although this is correct, there are other responses to this question that are also true. 
Choice (b.) is incomplete.  Protein function relies on proper folding and organization.  If a protein is 
not folded properly, it may be missing key structures that allow it to perform its job in the cell.  Although 
this is correct, there are other responses to this question that are also true. 
Choice (c.) is incomplete.  Proteins must have a correct sequence of amino acids, which follow the 
mRNA sequence.  Although this is correct, there are other responses to this question that are also true. 
Choice (d.) is correct.  All of the above responses are true about proteins and their function. 
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MODULE 2:  CELL CYCLE AND GENETICS 
 
 
1. The study of inherited differences found in and between human populations and individuals is called:  
a. Biochemistry 
b. Medicine 
c. Genetics 
d. Evolution 
 
Choice (a.) is incorrect.  Biochemistry is the study of the chemical processes in living organisms. 
Choice (b.) is incorrect.  Medicine is the practice of diagnosing, treating, and preventing disease. 
Choice (c.) is correct.  Genetics is the study of inheritance and inherited characteristics or 
differences in living organisms, such as humans.  
Choice (d.) is incorrect.  Evolution is the change or progress of inherited characteristics over 
generations, contributing to the development of populations. 
 
 
 
2. Humans have ____ pairs of chromosomes: 
a. 46 
b. 26 
c. 23 
d. 72 
 
Choice (a.) is incorrect.  Humans have 46 individual chromosomes, not 46 pairs of chromosomes. 
Choice (b.) is incorrect.  Humans have less than 26 pairs of chromosomes. 
Choice (c.) is correct.  Humans have 23 pairs of chromosomes, totaling 46 individual 
chromosomes.   
Choice (d.) is incorrect.  Humans have less than 72 pairs of chromosomes. 
 
 
 
3. The 22 pairs of chromosomes that are NOT sex chromosomes are called: 
a. Autosomes 
b. Germline 
c. Lysosomes 
d. X and Y 
 
Choice (a.) is correct.  Autosomes (chromosome pairs 1-22) are chromosomes that carry genes 
involved with physical characteristics, but not gender.  Both males and females have 22 pairs of 
autosomes. 
Choice (b.) is incorrect.  “Germline”  describes  the  cells  that  divide  to  form  gametes,  or  egg  and  sperm  
cells. 
Choice (c.) is incorrect.  Lysosomes are digestive structures inside a cell.  Their main role is to 
process or destroy materials that the cell no longer requires.  They are not related to chromosomes. 
Choice (d.) is incorrect.  X and Y are the sex chromosomes, which control gender.  Females have two 
X chromosomes, whereas males have one X and one Y chromosome. 
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4. Children resemble both their mother and father because: 
a. They have half of each of their genes 
b. They have all of their genes 
c. By chance 
d. Children do not resemble both their mother and father 
 
Choice (a.) is correct.  Children inherit half of their genetic information from their father and half 
of their genetic information from their mother.  A father passes on one copy of every 
chromosome (1-22 and either X or Y) and a mother passes on one copy of every chromosome 
(1-22 and X or X).  These chromosomes pair up at conception. 
Choice (b.) is incorrect.  Children  do  not  inherit  all  of  their  parents’  genes.    Otherwise,  they  would  
inherit 46 chromosomes from each parent, totaling to 92 chromosomes.  This is not compatible with life. 
Choice (c.) is incorrect.  It  is  not  “by  chance”  that  parents and children both have the same color eyes, 
hair, or other physical features.  Children resemble their parents because they inherit genes that control 
these traits from each parent. 
Choice (d.) is incorrect.  Children will have some resemblance to their mother and father, as well as 
other family members, due to inherited traits. 
 
 
5. A normal, female karyotype is written as: 
a. 46,XY 
b. 23,XY 
c. 46,XX 
d. 23,XX 
 
Choice (a.) is incorrect.  The karyotype 46,XY represents a normal male. 
Choice (b.) is incorrect.  The karyotype 23,XY does not exist.  There are not enough chromosomes. 
Choice (c.) is correct.  The karyotype 46,XX represents a normal female. 
Choice (d.) is incorrect.  The karyotype 23,XX does not exist.  There are not enough chromosomes.  
 
 
6. A human sperm has ____ chromosomes: 
a. 46 
b. 26 
c. 23 
d. 13 
 
Choice (a.) is incorrect.  Sperm do not carry 46 chromosomes.  This is incompatible with survival.  
Choice (b.) is incorrect.  Sperm do not carry 26 chromosomes.  This is incompatible with survival. 
Choice (c.) is correct.  Sperm carry 23 chromosomes.  A human sperm is created through 
meiosis, or a type of cell division that creates germ cells.  Meiosis halves the number of 
chromosomes (46 Æ 23).  This results in sperm that carry the correct number of chromosomes 
to fertilize an egg and contribute to normal human development. 
Choice (d.) is incorrect.  Sperm do not carry 13 chromosomes.  This is incompatible with survival. 
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7. Eggs and sperm are made by: 
a. Meiosis 
b. Mitosis 
c. Replication 
d. Transcription 
 
Choice (a.) is correct.  Meiosis is a type of cell division that halves the number of chromosomes 
(46 Æ 23).  This results in egg and sperm cells that carry 23 chromosomes each.  This is the 
correct number of chromosomes for fertilization and normal human development to occur. 
Choice (b.) is incorrect.  Mitosis is a type of cell division that most  of  the  body’s  cells  use  to  generate  
new cells, as it maintains the normal number of chromosomes (46 Æ 46).  Egg and sperm must have 
23 chromosomes to allow fertilization and normal development, therefore mitosis cannot be used. 
Choice (c.) is incorrect.  Replication is the process through which DNA is copied.  Although this is a 
step of any cell division, it is not the process used to create egg and sperm. 
Choice (d.) is incorrect.  Transcription describes the first to second step of The Central Dogma, or 
using DNA sequences to generate mRNA. 
 
 
8. Meiosis creates cells with: 
a. Half of the original genetic material 
b. The same amount of genetic material 
c. Double the amount of genetic material 
d. Any of the above 
 
Choice (a.) is correct.  Meiosis is a type of cell division that halves the amount of genetic 
material, or chromosomes (46 Æ 23), in egg and sperm cells. 
Choice (b.) is incorrect.  Meiosis does not maintain the same amount of genetic material during cell 
division.  However, mitosis maintains the same amount of genetic material, or chromosomes (46 Æ 46).  
Most  of  the  body’s  cells  use  mitosis  to  generate  new  cells. 
Choice (c.) is incorrect.  No cell division process results in cells with double the amount of genetic 
material. 
Choice (d.) is incorrect.  Meiosis is a defined process resulting in cells with half of the original genetic 
material.  It does not maintain or increase the amount of genetic material. 
 
 
9. Mitosis creates cells with: 
a. Half of the original genetic material 
b. The same amount of genetic material 
c. Double the amount of genetic material 
d. Any of the above 
 
Choice (a.) is incorrect.  Mitosis does not create cells with half of the original genetic material.  
However, meiosis is a type of cell division that halves the number of genetic material, or chromosomes 
(46 Æ 23), in egg and sperm cells. 
Choice (b.) is correct.  Mitosis maintains the same amount of genetic material, or chromosomes 
(46 Æ 46).    Most  of  the  body’s  cells  use  mitosis  to  generate  new  cells. 
Choice (c.) is incorrect.  No cell division process results in cells with double the amount of genetic 
material. 
Choice (d.) is incorrect.  Mitosis is a defined process resulting in cells with half of the original genetic 
material.  It does not maintain or decrease the amount of genetic material. 
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10. The cell cycle has four (4) active phases. Three (3) of the phases are called G1 Phase, G2 Phase, and M 
Phase. What is the missing phase called, and what happens during it? 
a. T Phase; DNA Transcription 
b. T Phase; RNA Translation 
c. S Phase; Mitosis 
d. S Phase; DNA Synthesis and Replication 
 
Choice (a.) is incorrect.  There is no T phase in the cell cycle, nor is transcription a part of the cell 
cycle.  Recall, transcription describes the first to second step of The Central Dogma, or using DNA 
sequences to generate mRNA. 
Choice (b.) is incorrect.  There is no T phase in the cell cycle, nor is translation a part of the cell cycle.  
Recall, translation describes the second to third step of The Central Dogma, or using mRNA sequences 
and tRNA molecules to generate protein. 
Choice (c.) is incorrect.  S phase is the correct answer; however, mitosis is not the process that 
occurs during the S phase. 
Choice (d.) is correct.  S  phase  is  the  correct  answer.    During  S  phase,  a  cell’s  DNA  is  
synthesized, replicated, and divided among the cells created during the cell cycle. 
 
 
 
11. What is happening during the G1 and G2 Phases of the cell cycle? 
a. Gene regulation 
b. Growth 
c. Genetic recombination 
d. None of the above 
 
Choice (a.) is incorrect.  Gene regulation is not part of the cell cycle.  This process is more important 
for active cells, so that the appropriate genes are turned on (expressed) or off (silenced). 
Choice (b.) is correct.  Both the G1 and G2 phases are times of cellular growth.  During G1, the 
cell is preparing for DNA synthesis (S phase).  During G2, the cell doubles its total mass, 
creating two new cells of equal size. 
Choice (c.) is incorrect.  Genetic recombination is not part of the cell cycle.  However, it is an 
essential part of meiosis that creates new combinations of genes to be passed onto children. 
Choice (d.) is incorrect.  This is incorrect, as G1 and G2 involve cellular growth (answer b). 
 
 
 
12. What letter of the alphabet is used to describe the short arm of a chromosome? 
a. c 
b. p 
c. q 
d. x 
 
Choice (a.) is incorrect.  The  letter  “c”  is not used to describe any part of a chromosome. 
Choice (b.) is correct.  The  letter  “p”  is  used  to  describe  the  short  arm  of  a  chromosome.    It  
represents  the  French  word  “petit,”  meaning  small. 
Choice (c.) is incorrect.  The  letter  “q”  is  used  to  describe  the long arm of a chromosome. 
Choice (d.) is incorrect.  A  capital  letter  “X”  identifies  one  of  the  sex  chromosomes.    However,  a  
lowercase  letter  “x”  is  not  used  to  describe  any  part  of  a  chromosome. 
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13. The correct order for organization of genetic material (from smallest to largest) is:  
a. Chromosome Æ Gene Æ Nucleotide 
b. Amino Acid Æ Protein Æ Enzyme 
c. Gene Æ Chromosome Æ DNA 
d. Nucleotide Æ Gene Æ Chromosome 
 
Choice (a.) is incorrect.  This is the reverse order, presented from largest to smallest. 
Choice (b.) is incorrect.  Amino acids, proteins, and enzymes are not involved in the organization of 
genetic material.  Amino acids are basic building blocks of proteins and enzymes are proteins involved 
in biochemical reactions. 
Choice (c.) is incorrect.  DNA is smaller than a gene and a chromosome.  Therefore, this order is not 
correct. 
Choice (d.) is correct.  Nucleotide Æ Gene Æ Chromosome is the correct order.  Nucleotides are 
the basic building blocks of DNA, DNA sequences create distinct genetic instructions called 
genes, and many genes are lined up along the length of a chromosome. 
 
 
 
14. Approximately how many genes are coded for in the human genome? 
a. 1,000 
b. 20,000 
c. 50,000 
d. 2,000,000 
 
Choice (a.) is incorrect.  There are more than 1,000 genes in the human genome. 
Choice (b.) is correct.  There are approximately 20,000 genes in the human genome. 
Choice (c.) is incorrect.  There are less than 50,000 genes in the human genome. 
Choice (d.) is incorrect.  There are less than 2,000,000 genes in the human genome. 
 
 
 
15. A piece of a gene that provides the code for a protein is called: 
a. an Exon 
b. an Instruction 
c. an Intron 
d. a Splice site 
 
Choice (a.) is correct.  An exon is the coding region of a gene that is transcribed from DNA Æ 
RNA during the first to second step of The Central Dogma.   
Choice (b.) is incorrect.  Generally,  a  gene  may  be  referred  to  as  an  “instruction.”    However,  this  does  
not describe the specific piece of a gene that codes for a protein. 
Choice (c.) is incorrect.  An intron is a noncoding part of a gene that is transcribed from DNA Æ RNA 
during the first to second step of The Central Dogma.  However, the process of splicing (occurring 
between transcription and translation) removes introns from mRNA before protein is generated. 
Choice (d.) is incorrect.  A splice site is a specific DNA sequence between exons (coding regions of a 
gene) and introns (non-coding regions of a gene).  Splice sites act as a signal, indicating what parts of 
a gene can be removed before protein is generated.  
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MODULE 3:  INHERITANCE 
 
 
1. Inherited traits: 
a. Are always present in every member of a family 
b. Skip generations 
c. Are passed from parent to child 
d. None of the above 
 
Choice (a.) is incorrect.  At  most,  a  child  inherits  half  of  a  parent’s  genetic  information  or  traits.    
Therefore, an inherited trait may only be present in some family members. 
Choice (b.) is incorrect.  Genes and inherited traits are passed directly from parent to child.  Although 
some traits or diseases do not appear in successive generations, this is due to a particular inheritance 
pattern or multifactorial effects. 
Choice (c.) is correct.  Inherited traits, controlled by genes, are passed from parent to child. 
Choice (d.) is incorrect.  One of the above statements is true (see choice c). 
 
 
2. Different forms of the same gene are called: 
a. Loci 
b. Nucleotides 
c. Alleles 
d. Homozygotes 
 
Choice (a.) is incorrect.  “Loci” (singular: locus) describes a position or place.  This term is often used 
in genetics to describe the chromosomal location of a specific gene. 
Choice (b.) is incorrect.  Nucleotides are the basic building blocks of DNA, which encode genes. 
Choice (c.) is correct.  “Allele” is the term used in genetics to describe different forms of the 
same gene.  For example, there are three alleles for the gene that determines our blood type 
(allele A, allele B, or allele O).  
Choice (d.) is incorrect.  A homozygote is a person who has the same allele at a particular locus.   
 
 
3. A  “disease-causing”  allele  can  sometimes  be called  a  “non-working  copy”  because  there  is  a: 
a. Mutation 
b. Deletion 
c. Duplication 
d. All of the above 
 
Choice (a.) is incorrect.  A mutation can disrupt a gene and be disease-causing; however, this answer 
is incomplete. 
Choice (b.) is incorrect.  A deletion can disrupt a gene or genes and be disease-causing; however, 
this answer is incomplete. 
Choice (c.) is incorrect.  A duplication can disrupt a gene or genes and be disease-causing; however, 
this answer is incomplete. 
Choice (d.) is correct.  Mutations, deletions, and duplications are all mechanisms by which a 
gene or genes can be disrupted and be disease-causing.  
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4. A family pedigree in which every child has an affected parent is consistent with which pattern of 
inheritance? 
a. Autosomal Dominant 
b. Autosomal Recessive 
c. X-Linked 
d. Multifactorial 
 
Choice (a.) is correct.  One major characteristic of an autosomal dominant pedigree is that each 
child affected by the disorder also has an affected parent.  This is because a parent, who has 
one non-working gene has a 50% chance to pass it on to each child, who will also be affected. 
Choice (b.) is incorrect.  Autosomal recessive pedigrees are characterized by multiple affected 
individuals in a single generation (brothers and sisters) or a single affected individual in a pedigree.  
Typically, parents of an affected child are unaffected carriers, not affected themselves. 
Choice (c.) is incorrect.  Affected and unaffected status in a X-linked pedigree depends on an 
individual’s  gender, where males are affected and females express few or no traits of the condition.  
Also, there is no male-to-male transmission of the condition.  Therefore, not every affected child has an 
affected parent. 
Choice (d.) is incorrect.  Typically, a multifactorial condition affects a single individual in a family.  
Although the genetic factors or predisposition for the condition may be passed on, children would also 
need to be exposed to the environmental influences that contribute to the condition.  Therefore, 
pedigrees displaying multifactorial conditions do not show a consistent pattern. 
 
 
 
5. In autosomal dominant inheritance, an affected parent has a ______ chance to pass the affected gene to 
his or her child. 
a. 25% 
b. 50% 
c. 75% 
d. 100% 
 
Choice (a.) is incorrect.  There is greater than a 25% chance for an affected parent to pass the non-
working gene for an autosomal dominant condition to his or her child. 
Choice (b.) is correct.  In autosomal dominant inheritance, an affected parent has a 50% (1 in 2) 
chance to pass on the non-working gene to his or her child, who will be affected.  This also 
means that the affected parent has a 50% chance to pass on the working gene to his or her 
child, who will not be affected. 
Choice (c.) is incorrect.  There is no inheritance pattern associated with a 75% chance to pass on an 
affected gene. 
Choice (d.) is incorrect.  There is less than 100% chance for an affected parent to pass the non-
working gene for an autosomal dominant condition to his or her child. 
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6. In classic autosomal recessive inheritance, a heterozygous individual with one working and one non-
working gene copy will be: 
a. An unaffected carrier 
b. Affected with the disorder 
c. Late onset 
d. Any of the above 
 
Choice (a.) is correct.  An unaffected carrier (heterozygote) has one working gene and one non-
working gene for an autosomal recessive disorder.  They will have no related symptoms. 
Choice (b.) is incorrect.  To be affected with an autosomal recessive disorder, an individual must have 
two non-working genes (homozygous). 
Choice (c.) is incorrect.  Individuals with one working gene and one non-working gene 
(heterozygotes) for an autosomal recessive condition are not expected to develop the full disease at 
any age. 
Choice (d.) is incorrect.  An individual with one working gene and one non-working gene 
(heterozygote) for an autosomal recessive condition are unaffected carriers (see choice a). 
 
 
 
7. In classic autosomal dominant inheritance, a heterozygous individual with one working and one non-
working gene copy will be: 
a. An unaffected carrier 
b. Affected with the disorder 
c. Late onset 
d. Any of the above 
 
Choice (a.) is incorrect.  An unaffected carrier describes an individual with one working gene and one 
non-working gene (heterozygote) for an autosomal recessive disorder.  This does not apply to 
autosomal dominant disorders because one non-working gene is sufficient to cause symptoms. 
Choice (b.) is correct.  An individual with one working gene and one non-working gene 
(heterozygote) for an autosomal dominant disorder will be affected.  This is because one non-
working gene is sufficient to cause symptoms. 
Choice (c.) is incorrect.  An individual with one working gene and one non-working gene 
(heterozygote) will be affected.  The age of onset varies between conditions and can range from before 
birth to adulthood.  
Choice (d.) is incorrect.  An individual with one working gene and one non-working gene 
(heterozygote) for an autosomal dominant disorder will be affected (see choice b). 
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8. If two parents are both carriers (unaffected heterozygotes) of an autosomal recessive disorder, the chance 
they will have an affected child is: 
a. 0% 
b. 25% 
c. 50% 
d. 100% 
 
Choice (a.) is incorrect.  There is greater than a 0% chance that two parents who are carriers of an 
autosomal recessive disorder will have an affected child. 
Choice (b.) is correct.  When two parents are carriers for the same autosomal recessive 
condition, the following scenarios are possible: 25% (1 in 4) chance that both parents pass on 
their non-working gene and have an affected child; 50% (2 in 4) chance that one parent will pass 
on the working gene and one parent will pass on the non-working gene, and the child will be an 
unaffected carrier;  25% (1 in 4) chance that both parents pass on their working gene and the 
child will neither be affected nor a carrier. 
Choice (c.) is incorrect.  When two parents are carriers for the same autosomal recessive condition, 
there is a 50% (2 in 4) chance that the child will be an unaffected carrier.  However, the risk for a child 
to be affected is less than 50%. 
Choice (d.) is incorrect.  There is less than a 100% chance that two parents who are carriers of an 
autosomal recessive disorder will have an affected child. 
 
 
 
9. All individuals affected with an autosomal recessive disorder MUST have: 
a. One working and one non-working copy of a gene 
b. Two non-working copies of a gene 
c. One affected parent 
d. Two affected parents 
 
Choice (a.) is incorrect.  In autosomal recessive disorders, one working gene will prevent symptoms 
of the disorder. 
Choice (b.) is correct.  In autosomal recessive disorders, two non-working genes are not 
producing enough normal protein to perform its necessary function. 
Choice (c.) is incorrect.  This is not a requirement for autosomal recessive inheritance.  Although an 
individual with an autosomal recessive disorder can have an affected parent, their unaffected parent 
must also be a carrier for the same condition and pass on their non-working gene for the child to be 
affected. 
Choice (d.) is incorrect.  This is not a requirement for autosomal recessive inheritance.  Although an 
individual with an autosomal recessive disorder can have two affected parents, it is more common for 
two parents to be unaffected carriers. 
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10. In X-linked inheritance, males are affected differently than females because: 
a. Their hormones are different 
b. They produce sperm 
c. They have a different number of total chromosomes 
d. They only have one (1) copy of the X chromosome 
 
Choice (a.) is incorrect.  Hormone differences between males and females have no effect on the 
inheritance or expression of an X-linked disorder. 
Choice (b.) is incorrect.  The male reproductive system has no effect on an X-linked disorder. 
Choice (c.) is incorrect.  Males and females have the same number of chromosomes (46). 
Choice (d.) is correct.  Males and females differ by the sex chromosomes, where males have 
one X chromosome and one Y chromosome and females have two X chromosomes.  When a 
male has a non-working gene on his X chromosome, there is no gene on his Y chromosome to 
mask the disorder; however, a female with a non-working gene on her X chromosome has a 
paired, working gene on her opposite X chromosome, which is sufficient to prevent symptoms. 
 
 
11. If only 70% of individuals with a known disease genotype are affected by the disease phenotype, this 
disease most likely displays: 
a. Reduced penetrance 
b. A new mutation 
c. Multifactorial inheritance 
d. Autosomal recessive inheritance 
 
Choice (a.) is correct.  Reduced penetrance means that the percentage of individuals who carry 
a known genetic mutation and display symptoms divided by all who carry the known genetic 
mutation (those with symptoms and those without symptoms) is less than 100%. 
Choice (b.) is incorrect.  A new (de novo) mutation may occur in a person with an autosomal 
dominant or X-linked condition, particularly when they are the first person affected in their family. 
Choice (c.) is incorrect.  Multifactorial inheritance is the combination of genetic and environmental 
factors that contribute to the development or expression of a condition or trait. 
Choice (d.) is incorrect.  Autosomal recessive inheritance is characterized by a 25% chance to be 
affected when two parents are unaffected carriers.  A person with an autosomal recessive disorder 
expresses symptoms, ranging from mild to severe.  It is uncommon for a person to have the genetic 
mutations for an autosomal recessive disorder and have no signs or symptoms. 
 
 
12. When multiple genes contribute to a disease phenotype, this is called: 
a. Genetic heterogeneity 
b. Reduced penetrance 
c. An Environmental factor 
d. X-linked inheritance 
 
Choice (a.) is correct.  Genetic  heterogeneity  (“hetero-”  meaning  different)  describes  a  
particular condition with numerous underlying genetic causes. 
Choice (b.) is incorrect.  Reduced penetrance describes the percentage of individuals with a known 
genetic mutation for a particular disease and who also display symptoms.  This relationship is 
independent of how many genes are associated with a specific disorder. 
Choice (c.) is incorrect.  Environmental factors may influence the expression of a multifactorial 
condition.  However, this is separate from the number of underlying genetic causes for a disorder. 
Choice (d.) is incorrect.  The inheritance pattern of a condition has no effect on the number of 
underlying genetic causes. 
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13. When many genes AND many environmental factors contribute to a disease phenotype, this is called: 
a. Autosomal dominant inheritance 
b. Single-gene inheritance 
c. Multifactorial 
d. Mitochondrial inheritance 
 
Choice (a.) is incorrect.  Autosomal dominant inheritance results when an individual has one non-
working copy of a gene.  Environmental factors do not influence how these conditions are inherited. 
Choice (b.) is incorrect.  Single-gene inheritance describes a genetic condition that is associated with 
only one underlying genetic cause without other influences, like multiple genes or the environment. 
Choice (c.) is correct.  Multifactorial inheritance is the combination of genetic and 
environmental factors that contribute to the development or expression of a condition or trait. 
Choice (d.) is incorrect.  Mitochondrial inheritance results from inheriting mutations in the 
mitochondrial DNA (mtDNA) from a mother.  Although some mitochondrial conditions can be influenced 
by environmental factors, this is not a requirement for expression of a mitochondrial disorder. 
 
 
14. Mitochondrial DNA: 
a. Has the same structure and shape as nuclear DNA 
b. Is inherited from your father 
c. Codes for more genes than nuclear DNA 
d. Is inherited from your mother 
 
Choice (a.) is incorrect.  Nuclear and mitochondrial DNA have different structures.  Nuclear DNA 
exists as a double-stranded helix, which condenses into chromosomes prior to cell division, where 
mitochondrial DNA exists as a double-stranded, circular molecule. 
Choice (b.) is incorrect.  Mitochondrial DNA is not inherited from your father, as there are very few 
mitochondria in the head of the sperm that fertilizes an egg. 
Choice (c.) is incorrect.  There are approximately 20,000 genes in the nuclear DNA, compared to 37 
genes in mitochondrial DNA. 
Choice (d.) is correct.  Mitochondrial DNA is inherited only from a mother.  The egg cell 
contributes all of the mitochondria in a future child.  The  sperm  only  contributes  the  father’s  
genetic information (DNA) when it fertilizes the egg. 
 
 
15. If an individual is the first in their family affected with a disease (i.e. they did not inherit it from a parent), this 
may be due to: 
a. A new mutation 
b. Dominant inheritance 
c. Mitochondrial inheritance 
d. All of the above 
 
Choice (a.) is correct.  A new (de novo) mutation may occur in an individual with an autosomal 
dominant or X-linked condition, particularly when they are the first person affected in their 
family. 
Choice (b.) is incorrect.  An autosomal dominant inheritance pattern cannot account for a single 
affected family member.  A characteristic of autosomal dominant inheritance is that every affected child 
has an affected parent. 
Choice (c.) is incorrect.  Mitochondrial inheritance may present with a single individual in a family; 
however, it is more common for multiple relatives through the maternal line to be affected. 
Choice (d.) is incorrect.  One of the above statements is true (see answer a). 
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MODULE 4:  MUTATIONS AND GENETIC TESTING 
 
1. A genetic disorder may be caused by: 
a. One gene 
b. More than one gene 
c. An unidentified gene 
d. All of the above 
 
Choice (a.) is incomplete.  A genetic disorder may also be caused by more than just a single gene as 
well as an unidentified gene. 
Choice (b.) is incomplete.  A genetic disorder may also be caused by a single or unidentified gene as 
well as more than one gene. 
Choice (c.) is incomplete.  A genetic disorder may also be caused by a single known gene or more than 
one gene. 
Choice (d.) is correct.  A genetic disorder may be caused by all of the above, a single known 
gene, more than one gene and a yet unidentified gene. 
 
2. Which of the following is a type of chromosome abnormality? 
a. Deletion 
b. Duplication 
c. Aneuploidy 
d. All of the above 
 
Choice (a.) is incomplete.  A deletion is a form of chromosome abnormality resulting in missing 
chromosome material but duplications and aneuploidy are chromosome abnormalities as well. 
Choice (b.) is incomplete.  A duplication is a form of chromosome abnormality resulting in extra 
chromosome material but deletions and aneuploidy are also chromosome abnormalities. 
Choice (c.) is incomplete.  Aneuploidy (monosomy or trisomy) is a form of chromosome abnormality 
where there is an entire extra or missing chromosome but deletions and duplications are chromosome 
abnormalities as well. 
Choice (d.) is correct.  Deletions, duplications and aneuploidy are all examples of types of 
chromosome abnormalities.   
 
3. In general, what type of chromosome abnormality has the most severe effect? 
a. Deletion 
b. Duplication 
c. Balanced translocation 
d. They are equally severe 
 
Choice (a.) is correct.  A deletion of chromosome material typically presents with more severe 
symptoms since the individual is missing one copy of every gene carried in that region of the 
chromosome. 
Choice (b.) is incorrect.  Often duplications cause overexpression of a gene because there are 3 copies 
instead of two. This is generally less severe than a deletion of the same gene, but duplications of large 
regions may lead to severe disease. 
Choice (c.) is incorrect.  A balanced translocation typically does not result in loss or gain of 
chromosome material.  Individuals with balanced translocations typically do not show disease. 
Choice (d.) is incorrect.  Individual with deletions are typically more severely affected than those with 
duplications.  Individuals with balanced translocations are typically unaffected.  Therefore, they are not 
equally severe.   
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4. A mutation is defined as: 
a. A change or alteration in a gene 
b. Missing a chromosome 
c. Having an extra chromosome 
d. All of the above 
 
Choice (a.) is correct.  A mutation is defined as a change or alteration in a gene. 
Choice (b.) is incorrect.  Monosomy is when there is a missing chromosome.  This is a type of 
aneuploidy, not a gene mutation. 
Choice (c.) is incorrect.  Trisomy is when there is an extra chromosome present in the cells.  This is a 
type of aneuploidy, not a gene mutation. 
Choice (d.) is incorrect.  Only answer (a.) is correct. 
 
 
5. Having a mutation may: 
a. Have no effect 
b. Cause a protein to function improperly 
c. Cause a disease 
d. All of the above 
 
Choice (a.) is incomplete.  Having a mutation may have no effect on the individual but it may also cause 
a disease.   
Choice (b.) is incomplete.  Having a mutation may cause a protein to function improperly but may not 
result in disease.   
Choice (c.) is incomplete.  Having a mutation may cause disease but it may also have no effect on the 
individual.  
Choice (d.) is correct.  Having a mutation may have no effect or it may also cause a disease due 
to improper functioning of the protein it codes.  
 
 
6. What type of genetic mutation creates a stop codon? 
a. Missense mutation 
b. Nonsense mutation 
c. Dominant mutation 
d. Silent mutation 
 
Choice (a.) is incorrect.  A missense mutation will result in a single amino acid change, not a stop 
codon.  
Choice (b.) is correct.  A nonsense mutation is a sequence change which results in a stop 
codon which stops translation and truncates or shortens the protein.   
Choice (c.) is incorrect.  A dominant mutation describes the type of inheritance, meaning that it requires 
only one of the two genes to have a mutation in order to show symptoms of the disease.  A dominant 
mutation may be a missense, nonsense or frame shift. 
Choice (d.) is incorrect.  A silent mutation is a DNA change which codes for the same amino acid or a 
similar one.  A silent mutation does not change the functioning of the protein. 
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7. Another word for a “new” mutation is: 
a. De novo 
b. Unique  
c. Original 
d. Single 
 
Choice (a.) is correct.  A de novo mutation is one that is new in that individual and not found in 
either parent.  
Choice (b.) is incorrect.  A new mutation is not called unique.   
Choice (c.) is incorrect.  A new mutation is not called original. 
Choice (d.) is incorrect.  A new mutation is not called single. 
 
 
8. What is genetic screening? 
a. Diagnosing individuals with genetic diseases or syndromes 
b. Identifying individuals at increased risk for developing a genetic disease 
c. Obtaining a family history of genetic disease 
d. Discussing genetics and testing with a patient 
 
Choice (a.) is incorrect.  A genetic screening test does not diagnose individuals with a genetic disease.  
This is called a diagnostic test. 
Choice (b.) is correct.  A genetic screening test is one which identifies individuals at increased 
risk for developing a genetic disease. 
Choice (c.) is incorrect.  Obtaining a family history of genetic disease is part of the genetic education 
session, not genetic screening. 
Choice (d.) is incorrect.  Discussing genetics and testing with a patient is part of the genetic education 
session, not genetic screening. 
 
 
9. A benefit of genetic testing is: 
a. Gives patients more information 
b. Can improve management and treatment 
c. Can affect family planning decisions 
d. All of the above 
 
Choice (a.) is incomplete.  Genetic testing does give patients more information but it can also improve 
management and affect family planning. 
Choice (b.) is incomplete.  Genetic testing may improve the management and treatment of a patient if it 
confirms a diagnosis but it also provides more information to the patient and can affect family planning.   
Choice (c.) is incomplete.  Genetic testing may affect family planning decisions but it may also provide 
patients with more information and may improve management and treatment. 
Choice (d.) is correct.  All of the above listed statements are true of genetic testing. 
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10. What type of sample is most often used for genetic testing? 
a. Blood 
b. Hair root 
c. Skin 
d. The part of the body where the person has health problems 
 
Choice (a.) is correct.  Blood is the most often type of sample used for genetic testing.  
Choice (b.) is incorrect.  While hair root may be a source of DNA, it is not the most often used sample 
for testing.   
Choice (c.) is incorrect.  Skin may be used as a source of DNA but it requires a biopsy and is not the 
most often used sample for testing. 
Choice (d.) is incorrect.  Disease-causing genetic changes are generally found in every cell of the body, 
so it is not usually necessary to use tissue from the affected body part. 
 
 
11. Generally, who in a family should be the first person to have a genetic test? 
a. A person affected with the disorder 
b. The father 
c. The mother 
d. The oldest person in the family 
 
Choice (a.) is correct.  The first person in a family who should be tested is a person affected 
with the disorder.  This allows for the most accurate interpretation of the results and if positive, 
then allows for testing of other family members.   
Choice (b.) is incorrect.  The first person tested in a family should be an affected person, not a relative.   
Choice (c.) is incorrect.  The first person tested in a family should be an affected person, not a relative.   
Choice (d.) is incorrect.  The first person tested in a family should be an affected person, not a relative.   
 
 
12. What is a reason to order genetic testing for a patient? 
a. The patient has experienced multiple pregnancy losses 
b. The patient has multiple congenital anomalies 
c. There is a family history of a particular disorder 
d. All of the above 
 
Choice (a.) is incomplete.  While a physician may order genetic testing for a couple experiencing 
multiple pregnancy losses, this is not the only correct answer. 
Choice (b.) is incomplete.  While a physician may order a genetic test for a patient with multiple 
congenital anomalies, this is not the only correct answer.    
Choice (c.) is incomplete.  While a physician may order a genetic test for an affected patient with a 
family history of a particular disorder, this is not the only correct answer. 
Choice (d.) is correct.  All of the answers listed above are potential reasons why a physician 
may order a genetic test for a patient. 
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13. What genetic test evaluates the structure and number of all chromosomes? 
a. DNA sequencing 
b. Genome sequencing 
c. FISH 
d. Karyotype 
 
Choice (a.) is incorrect.  DNA sequencing is a test which reads the nucleotide sequence.  By comparing 
to the known coding sequence, it may detect single base pair mutations and small frame shift mutations 
within a single gene.  It provides no information about the chromosomes. 
Choice (b.) is correct.  Genome sequencing is new technology which sequences thousands of genes 
but does not provide any information about the structure and number of chromosomes.  
Choice (c.) is incorrect.  FISH (Fluorescent in situ hybridization) is a special test used to detect changes 
of genetic material at the chromosome level.  While it can provide information about a specific 
chromosome sequence, it does not evaluate the structure and number of all the chromosomes as an 
initial test. 
Choice (d.) is correct.  A karyotype is a test which evaluates the structure and number of all the 
chromosomes within a cell. 
 
 
14. What genetic test can detect a single base pair mutation in a gene? 
a. DNA sequencing 
b. Deletion/Duplication analysis 
c. FISH 
d. Karyotype 
 
Choice (a.) is correct.  DNA sequencing is a test which reads the nucleotide sequence.  By 
comparing to the known coding sequence, it may detect single base pair mutations and small 
frameshift mutations within a single gene.   
Choice (b.) is incorrect.  Deletion/Duplication studies are performed to determine if there are large 
pieces of extra or missing DNA sequence within a gene.  This testing will not detect a single base pair 
mutation.   
Choice (c.) is incorrect.  FISH (Fluorescent in situ hybridization) is a special test used to detect changes 
of genetic material at the chromosome level.  While it can provide information about a specific 
chromosome sequence, it does not detect single gene mutations. 
Choice (d.) is incorrect.  A karyotype is a test which evaluates the structure and number of all the 
chromosomes within a cell.  It does not detect mutations in the DNA sequence. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  125 
!
 
 
 
 
 
 
15. What does a negative genetic test result mean? 
a. A person does not have any of the mutations tested for in a certain gene 
b. A person does not have any genetic diseases 
c. A person does not have a genetic cause for their disease 
d. None of the above 
 
Choice (a.) is correct.  A genetic test looks specifically for mutations within a certain gene. A 
negative genetic test result simply means that no mutations were detected in that specific gene 
by that specific test.   
Choice (b.) is incorrect.  A genetic test only looks at mutations within a certain gene. If the result is 
negative, there still may be mutations undetectable by that test, or in other genes that could cause 
genetic diseases.   
Choice (c.) is incorrect.  Genetic testing often cannot detect all disease-causing mutations. It is also 
possible that the patient has a genetic cause for disease which has not been discovered in the disease 
population.   
Choice (d.) is incorrect.  Answer (a.) is correct. 
 
 
 
 
 
 
  126 
!
 
 
 
MODULE 5: INHERITED CONGENITAL ANOMALIES OF THE EYE 
 
 
1.  A congenital disorder is: 
a. A disorder you get when you’re older 
b. A disorder you are born with 
c. A type of heart disease 
d. A reproductive system disorder 
 
Choice (a.) is incorrect.  A congenital disorder is not a disorder you get or develop when you are older, 
it is something you are born with. 
Choice (b.) is correct.  A congenital disorder is a disease or malformation that you were born 
with and was present at the time of birth. 
Choice (c.) is incorrect.  A congenital disorder is not a type of heart disease.  Disorders related to the 
heart are called cardiac disorders.  A cardiac disorder may be congenital if an individual is born with it. 
Choice (d.) is incorrect.  A congenital disorder is not a reproductive system disorder.   
 
 
2.  An inherited congenital anomaly of the eye: 
a. Must be found in multiple family members 
b. Has a known genetic cause 
c. Is never associated with other health problems 
d. None of the above 
 
Choice (a.) is incorrect.  An inherited congenital anomaly of the eye does not need to be found in any 
other family members.  It may be a recessive or X-linked disorder for which parents may be unaffected 
carriers of the genetic change.  However, having multiple affected family members does raise suspicion 
for a genetic eye disorder. 
Choice (b.) is incorrect.  An inherited congenital anomaly of the eye may or may not have a known 
genetic cause.  Many of the genes which cause inherited congenital eye anomalies are yet unknown.   
Choice (c.) is incorrect.  An inherited congenital anomaly of the eye may be isolated (meaning the only 
manifestation) or syndromic (associated with other symptoms often including other parts of the body) 
Choice (d.) is correct.  None of the above answers are correct about an inherited congenital 
anomaly of the eye.   
 
 
3. Approximately what percent of genetic diseases have eye abnormalities? 
a. 8% 
b. 20% 
c. 33% 
d. 50% 
 
Choice (a.) is incorrect.  More than 8% of genetic disease have eye abnormalities. 
Choice (b.) is incorrect.  More than 20% of genetic disease have eye abnormalities.   
Choice (c.) is correct.  Approximately 1/3 or 33% of all genetic disease have eye abnormalities. 
Choice (d.) is incorrect.  Less than 50% of genetic disease have eye abnormalities. 
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4. A recurring pattern of anomalies that are the result of the same genetic cause is called a/an: 
a. Syndrome 
b. Association 
c. Disruption 
d. Environmental effect 
 
Choice (a.) is correct.  A syndrome is defined as a recurring pattern of anomalies that are the 
result of the same underlying genetic cause.  CHARGE is a syndrome because it may affect the 
eye, ear, heart, and other organ systems and it has a single underlying cause. 
Choice (b.) is incorrect.  An association is the occurrence of two or more anomalies together which are 
seen more often than expected by chance alone.  Associations do not have a known underlying genetic 
cause. 
Choice (c.) is incorrect.  A disruption results from the destruction or loss of fetal tissue that would 
otherwise develop normally.  One example is of a cause of disruption is amniotic bands. 
Choice (d.) is incorrect.  An environmental effect is when a condition or disease is either caused by or 
triggered by exposure to certain risk factors in our environment.  If a disease is the result of a 
combination of genetic and environmental influences, this is called multifactorial. 
 
 
5. An eye condition that is not associated with other health problems is: 
a. Syndromic 
b. Unique 
c. Isolated 
d. Single 
 
Choice (a.) is incorrect.  A syndromic eye condition is one which IS associated with other health 
problems in the individual due to the same genetic cause. 
Choice (b.) is incorrect.  Unique is not a term used to describe an eye condition. 
Choice (c.) is correct.  An isolated eye condition means that the condition ONLY involves the 
eye and no other organ systems of the body. 
Choice (d.) is incorrect.  Single is not a term used to describe an eye condition.  Single often is used to 
describe a single-gene disorder, meaning only one gene is involved. 
 
 
6. A condition that shows a range of severity is called a/an: 
a. Spectrum 
b. Association 
c. Assortment 
d. Field defect 
 
Choice (a.) is correct.  A condition which shows a spectrum is one which results in a range of 
severity or expression in individuals either in different families or within the same family. 
Choice (b.) is incorrect.  An association is the occurrence of two or more anomalies together which are 
seen more often than expected by chance alone.  It does not speak to the severity of a condition.   
Choice (c.) is incorrect.  Assortment is the random distribution of genetic material from parents to 
children.   
Choice (d.) is incorrect.  A field defect refers to a disturbance or problem in the visual field, the full view 
seen by an eye that is fixating straight ahead. 
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7. Approximately what percent of the body’s genes are expressed in the eye? 
a. 10% 
b. 50% 
c. 90% 
d. 100% 
 
Choice (a.) is incorrect.  Greater than 10% of the body’s genes are expressed by cells in the eye.  
Choice (b.) is incorrect.  Greater than 50% of the body’s genes are expressed by cells in the eye. 
Choice (c.) is correct.  90% of the body’s genes are expressed by cells in the eye.   
Choice (d.) is incorrect.  Less than 100% of the body’s genes are expressed by cells in the eye. 
 
 
8. A gene mutation that results in a congenital eye anomaly is: 
a. Not able to be found, even with genetic testing 
b. Only in the cells of the eye 
c. Only in parts of the body where a person has health problems 
d. In every cell of the body 
 
Choice (a.) is incorrect.  A genetic test may be able to identify a gene mutation for a congenital eye 
anomaly.   
Choice (b.) is incorrect.  The genetic mutation which causes a congenital eye anomaly is typically 
present in every cell of the body, not only in the cells of the eye.     
Choice (c.) is incorrect.  The genetic mutation which causes a congenital eye anomaly is typically in 
every cell of the body, not just the affected body part. 
Choice (d.) is correct.  The genetic mutation which causes a congenital eye anomaly is present 
in every cell of the body, not just in the eye.   
 
 
9. What percent of pediatric blindness is due to a genetic cause? 
a. Less than 5% 
b. 25% 
c. 50% 
d. 80% 
 
Choice (a.) is incorrect.  More than 5% of pediatric blindness is due to a genetic cause. 
Choice (b.) is incorrect.  More than 25% of pediatric blindness is due to a genetic cause. 
Choice (c.) is correct.  Approximately half or 50% of pediatric blindness is due to a genetic 
cause. 
Choice (d.) is incorrect.  The genetic cause of pediatric blindness is less than 80%. 
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10. A person does not have an inherited eye condition if: 
a. They have a healthy eye exam as a baby 
b. Their family members do not have eye problems 
c. Their genetic testing is negative 
d. None of the above 
 
Choice (a.) is incorrect.  A healthy eye exam as an infant does not rule out an inherited eye condition.  
For example, retinitis pigmentosa is an inherited eye disease which can onset after childhood. 
Choice (b.) is incorrect.  Having a family history in which no family members have eye problems does 
not rule out an inherited condition in the patient.    
Choice (c.) is incorrect.  A negative genetic test does not rule out an inherited eye condition in the 
patient. 
Choice (d.) is correct.  None of the above statements are correct about an inherited eye 
condition. 
 
 
11. Leber’s Congenital Amaurosis (LCA) is an example of an inherited eye disease that may be caused by: 
a. One mutation in all patients 
b. One gene in all patients 
c. Many genes that differ among patients 
d. Environmental exposures 
Choice (a.) is incorrect.  There is no one mutation that is responsible for all patients' LCA. It can be 
caused by many mutations. 
Choice (b.) is incorrect.  There is no one gene that is responsible for all patients' LCA. It can be 
caused by many genes. 
Choice (c.) is correct.  LCA can be caused by many different genes and different people with 
LCA may have different mutations in different genes. 
Choice (d.) is incorrect.  Environmental exposures do not cause LCA. 
 
 
12. Retinitis Pigmentosa (RP) is a genetic eye disease that is passed down in a/an: 
a. Autosomal dominant trait 
b. Autosomal recessive trait 
c. X-linked trait 
d. All of the above 
 
Choice (a.) is incomplete.  Retinitis pigmentosa can be passed through a family as an autosomal 
dominant trait but it is not the only form of inheritance.   
Choice (b.) is incomplete.  Retinitis pigmentosa can be passed through a family as an autosomal 
recessive trait but it is not the only form of inheritance.   
Choice (c.) is incomplete.  Retinitis pigmentosa can be passed through a family as an X-linked trait but 
it is not the only form of inheritance.   
Choice (d.) is correct.  All of the above are forms of inheritance of retinitis pigmentosa (also 
includes mitochondrial) 
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13. Which of the following statements are true about retinoblastoma (RB)? 
a. All of the children of a parent with RB will be affected 
b. A child can only be affected with RB if one of their parents is affected 
c. RB can either be inherited or sporadic 
d. A parent with RB is not at risk to have an affected child 
 
Choice (a.) is incorrect.  Not all children of an affected parent will be affected.  Retinoblastoma may be 
sporadic in the parent and not something they would pass on to their child.  Also, even if it is an 
inherited form, there is only a 50% or 1 in 2 chance of passing on the responsible gene with dominant 
inheritance. 
Choice (b.) is incorrect.  A child does not need to have an affected parent in order to have 
retinoblastoma.  Some individuals have a sporadic form in which the genetic changes are present only 
in that individual. 
Choice (c.) is correct.  Retinoblastoma may be either inherited in an autosomal dominant 
fashion (germline mutations) or sporadic, meaning the only individual in the family with the 
genetic changes in the tumor cells. 
Choice (d.) is incorrect.  A parent with retinoblastoma is at risk to have an affected child if they have an 
inherited form (germline mutation).  They would have a 50% chance to pass on the responsible gene to 
any of their future children. 
 
 
14. A congenital cataract is an example of an eye condition where: 
a. All of the underlying genetic causes are known 
b. None of the genetic causes are known 
c. Some of the genetic causes are known, and some are yet to be identified 
d. It is never genetic 
 
Choice (a.) is incorrect.  Many of the genetic causes of congenital cataract are still unknown. 
Choice (b.) is incorrect.   
Choice (c.) is correct.  Some of the genetic causes of congenital cataract are known while some 
are yet unknown.   
Choice (d.) is incorrect.  There are known genetic causes for congenital cataract. 
 
 
15. Leber’s Hereditary Optic Neuropathy (LHON) is caused by: 
a. Nuclear gene mutations 
b. Mitochondrial mutations 
c. Chromosome deletions 
d. All of the above 
 
Choice (a.) is incorrect.  LHON is not caused by nuclear gene mutations. 
Choice (b.) is correct.  LHON is caused by mitochondrial DNA (mtDNA) mutations. 
Choice (c.) is incorrect.  LHON is not caused by chromosome deletions. 
Choice (d.) is incorrect.  One answer above (b.) is correct. 
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MODULE 6:  TALKING TO A PATIENT I – PATIENT EDUCATION BASICS 
 
 
1. A Genetic Educator should be: 
a. Sensitive 
b. Respectful 
c. Informative 
d. All of the above 
 
Choice (a.) is incorrect.  A Genetic Educator should be sensitive when speaking with a patient or 
family about health-related information.  However, there are additional, helpful qualities listed above.  
Choice (b.) is incorrect.  A Genetic Educator should be respectful of a patient or family when 
providing care, particularly regarding their actions, values, and beliefs.  However, there are additional, 
helpful qualities listed above. 
Choice (c.) is incorrect.  A Genetic Educator should be informative to a patient or family, providing a 
simplified explanation of genetic concepts.   However, there are additional, helpful qualities listed 
above. 
Choice (d.) is correct.  All of these qualities are useful when interacting with a patient or family. 
 
 
2. The goal of giving genetic information to a patient is: 
a. To teach them to be geneticists 
b. To show them how much you know 
c. To help them better understand their own health 
d. To cure their health problems 
 
Choice (a.) is incorrect.  It is not possible to teach a patient all of the scientific concepts and facts 
about genetics. 
Choice (b.) is incorrect.  It is not helpful to provide an excess of genetic information to a patient with 
the purpose of demonstrating your level of knowledge. 
Choice (c.) is correct.  Providing basic genetic information allows a patient to begin the process 
of understanding their health in the context of genetics. 
Choice (d.) is incorrect.  Regardless of the amount of genetic information provided to a patient, the 
information does not lead to a cure for their health problem. 
 
 
3. Finding  out  about  a  genetic  diagnosis  can  change  a  patient’s: 
a. Management and treatment 
b. Culture 
c. Genes 
d. None of the above 
 
Choice (a.) is correct.  A genetic diagnosis may guide management and lead to treatment 
options, based on the underlying condition and its natural history. 
Choice (b.) is incorrect.  Learning about a genetic diagnosis does not change the characteristics that 
one learns from their culture or nation, such as values, beliefs, attitudes, or customs. 
Choice (c.) is incorrect.  A  genetic  diagnosis  may  result  because  a  change  in  a  person’s  genetic  
information; however, learning of  the  diagnosis  does  not  cause  a  subsequent  change  in  a  person’s  
genes. 
Choice (d.) is incorrect.  One of the above answers is correct (see answer a). 
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4. Factors  that  will  affect  a  patient’s  understanding  of  genetics  include: 
a. Educational background 
b. Cultural practices 
c. Language barriers 
d. All of the above 
 
Choice (a.) is incorrect.  Educational  background  can  affect  a  patient’s  understanding  of  genetics,  
particularly if they had limited schooling or did not have significant time spent in biology courses. 
Choice (b.) is incorrect.  A  patient’s  cultural  background  and  beliefs  may  affect  the  way  they  accept  
and interpret genetic information. 
Choice (c.) is incorrect.  Given the specialized care provided by ophthalmic clinics, your patient may 
speak a different language and have difficulty understanding technical, genetic terms in a less familiar 
language. 
Choice (d.) is correct.  All  of  the  above  factors  will  affect  a  patient’s  understanding  of  genetics. 
 
 
5. When meeting with a patient, after you introduce yourself, the first thing you will do is: 
a. Give them a diagnosis 
b. Explain chromosomes 
c. Take his or her family pedigree 
d. Ask what their job is 
 
Choice (a.) is incorrect.  Providing a medical diagnosis is the responsibility of the examining 
physician.  This is not required to provide basic genetic information to a patient. 
Choice (b.) is incorrect.  Although discussing chromosomes and genetic information may be relevant 
to  a  patient’s  situation,  it  is  not  the  first  topic  that  should  be  presented  after  meeting  a  patient. 
Choice (c.) is correct.  A family pedigree is one of the first tasks of a Genetic Educator because 
it  provides  an  organized  and  detailed  overview  of  the  family’s  health. 
Choice (d.) is incorrect.  Knowing  a  patient’s  occupation  is  not  relevant  when  providing basic genetics 
information. 
 
 
6. When speaking with a patient, a Genetic Educator should: 
a. Speak in all medical/technical terms 
b. Tell the patient what to do  
c. Give the patient a diagnosis 
d. Simplify concepts so they are easy to understand 
 
Choice (a.) is incorrect.  Speaking in all medical/technical terms is the opposite of how a Genetic 
Educator should speak to a patient.  It is unlikely for a patient to fully understand scientific terms 
relevant to genetics and using this language will make communicating this information more difficult. 
Choice (b.) is incorrect.  It is not the responsibility of a Genetic Educator to tell a patient what to do.  A 
patient’s  autonomy,  or  ability  to  make  informed  decisions  on  their  own,  must  be  respected. 
Choice (c.) is incorrect.  Providing a medical diagnosis is the responsibility of the examining 
physician.  This is not a responsibility or expectation of a Genetic Educator. 
Choice (d.) is correct.  Simplifying genetic information into easy to understand terms is an 
essential task of a Genetic Educator.  Speaking slowly, clearly, and avoiding technical terms will 
allow a patient to understand genetic information relevant to their health. 
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7. Terms that should be defined to patients include: 
a. Inherited 
b. Congenital 
c. Genetic Disorder 
d. All of the above 
 
Choice (a.) is incorrect.  A  patient  may  not  understand  the  term  “inherited,”  and  it  must  be  explained  
so that they can understand potential inheritance patterns.  However, It is very likely that there are 
many technical or medical terms a patient may not understand. 
Choice (b.) is incorrect.  A  patient  may  not  understand  the  term  “congenital,”  and  it  must  be  explained  
so that they can understand the onset of particular conditions.  However, It is very likely that there are 
many technical or medical terms a patient may not understand. 
Choice (c.) is incorrect.  A  patient  may  not  understand  “genetic  disorder,”  and  it  must  be  explained  so  
that they can understand certain diagnoses provided by an examining physician.  However, It is very 
likely that there are many technical or medical terms a patient may not understand. 
Choice (d.) is correct.  All of the above terms, and likely many others, must be defined for 
patients so that they can understand the information provided. 
 
 
8. When should patients be allowed to ask questions? 
a. Never during the session 
b. At any time during the conversation 
c. Only at the beginning of the meeting 
d. Only at the end of the meeting 
 
Choice (a.) is incorrect.  It is unrealistic to expect a patient to understand all of the information 
provided, without having the need or desire to ask a question. 
Choice (b.) is correct.  In order to maximize the benefit of providing genetic information, a 
patient should be allowed and encouraged to ask questions during a session. 
Choice (c.) is incorrect.  A patient may not know what to expect from a Genetic Educator and is 
unlikely to have questions related to genetics prior to a session.  Additionally, their questions may be 
addressed at some point during the session, which does not maximize the usefulness of the time spent 
with a patient. 
Choice (d.) is incorrect.  It may be less helpful for a patient to hold their questions until the end of a 
session, because they may have limited understanding that could be addressed or forget the question 
they wanted to ask. 
 
 
9. If  the  Genetic  Educator  does  not  know  the  answer  to  a  patient’s  question,  he  or  she  should: 
a. Be honest and encourage the patient to ask their ophthalmologist 
b. Make up an answer to appear informed 
c. Not respond 
d. None of the above 
 
Choice (a.) is correct.  It is not realistic or expected for a Genetic Educator to have an answer to 
every  patient  question.    If  you  do  not  know  the  answer  to  a  patient’s  question,  it  is  best  to  say  
that you do not know, but the ophthalmologist may have a response.  
Choice (b.) is incorrect.  It  is  not  appropriate  to  make  up  an  answer  to  a  patient’s  question,  particularly  
because this misinformation may affect their understanding of genetics or family health history. 
Choice (c.) is incorrect.  It is disrespectful to ignore  a  patient’s  question  or  request. 
Choice (d.) is incorrect.  One of the above answers is correct (see choice a). 
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10. If the patient needs more help understanding a certain topic, a Genetic Educator should: 
a. Use names and diagnoses of other patients as examples 
b. Keep talking and hope that if they hear more they will understand 
c. Have the patient ask the ophthalmologist for more information 
d. Start over from the beginning 
 
Choice (a.) is incorrect.  It  is  not  appropriate  to  use  other  patient’s  names  and  diagnoses to help a 
person understand genetic information.  It is your responsibility to keep such information private. 
Choice (b.) is incorrect.  If a patient has difficulty with a particular topic, it is unlikely that further, 
detailed explanations will allow them to understand it more clearly.  Rather, this may become frustrating 
for a patient and have the opposite effect. 
Choice (c.) is correct.  Given the limited amount of information addressed during a session, it is 
best to direct further  questions  to  the  patient’s  ophthalmologist.       
Choice (d.) is incorrect.  It is not helpful to review all of the information covered during a session in 
order to help a patient understand a particular topic.  Also, given the potential time limitations in clinic, 
starting a session from the beginning will only waste time and likely not lead to better understanding. 
 
 
11.  Taking a pedigree is important because: 
a. It is a visual tool that may aid in diagnosis and inheritance pattern identification 
b. It quizzes the patient 
c. It provides all of the information necessary to make a genetic diagnosis 
d. None of the above 
 
Choice (a.) is correct.  A pedigree is a visual tool that demonstrates how individuals in a family 
are  related  and  lists  each  person’s  health  problems.    Having an overview of the family may link 
together diagnoses and demonstrate a particular inheritance pattern; however, this is not true 
of all pedigrees.  
Choice (b.) is incorrect.  The purpose of a pedigree is not to quiz the patient about their relatives and 
the family health history. 
Choice (c.) is incorrect.  It is not possible for a pedigree to provide all of the information for an 
ophthalmologist to make a genetic diagnosis.  Many genetic diagnoses are based on clinical 
examinations or blood tests, which are supplemented by the information on a pedigree. 
Choice (d.) is incorrect.  One of the above answers is correct (see choice a) 
 
 
12. Pedigrees include useful information for a: 
a. Patient 
b. Patient’s  family 
c. Ophthalmologist 
d. All of the above 
 
Choice (a.) is incorrect.  A pedigree includes important information for a patient; however, it is also 
useful to other individuals. 
Choice (b.) is incorrect.  A  pedigree  includes  important  information  for  a  patient’s  family;;  however,  it  is  
also useful to other individuals. 
Choice (c.) is incorrect.  A pedigree includes important information for an ophthalmologist; however, it 
is also useful to other individuals. 
Choice (d.) is correct.  A pedigree includes important information for many people.  A patient, 
family, and ophthalmologist can use it to understand and visualize the health problems in a 
family and potentially reveal an inheritance pattern.  
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13. After taking a pedigree, a Genetic Educator should: 
a. Put it in  the  patient’s  file  
b. Throw it away 
c. Give the only copy to the patient to take home 
d. Keep it for your reference 
 
Choice (a.) is correct.  A  completed  pedigree  should  be  put  in  the  patient’s  file  so  that  the  
ophthalmologist can refer to it and add further information during the appointment and future 
visits.   
Choice (b.) is incorrect.  It is not appropriate to collect health information without purpose.  Also, the 
pedigree  is  an  important  piece  of  understanding  a  family’s  health  history  and  it  should  be  maintained  
and stored for reference and interpretation. 
Choice (c.) is incorrect.  Although a patient may request a copy of their pedigree, the original should 
be stored in the clinic for reference and interpretation. 
Choice (d.) is incorrect.  It is appropriate to share the pedigree with the ophthalmologist, as it may 
provide  information  relevant  to  a  patient’s  diagnosis  and  care. 
 
14. When speaking with a patient, a Genetic Educator should: 
a. Talk as fast as possible to get to the next patient 
b. Talk clearly so the patient can understand 
c. Skip over information that you do not think is important 
d. Talk about yourself 
 
Choice (a.) is incorrect.  It is not respectful to speak with patients as fast as possible.  This is unlikely 
to lead to good understanding of genetic information. 
Choice (b.) is correct.  It is helpful to speak clearly when providing genetic information to 
minimize  a  patient’s  misunderstanding. 
Choice (c.) is incorrect.  It is not the responsibility of a Genetic Educator to determine what 
information is relevant to a patient or their diagnosis. 
Choice (d.) is incorrect.  It is not appropriate for a Genetic Educator to provide personal information 
about themselves to a patient. 
 
 
15. An effective communicator: 
a. Actively listens 
b. Speaks in a way that aids the understanding of other people 
c. Is confident about the information they are presenting 
d. All of the above  
Choice (a.) is incorrect.  Active listening – the process of listening, responding, and understanding a 
person who is speaking – is an important skill.  However, there are additional traits that lead to effective 
communication. 
Choice (b.) is incorrect.  Speaking in a way that leads to improved patient’s understanding is an 
important skill.  However, there are additional traits that lead to effective communication. 
Choice (c.) is incorrect.  It is important to understand and have confidence in the information that is 
presented.  However, there are additional traits that lead to effective communication.  
Choice (d.) is correct.  All of the above skills are important for effective communication. 
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MODULE 7:  TALKING TO A PATIENT II – TAKING A FAMILY PEDIGREE 
 
 
 
1. A useful family history should include ____ generations of information: 
a. 1 
b. 2 
c. 3 
d. Does not matter 
 
Choice (a.) is incorrect.  Including only one generation in a family history is not useful because it only 
documents the health information of a patient and their brothers and sisters.  This limited history would 
not allow accurate identification of potential inheritance patterns. 
Choice (b.) is incorrect.  Including only two generations (children and parents/aunts/uncles/cousins) in 
a family history may lack important information, especially for X-linked conditions where more distant 
generations may display related health problems.  Having information about further generations can be 
very important in interpreting a family history. 
Choice (c.) is correct.  Including three generations in a family history is most useful because it 
will help allow for interpretation of inheritance patterns.  Demonstrating the health status of 
grandchildren through grandparents will provide the ophthalmologist with the most complete 
history from which to determine inheritance patterns. 
Choice (d.) is incorrect.  It is important to include 3 generations as part of a family history in order to 
make it most useful to the ophthalmologist. 
 
 
 
 
2. When taking a family pedigree, an arrow is drawn to the symbol representing: 
a. The oldest individual in the family 
b. The youngest individual in the family 
c. All individuals affected with a disorder 
d. The current patient 
 
Choice (a.) is incorrect.  The oldest individual in the family may not be relevant to the reasons a family 
history is recorded, regardless of their health. 
Choice (b.) is incorrect.  The youngest individual in the family may not be relevant to the reasons a 
family history is recorded, regardless of their health. 
Choice (c.) is incorrect.  All individuals affected with a specific disorder are identified by shading, or 
filling in, their respective symbols with a pattern.  An arrow is not used for this reason. 
Choice (d.) is correct.  An arrow in a pedigree is drawn to indicate the current patient, also 
known as the proband. 
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3. Useful information to include for each person on a family pedigree is: 
a. Age 
b. Any vision problems 
c. Any diagnoses of eye disorders 
d. All of the above 
 
Choice (a.) is incorrect.  Although documenting age is important information on a family pedigree, 
especially when recording an age at diagnosis or death, it is not the only information to be documented. 
Choice (b.) is incorrect.  In the ophthalmology clinic, it is important to document the vision problems of 
family members; however, there is additional health information that should be documented. 
Choice (c.) is incorrect.  In the ophthalmology clinic, it is important to document diagnosed eye 
conditions; however, there is additional health information that should be documented. 
Choice (d.) is correct.  When obtaining a family pedigree, it is important to document age of the 
individual as well as age of diagnosis or death, any vision problems, and any diagnoses of eye 
disorders for each person in the family.   
 
 
 
4. On a pedigree, a line represents a: 
a. Person 
b. Pregnancy 
c. Familial relationship 
d. None of the above 
 
Choice (a.) is incorrect.  A person or individual in a pedigree is represented by a symbol.  Specifically, 
squares indicate males, circles indicate females, and diamonds indicate individuals where the gender is 
unknown (for example: distant relatives, etc.). 
Choice (b.) is incorrect.  A  pregnancy  is  indicated  by  a  symbol  with  the  letter  “P”  written  inside.    If  the  
gender of the pregnancy is known, the symbol can reflect this (squares for males, circles for females).  
If the gender of the pregnancy is not yet known, a diamond should be used. 
Choice (c.) is correct.  All relationships within a pedigree are represented by a line.  Marriages 
or couples are indicated by a horizontal line, and children are connected to a couple using a 
vertical line.  If there are multiple children, the vertical line is branched to show that they are all 
related through the same parents. 
Choice (d.) is incorrect.  One of the above answers is correct (see choice c). 
 
 
 
5. On a pedigree, a male is represented by a: 
a. Circle 
b. Square 
c. Triangle 
d. Diamond 
 
Choice (a.) is incorrect.  A female is represented by a circle 
Choice (b.) is correct.  A male is represented by a square. 
Choice (c.) is incorrect.  A miscarriage is represented by a triangle. 
Choice (d.) is incorrect.  Individuals of unknown gender are represented by a diamond. 
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6. On a pedigree, a female is represented by a: 
a. Circle 
b. Square 
c. Triangle 
d. Diamond 
 
Choice (a.) is correct.  A female is represented by a circle. 
Choice (b.) is incorrect.  A male is represented by a square. 
Choice (c.) is incorrect.  A miscarriage is represented by a triangle. 
Choice (d.) is incorrect.  Individuals of unknown gender are represented by a diamond. 
 
 
 
 
7. On a pedigree, a miscarriage is represented by a: 
a. Circle 
b. Square 
c. Triangle 
d. Diamond 
 
Choice (a.) is incorrect.  A male is represented by a square. 
Choice (b.) is incorrect.  A female is represented by a circle. 
Choice (c.) is correct.  A miscarriage is represented by a triangle. 
Choice (d.) is incorrect.  Individuals of unknown gender are represented by a diamond. 
 
 
 
 
8. When two parents are related by blood, their relationship is depicted by: 
a. A single horizontal line 
b. A double horizontal line 
c. A vertical line 
d. A diagonal line 
 
Choice (a.) is incorrect.  A single horizontal line represents a relationship where the two individuals 
(parents) are not related by blood. 
Choice (b.) is correct.  A double horizontal line represents a relationship where the two 
individuals (parents) are related by blood. 
Choice (c.) is incorrect.  A vertical line represents the familial relationship between parents and 
children. 
Choice (d.) is incorrect.  A diagonal line through a symbol indicates that the individual is deceased.  
Diagonal lines from a common point represent individuals who are twins. 
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9. Which symbol is used for a female carrier (unaffected, heterozygous) of an autosomal recessive or X-
linked disorder? 
 
 
 
 
 
 
 
 
 
 
 
Choice (a.) is correct.  A female is represented by a circle and an unaffected carrier is identified 
by a dot within the symbol.   
Choice (b.) is incorrect.  A female is represented by a circle.  However, there is no indication that this 
female is an unaffected carrier of a genetic condition.  Carriers are identified on a pedigree by a dot 
within a symbol. 
Choice (c.) is incorrect.  A male is represented by a square.  This symbol is shaded, indicating that 
this male is affected with a condition or genetic disorder. 
Choice (d.) is incorrect.  A female is represented by a circle.  This symbol is shaded, indicating that 
this female is affected with a condition or genetic disorder. 
 
 
 
 
 
Use the following pedigree to answer questions 10 and 11. 
 
 
 
 
 
 
 
 
 
 
10. In the above pedigree, which individual is the proband? 
a. I-1 
b. I-2 
c. II-1 
d. II-3 
 
Choice (a.) is incorrect.  I-1  is  the  proband’s  father.  The proband is indicated by the arrow. 
Choice (b.) is incorrect.  I-2  is  the  proband’s  mother.  The proband is indicated by the arrow. 
Choice (c.) is correct.  II-1 is the proband, indicated by the arrow. 
Choice (d.) is incorrect.  II-3  is  the  proband’s  sister.  The proband is indicated by the arrow. 
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11.  In the above pedigree, what is the relationship between II-2 and II-3? 
a. Husband and wife 
b. Siblings 
c. Half siblings 
d. Father and daughter 
 
Choice (a.) is incorrect.  A husband and wife relationship is depicted using a single horizontal line.  In 
this pedigree, individuals I-1 and I-2 are husband and wife. 
Choice (b.) is correct.  Individuals II-2 and II-3 are siblings (brother and sister).  This is depicted 
using branching vertical lines from the parents (I-1 and I-2).  
Choice (c.) is incorrect.  Half-siblings are not directly connected with horizontal or vertical lines.  Half-
siblings would be connected through their common parent on separate vertical lines from each other.  
There are no half-siblings shown in this pedigree. 
Choice (d.) is incorrect.  A father and daughter relationship is depicted using a vertical line (if an only 
child) or a branched vertical line (if there are multiple children).  In this pedigree, individual I-1 is the 
father and individuals II-1 and II-3 are his daughters. 
 
 
 
Use the following pedigree to answer questions 12-15. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
12. In the above pedigree, which individual is deceased? 
a. I-1 
b. I-2 
c. III-1 
d. III-3 
 
Choice (a.) is incorrect.  Individual I-1 is living.  On a pedigree, a diagonal line through a symbol 
indicates that the individual is deceased. 
Choice (b.) is correct.  Individual I-2 is deceased.  On a pedigree, a diagonal line through a 
symbol indicates that the individual is deceased. 
Choice (c.) is incorrect.  III-1 is living and affected with a condition or genetic disorder, indicated by 
shading.  On a pedigree, a diagonal line through a symbol indicates that the individual is deceased. 
Choice (d.) is incorrect.  III-3  is  a  current  pregnancy  (indicated  by  “P”)  where  the  gender  is  not  yet  
known.  On a pedigree, a diagonal line through a symbol indicates that the individual is deceased. 
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13. In the above pedigree, how many current children does the patient (II-2) have? 
a. 0 
b. 1 
c. 2 
d. 3 
 
Choice (a.) is incorrect.  The patient (II-2) has children.  This relationship is represented by the 
descending and branched vertical line.  An individual without children will not be connected to other 
symbols with a descending vertical line. 
Choice (b.) is incorrect.  The patient (II-2) has children.  This relationship is represented by the 
descending  and  branched  vertical  line.    An  individual  with  one  child  will  be  connected  to  the  child’s  
symbol by a single vertical line. 
Choice (c.) is correct.  The patient (II-2) has two current children and one pregnancy.  This 
relationship is represented by the descending and branched vertical line.   
Choice (d.) is incorrect.  The patient (II-2) does not have three children.  Rather, the patient has two 
current  children  and  one  pregnancy  (represented  by  the  diamond  with  the  letter  “P”).     
 
 
14. In the above pedigree, what is the relationship between I-1 and III-2? 
a. Grandfather and grandson 
b. Grandmother and granddaughter 
c. Uncle and niece 
d. Uncle and nephew 
 
Choice (a.) is correct.  Individuals I-1 and III-2 are related as a grandfather and grandson.  This is 
most easily recognized by their generation numbers (I and III), and that they are separated by a 
full generation (generation II).  Also, both individuals are male, as indicated by squares. 
Choice (b.) is incorrect.  Individuals I-1 and III-2 are not related as a grandmother and granddaughter.  
Although the generational separation is correct, I-1 and III-2 are males, as indicated by squares. 
Choice (c.) is incorrect.  Individuals I-1 and III-2 are not related as an uncle and niece.  An uncle and 
niece would be separated by a single generation (not demonstrated in this pedigree) and both I-1 and 
III-2 are males, where a niece would be female and represented by a circle. 
Choice (d.) is incorrect.  Individuals I-1 and III-2 are not related as an uncle and nephew.  An uncle 
and nephew would be separated by a single generation (not demonstrated in this pedigree). 
 
 
15. In the above pedigree, what is III-3? 
a. A son of II-2 
b. A daughter of II-2 
c. An unborn child (pregnancy) of II-2 
d. None of the above  
Choice (a.) is incorrect.  Because III-3 is demonstrating a diamond with a P in the center, we know that 
this is an unborn child.  Sons are represented by a square from a decending vertical line.  The son of II-
2 is III-2; he is unaffected because he is not shaded.   
Choice (b.) is incorrect.  Because III-3 is demonstrating a diamond with a P in the center, we know that 
this is an unborn child.  Daughters are represented by a circle from a descending vertical line.  The 
daughter of II-2 is III-1; she is affected because she is shaded. 
Choice (c.) is correct.  The symbol, a diamond with the letter P in the center represents the 
unborn child (pregnancy) of II-2, the mother.   
Choice (d.) is incorrect.  One answer above is correct (see answer c). 
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APPENDIX F 
QUESTIONNAIRES 
F.1 DEMOGRAPHIC QUESTIONNAIRE 
1. Education:  ______________________ 
2. Title in workplace:  _____________________________ 
3. Number of years employed at current workplace:  ______________________ 
4. Average total number of patients seen per day at clinic:  ___________ 
5. Average number of patients you see per day:  __________ 
6. How would you rank your knowledge of genetics? 
a. No Knowledge 
b. Very Poor 
c. Poor 
d. Satisfactory 
e. Good 
f. Very Good 
7. Have you received any formal genetics education? 
a. Yes If yes, please describe: __________________________________ 
b. No 
8. Do you know of a genetics clinic in your institution? 
a. Yes 
b. No 
9. In general, how comfortable do you feel with dealing with genetics issues with your 
patients? 
a. Very Comfortable 
b. Comfortable 
c. Neither comfortable nor uncomfortable 
d. Uncomfortable 
e. Very Uncomfortable 
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10. How often do you complete a family history for a new patient? 
a. Never 
b. Sometimes 
c. Often 
d. Always 
11. In your practice, how often do you discuss genetics with a patient? 
a. Never 
b. Only if the patient has a genetic condition 
c. Occasionally, but only if there seems to be good reason for it 
d. Often, whenever it seems appropriate 
e. Mostly, it is my usual practice 
f. Almost always, with almost all patients when taking a medical history 
F.2 FOLLOW-UP QUESTIONNAIRES 
The following questionnaire was administered at 3 time points: post-course, post-workshop, and 
post-implementation (final). 
 
1. Average total number of patients seen per day at clinic:  ___________ 
2. Average number of patients you see per day:  __________ 
3. How would you rank your knowledge of genetics? 
a. No Knowledge 
b. Very Poor 
c. Poor 
d. Satisfactory 
e. Good 
f. Very Good 
4. Now, in general, how comfortable do you feel with dealing with genetics issues with 
your patients? 
a. Very Comfortable 
b. Comfortable 
c. Neither comfortable nor uncomfortable 
d. Uncomfortable 
e. Very Uncomfortable 
5. How often do you complete a family history for a new patient? 
a. Never 
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b. Sometimes 
c. Often 
d. Always 
6. In your practice, how often do you discuss genetics with a patient? 
a. Never 
b. Only if the patient has a genetic condition 
c. Occasionally, but only if there seems to be good reason for it 
d. Often, whenever it seems appropriate 
e. Mostly, it is my usual practice 
f. Almost always, with almost all patients when taking a medical history 
 
Directions:  Please choose the number that best represents your attitude toward the 
corresponding statement. 1 = Strongly Disagree; 2 = Moderately Disagree;  
3 = Neutral/Don’t Know; 4 = Moderately Agree; 5 = Strongly Agree 
 
 
Example 1:  I live in the country of India. 
Strongly disagree  1 2 3 4 5 Strongly agree 
 
Example 2:  I like American football. 
Strongly disagree  1 2 3 4 5 Strongly agree 
 
 
1. This training program advanced my professional development. 
 Strongly disagree  1 2 3 4 5 Strongly agree 
 
2. This training program increased my knowledge and understanding of genetics. 
 Strongly disagree  1 2 3 4 5 Strongly agree 
 
3. This training program helped me to communicate basic inheritance patterns to 
patients. 
 Strongly disagree  1 2 3 4 5 Strongly agree 
 
4. I feel confident in my ability to provide basic genetic education to patients. 
 Strongly disagree  1 2 3 4 5 Strongly agree 
 
5. Providing patients with basic genetic education fits into the workflow of our clinic. 
 Strongly disagree  1 2 3 4 5 Strongly agree 
 
6. Basic genetic education benefits the patients to whom I provide it. 
 Strongly disagree  1 2 3 4 5 Strongly agree 
 
7. It is important for me to stay current on fundamental information on inherited genetic 
diseases of the eye. 
 Strongly disagree  1 2 3 4 5 Strongly agree 
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CERTIFICATE OF COMPLETION 
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APPENDIX H 
DR SHROFF CHARITY EYE HOSPITAL PEDIGREE FORM 
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